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SUMMARY
Treatment of bovine milk fat globules with pronase resulted in 
the release of a soluble sialoglycopeptide fraction which was 
chromatographed on Sephadex G-50 as a single peak. Fractionation 
of this fraction by ion-exchange chromatography allowed the separation 
of two sialoglycopeptides} the sialic acid-poor (SP) and the sialic- 
acid-rich (SR) glycopeptides. Both fractions were found to be 
homogeneous by SDS-PAGE cind by gel filtration on Sephadex G-75. 
Antisera were raised against both fractions and their contribution 
to the antigenicity of the bovine milk fat globule membrane (MFGM) 
was briefly studied. The carbohydrate composition of both glycopeptide 
fractions was determined by gas liquid chromatography. Preliminary 
amino acid analysis showed that the major amino acids in the SR 
fraction were serine and threonine whereas the dominant amino acid 
in the SP fraction was found to be asparagine.
The accessibility of specific carbohydrate residues on the 
surfaces of intact and neuraminidase treated bovine and human milk 
fat globules was compared by means of lectin-based agglutination 
assay and by the use of the Fluorescence-Activated Cell Sorter.
The presence of galactose, mannose and/or glucose and N-acetyl- 
glucosamine, but not fucose was detectable on both bovine and 
human globules. The major differences between bovine and human 
milk fat globules were the presence on human globules of high 
amounts of Arachis hypogaea receptor (Thomsen-Freideriech antigen), 
none of which was apparently masked by sialic acid and the presence 
of unsubstituted N-acetylgalactosamine on bovine but not on human 
milk fat globules.
Ill
Pooled bovine, but not human, milk fat globules were found to 
be agglutinated by relatively high dilutions of the K99 adhesin 
(antigen) isolated from E>.coli B41. Parallel studies of K99- 
induced agglutination of bovine globules and sheep erythrocytes 
were carried out by using bovine MFGM-derived sialoglycopeptides 
and a range of monosaccharides as specific inhibitors. The results 
suggest that N-acetylgalactosamine-containing carbohydrate complexes 
are the most likely candidates for the K99 receptor on the surfaces 
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The development of ideas on membrane structure
Early ideas about the composition and structure of biological mem­
branes were based upon what could be gleaned from histological examination 
under the light microscope and what could be deduced from their functions. 
More accurate knowledge of their make-up depended upon the development 
of suitable methods of isolation coupled with the discovery of more 
specific histochemical techniques. In fact the cell membranes were 
not actually seen until the introduction of the electron microscope, 
which revealed not only the plasma membrane bounding the cell but 
also many membranes within it. The development of ideas on the 
structure of biological membrernes has been dealt with in a number of 
reviews (Robertson, 1964; Singer, 1971, 1977; Nicolson, 1976; Harrison 
and Lunt, 1980). In this section the historically-most important 
models of biological membranes will be briefly discussed.
I• The Danielli-Davson-Robertson Model
In 1925 Gorter and Grendel, from their studies cm acetone 
extracts of erythrocyte membranes from a variety of species, con­
cluded that the area occupied by the membrane lipids in the Langmuir 
trough was approximately double that of the surface area of the intact 
erythroczytes. They pointed out that this is consistent with the 
presence in the erythrocyte membrane of a lipid bilayer in which 
the hydrocarbon chains all occupy the centre of the bilayer and the 
polar head groups face outward as shown in Fig. 1. The work of 
Gorter and Grendel was later criticised by Winkler and Bungenberg 
(1941) and by Hoffman (1962), who suggested that the erythrocyte 
lipids not only were incomplétely extracted but that the erythrocyte 
surface area was underestimated. Davson (1962) pointed out that 
the errors in Gorter and Grendels' work fortuitously cancelled each
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Fig. 1. After Gorter and Grendel (1925)
other out to give a working model system. It is now well known that 
sufficient lipid is indeed available to cover the erythrocyte surface 
completely as a bilayer, but only if that bilayer is highly expanded.
The presence of proteins (Fig. 2) in biological membranes was 
first proposed by Danielli and Davson (1935) in order to explain 
what seemed to be anomalously low surface tensions of biological 
membranes conpared with those of model lipid systems. This model 
formed the basis of membrane structure for over thirty years although 
it was subsequently modified by Danielli (1958) to include protein- 
lined pores which penetrated the lipid bilayer and so allowed to the 
possibility of transmembrane permeability (Fig. 3).
The fact that electron micrographs of membranes from a variety 
of sources exhibited a characteristic trilayer appearance led 
Robertson (1964) to propose the concept of a universal 'unit membrane'
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Fig. 2. After Danielli and Davson (1935).
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Fig. 3. After Danielli (1958)
based on the Danielli-Davson model. Because of the findings in the 
early 1960s that the plasma membrane was an asymmetric structure, 
Robertson (1964) modified the model of Danielli and Davson by intro­
ducing an asymmetric distribution of protein molecules about the 
lipid bilayer. (Fig. 4). Although this model was supported by 
the electron microscopic appearcince of biological membranes, particularly 
myelin, it has since been realised to be inadequate in a number of 
respects. Thus,
(i) It bases a general model for membrane structure on the
electron microscopic observation of myelin. This led Korn 
(1966) to emphasise that myelin is not typical of membranes 
as a whole, particularly with respect to its lipid content 
which is 80% of the dry weight of the membrane compared 
with about 50% for most membranes.
(ii) The trilaminar patterns of 'typical membrane electron
micrographs' require the use of tissue fixing reagents, 
whose mode of action is not clearly understood and indeed 
electron micrographs remarkably similar to those of 
natural membranes have been obtained from artificial 
lipid bilayers containing no protein (Palmier and Hall,
1972).
(iii) The model is inherently inflexible in explaining the 
obvious variations in composition and function of 
membranes from various sources.
(ivj Optical activity data indicate that membrane proteins 
are globular proteins containing 25 - 40% a-helical 
structure (Urry et al., 1970; Urry, 1972; Zahler et al., 1972) 
and not ^-sheets as required by the dimensional restrictions
of the Danielli-Davson-Robertson model (Vandenheuvel, 1965).
^ (v) The Danielli-Davson-Robertson model predicts that ionic
head groups of phospholipids would be shielded from contact 
with the aqueous phase by the polar groups of the protein 
monolayers. This burying of polar groups in a non-polar 
environment is energetically unfavourable,
Futther discussion of these points can be found in Singer (1971) and 
Harrison and Lunt (1980).
II. Subunit Models
As the methods of tissue sectioning and electron microscopy improved, 
the discontinuities in the tramline appearance of sectioned membrane 
became more apparent. A speculative suggestion at the time by Lucy 
(1964) was that phospholipid could also exist in a micellar form, 
either entirely or in equilibrium with the bilayer, thus explaining 
the discontinuous patterns observed.
Evidence from mitochondrial membrane preparations indicated that 
the membrane might be constructed from repeating globular units, 
which led Sjostrand (1968) to suggest a subunit arrangement of 
structural membrane canponents based on the suggestion of Lucy, but. 
with protein filling the space between the lipid micelles (Fig. 5). A 
similar model of Green et al. (1967) proposed that membranes are made 
of repeating cuboidal units which interact to form a membranous sheet. 
This model was again based on mitochondrial membranes although it was 
vigorously promoted as a general structure in membranes.
The subunit models based on electron microscopic phenomena and 
biochemical studies of mitochondrial inner membranes, were criticised
V W V V V X A A A A /
A / W W V \ A A A A





Fig. 5. After Sjostrand (1968)
mainly because of:
(i) Mitochondrial membranes are exceptional in having a high 
content of protein (80%) and a strong requirement for 
structured organization.
(ii) X-Ray diffraction studies on the membrane did not show
any indication of globular substructures (Thompson et al., 
1968) which were accordingly suggested to be artefacts.
III. Mosaic Models
Evidence that both proteins and lipids were exposed on the surface 
of cell membranes led Wallach and Zahler (1966) and Lenard and Singer 
(1966) to propose a model involving a mosaic arrangement of the 
two components in the membrane. As shown in Fig. 6, this model involves 
globular proteins embedded in, and occasionally crossing, a lipid 
bilayer core. In such a structure the polar groups oflipid and protein 
cure in direct contact with the aqueous surroundings, while the non­
polar residues of both molecular species are sequestered in the heart 
of the structure, away from water. This model satisfies the physico­
chemical data and offers a thermodynamically sound alternative to 
the earlier models as well as allowing a potential route through the 
lipid bilayer barrier by way of the transmembrane protein. In contrast 
to the Danielli-Davson-Robertson model, which requires that the 
protein on the surface be predominantly in the 3-conformation, the 
mosaic model proposes that membrane protein exists as globular protein 
which commonly contains proteins of a-helix and random coil conform­
ation in accord with optical evidence. Some of these globular proteins 
are seen as penetrating the lipid bilayer whereas others are arranged 
on the surface bounding the lipid core. The idea of two classes of
membrane proteins agrees with experimental findings that some proteins 
l^integral (Singer, 1971) or intrinsic (Vanderkooi, 1972) proteins J 
can only be extracted by agents causing extensive disruption of 
the membrane. A second class of proteins known as peripheral (Singer,
1971) or extrinsic (Vanderkooi, 1972) proteins are characterised by 
being dissociated from membranes by mild treatments such as increased 
ionic strength or chelating agents. In contrast to integral proteins, 
they can be obtained in soluble form in simple aqueous solutions.
Enzymic modification of the lipid components of erythrocyte membranes 
has indicated that the lipid bilayer is, indeed, interrupted by non­
lipid components to the extent of 30% (Finean et al., 1971; Coleman 
et al., 1970). Evidence that some proteins actually cross the lipid 
bilayer was provided by Bretscher(1971) who used the membrane-imper­
meable reagent ^^^sJ-FMMP (formyl methionyl sulphone methyl phosphate) 
to label membrane proteins in both intact erythrocytes and erythrocyte 
ghosts. Certain proteins were found to be doubly-labelled following 
extraction from ghosts but not from intact membrane. These findings 
led Bretscher to conclude that two major proteins, of molecular 
weights 105,000 and 90,000 respectively, span the membrane. These 
conclusions are generally accepted, although it could be argued that 
labelling of certain polypeptides only in ghosts arises from reorganisation 
of such proteins during the preparation of the ghosts rather than from 
their location on the inside of the membrane. Evidence was also 
provided from SDS-electrophoretic patterns of the major erythrocyte 
protein (band 3 polypeptide) (Jenkins and Tanner, 1975; Robert et al., 
1977). More obvious demonstrations of the existence of proteins 
embedded in the membrane comes frcm freeze-etching or freeze-fracture 
electron microscopy. In this procedure, a fresh membrane specimen is
rapidly frozen under vacuum and fractured with a microtone knife.
Frozen water is then sublimed (freeze-etched) from the exposed surface, 
which is metal shadowed and replicated. Electron microscopy of the 
surface replica reveals the topography of the interior hydrophobic 
exposed face. Such studies on, for example, the erythrocyte membrane 
(Pinto da Silva and Branton, 1970; Pinto da Silva and Nicolson,
1974), the chloroplast lamellae (Branton and Pcirk, 1967), cind the 
retinêüL rod outer segment (Clark eind Branton, 1968) provide visual 
evidence of protein molecules apparently crossing the mid-plane of 
the lipid bilayer of the membrane.
As specific membrane proteins have become better characterised, 
it has become possible to demonstrate that some integral proteins 
possess hydrophobic amino acid sequences which apparently correspond 
to those sections of the polypeptide that cross the lipid bilayer.
Thus, amino acid sequences of this type have been demonstrated, in 
glycophorin A of human erythrocyte manbrane (Marchesi et al., 1972) 
and in cytochrome b^ (Ozols, 1972). The lipoprotein of E. coli 
outer membrane is particularly interesting in that its hydrophobic 
amino acids are so arranged that in an a-helical form, the peptide has 
a hydrophobic and hydrophilic face. Aggregation of several such 
helices could provide a hydrophilic ion-transporting channel encased 
in a hydrophobic exterior in contact with the lipid bilayer. A model 
of this type shown in Fig. 7 demonstrates the self-association of 
integral membrane glycoprotein molecules to frcm hydrophilic trans­
mem krane channels (Hughes, 1975). In this case, the pore diameter 
generated by self-assembly of six a-helical subunits (1 nm) would 
probably be sufficient for the transport of small hydrated ions.
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Integral proteins
Fig. 6. After Lenard and Singer (1966)








Fig. 7. Hypothesis for generation of water filled channels by self 
assembly of glycoprotein subunits, (a) the assembly of six 
helical peptide segments projects a hydrophilic face to the 
inside of the pore, (b) side view of the assembly showing 
the polypeptide spanning the lipid bilayer of the membrane 
and the carbohydrate chains of the glycoprotein subunits 
extending to the external space (after Hughes, 1975 ).
il
nutrients or even larger extended molecules and could, of course, 
be considerably greater than this if higher aggregates are formed.
Aggregation of membrane proteins implies lateral motion within 
the plane of the membrane and indeed the mosaic model was amplified 
by Singer and Nicolson (1972) when they stressed the dynamic aspects 
of membrane structure in describing the fluid mosaic model (Fig; 8). 
The fluid mosaic model sees the membrane as a solution of proteins 
in a two-dimensional viscous solvent system of phospholipids,the 
bulk of which is organised as a discontinuous fluid bilayer. By 
introducing the fluidity into the mosaic model some of the previously 
unexplained membrane phencanena could be clarified. For example, 
deviations from the electron mierosopic tramline appearance of 
sectioned membrane preparations, in regions of membrane specialisation 
such as tight and gap junctions (McNutt and Weintein, 1973) can be 
explained in terms of local reorganisation of intercalating membrane 
components. The fluid mosaic model is essentially a dynamic one 
and considerable emphasis is placed on the diffusion of proteins 
within the lipid matrix, which is assumed to be predominantly in a 
bilayer form. The studies of Chapman et al. (1967), using nuclear 
magnetic resonance (n.m.r.) indicated that the molecular motion of 
individual carbon atoms along the fatty acyl chains of phospholipids 
increases towards the interior of the membrane giving the whole 
a viscosity resembling that of a light oil. Sharp signals obtained 
from choline, sialic acids and neutral sugars indicated that these 
groups are relatively unconstrained on the exterior of the membrane. 
Electron-spin resonance (e.s.r.) studies of Komberg and McConnell 
(1971) and Scandella et aj,. (1972) indicated that phospholipid 
molecules move rapidly in the plane of the membrane. Integral membrane
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proteins have also been shown not only to rotate about cm axis
perpendicular to the plane of the membrane (Brown , 1972; Cone, 1972)
but also to diffuse laterally within the plane of the membrane. This
was first demonstrated by Frye and Edidin (1970) who reported the
random mixing of fluorescently-labelled cell surface and antigens
following the virally-induced formation of mouse-human heterokaryons.
Labelled antibodies were also used in similar experiments on muscle
fibre surface antigens (Edidin and Fambrough, 1973). By following the
redistribution of rhodopsin molecules after bleaching of part of the
retinal rod membrane, Poo and Cone (1974) established a lateral
-9 2diffusion coefficient for rhodopsin of 3.5 x lO cm /S. E.s.r., n.m.r.
and more recently, fluorescence techniques have all been applied to
measure the lateral diffusion coefficients (D) of lipid probes, and
—8 2similar values of D (of the order of lO cm /s) have been found 
both in a range of cell membranes and, above the phase transition, 
in model phospholipid bilayer systems (Devaux and McConnell, 1972;
Brown, 1972; Cone, 1972; Poo and Cone, 1974; Koppel et al. 1976).
Tayler ^t al.(1971) studied the effects produced on lymphocytes by 
the addition of divalent antibodies directed to their surface immuno­
globulin molecules. The antibodies induce a redistribution and 
pinocytosis of these surface immunoglobulins, so that within about 
30 minutes at 37°C the surface immunoglobulins are completely 
swept out of the membrane. The ch^ages in the distribution of the 
surface immunoglobulins (receptors) involve firstly the formation 
(metabolism-independent) of clusters and patches of receptors and 
secondly the emergence (metabolism-dependent) of a 'cap' of aggregated 
receptors over one pole of the cell (Fig. 9). Clustering of the intra- 





Fig. 8. After Singer and Nicolson (1972).
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Fig. 9. Stages resulting from the interaction of a polyvalent
ligand with surface receptors on a lymphoid Cell (After 
Nicolson, 1976).
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of mouse plasmacytoma cells by concanavalin A agglutinin (Benedetti 
et al., 1973). It has been reported that polymeric antigens can 'cap' 
lymphocyte receptors in the same way (Diener and Paetkau, 1972; Raff 
et al., 1973; De Luca, 1975). This aggregation of surface receptors 
in the plane of the membrane can clearly only occur if the receptors 
are free to diffuse in the membrane. The phencxnenon of 'capping' 
suggests moreover that movement of integral membrane proteins can 
be a concerted process subjected to overall direction. In this 
context the finding of Nicolson and Painter (1973) that the binding of 
specific antibodies to spectrin on the cytoplasmic side of the ery­
throcyte ghost membrane causes a redistribution of sialyl groups 
(of glycoproteins) on the outer side of the membrane is of significance. 
This suggests that extrinsic proteins may control the distribution 
and mobility of intrinsic transmembrane components which have their 
prime activity at the external face of the membrane structure. It is 
possible that extrinsic proteins can also act to restrict the motion 
of intrinsic proteins and indeed the red cell has been noted as 
unusual in that, unlike many other mammalian cells, antigen-antibody 
complexes on its surface often fail to clump in the plane of the 
membrane. The interaction of the intrinsic transmembrane antigen 
with spectrin on the cytoplasmic face of the membrane could explain 
this. Although spectrin is unique to the erythrocyte membrane most 
mammalian cells have an analogous cytoplasmic protein network 
composed of microfilaments eind microtubules. On the basis of the 
above and other data Edelman and Yahara (1973, 1974, 1975a, b) proposed 
a model to account for receptor diffusion in the plane of the membrane 
involving transmembrane control by microtubule - microfilament 
systems (Fig. 10). In this model, the function of microfilaments
15
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Fig. 10. Transmembrane control by membrane-associated cytoskeletal 
elements as proposed by Edelman (197 4). Receptors are 
assumed to interact with colchicine binding proteins (CBP) 
in an equlibrium consisting of two states, anchored (A) and 
free (F). As indicated in (1), receptors may interact 
directly or indirectly via the membrane-intercalated particles 
Alternatively, as shown in (2), only certain glycoprotein 
receptors may interact with the CBP and the CBP may interact 
with membrane associated microfilament assemblagens.
is envisaged as being mainly contractile, serving to direct the 
movement of receptors within the plane of the membrane, whereas that 
of microtubules is skeletal, maintaining a network of membrane 
'anchorage' points which may restrict or release surface receptor 
depending on both extra- and intracellular stimuli. The details of 
this cytoskeletal control system are far from clear but currently a
16
great deal of research is being devoted towards clarification of 
its role in controlling a range of cellular functions including cell 
adhesion, motility and response to extracellular agents generally.
It is likely that significant advances in biochemical understanding 




Glycoproteins make up a large and heterogeneous group of 
macromolecules and serve a variety of different functions. They 
occur as soluble secreted molecules such as plasma glycoproteins, 
protein hormone^, immunoglobulins, mucins, blood group substances, 
acid mucopolysaccharides (glycosaminoglycans) and also in collagens 
and basement membranes. Current interest in membrane structure has 
drawn the attention of many researchers to the fact that glycoproteins 
also occur in an insoluble form as components of cell membranes.
The fluid mosaic model of membrane structure {Singer and Nicolson,
1972) emphasized the occurrence of integral proteins, the structure 
of seme of which have recently been studied, and shown to include 
carbohydrate. Some membrane glycoproteins have been isolated by 
extraction of the membrane with dissociating reagents (Juliano, 1978) 
while the presence of others has been detected by more indirect
f
methods such as the use of JLeptihs (Lotan and Nicolson, 1979), cell 
electrophoresis (Pertlow and Pertlow, 1979) and cytochemical 
reagents (Juliano, 1978).
Cytochemical techniques such as those involving the periodic 
acid-Schiff (PAS) reagent (Leblond, 1950) have shown carbohydrate to 
be a characteristic feature of all cell surfaces except in the 
region of junction conç>lexes (Hambourg élb al. , 1966) . The PAS stain 
for carbohydrate depends on periddate oxidation of carbon-carbon 
bonds bearing vicinal hydroxyl groups to give carbonyl groups. These 
will react with Schiff's reagent (leucofuchsin) yielding a pink or 
purple Schiff's Base. Carbohydrates staining with PAS is always 
asymmetrical in that the stain is found to be distributed on the
18
external surface but not on the cytoplasmic surface of the plasma 
membrane (Hambourg and Leblond, 1967).
Electron-dense markers such as colloidal iron (Gasic and Berwick, 
1962; Benedetti and Emmelot, 1967), colloidal thorium (Hambourg and 
Leblond, 1967), ruthenium red (Luft, 1971) and cationized ferritin 
(Danon et al., 1972; Hakenbrock and Miller, 1975) have been used 
to demonstrate the presence of acidic or anionic sites on the cell 
Surface. These reactions are usually attributed to the presence of 
carboxyl groups of sialic acid residues of integral membrane proteins 
e3Ç>osed at the external surface of the cell (WLnzler, 1969). As is 
the case for PAS staining, carbohydrate is not normally detected by 
these means on the cytoplasmic face of the plasma membrane although 
anionic binding sites have been detected by cationised ferritin on 
the outer (cytoplasmic) face of the Golgi complex (Abe et al., 1976). 
However, the membrane-associated carbohydrates on the cytoplasmic 
surface are of much-lower density than those of the cisternal membrane 
face. Concanavalin A has also been used to detect surface carbohydrates 
(mannose) residu^es and has been shown to bind not only to the cisternal 
surface but also, to a limited extent, to the cytoplasmic surface of 
Golgi membranes (Abe et al., 1977). This suggests that carbohydrate 
residues ara present, and probêüDly assembled, mainly on the inner 
aspect of the membrane, but that some may also be exposed on the 
cytoplasmic surface.
In view of the possible involvement of carbohydrate in some of 
the biological functions displayed by glycoproteins, a great deal 
of effort has been extended in recent yeairs to determine the structure
19
of the oligosaccharide chains of both soluble and membrane glycoproteins, 
The sugars present in the carbohydrate portion of membrane glyco­
proteins are few and include D-galactose, D-mannose, D-glucose (rarely) 
L-fucose, N-acetyl-D-glucosamine, N-acetyl-D-galactosamine and sialic 
acid, arranged in oligosaccharide side chains of varying sizes and 
glycosidically-linked to a polypeptide backbone. It has become 
customary to classify glycoprotein oligosaccharide structures on the 
basis of the nature of the carbohydrate-peptide linkage. This approach 
has been useful because the carbohydrate-amino acid linkage dictates 
the properties of the associated oligosaccharide group cuid because 
a single glycoprotein molecule may contain oligosaccharides of more 
than one linkage type. On this basis two major types of oligosaccharide 
complex have been shown to occur in glycoproteins. The first of these 
involves an N-glycosidic bond frcm N-acetylglucosamine to the amide 
nitrogen of asapragine (Fig. 11) which is relatively stable to 
hydrolysis by strong alkali. The second type of linkage contains an 
0-glycosidic bond from N-acetylgalactosamine to the hydroxy group 
of serine or threonine (Fig. 11) and can be cleaved by mild alkaline 
treatment which promotes a 3-elimination reaction (Fig. 13). This 
difference between N-glycosidic and 0-glycosidic linkages has been 
exploited to advantage in the detection and separation of the two 
types of oligosaccharide chains.
The structures of some glycopeptides which contain 0-glycosidic 
linkages involving N-acetylgalactosamine as the linkage sugar are 
shown in Table 1. N-glycosidically-linked (to aspragine) oligor 
saccharide units are usually found to be of two types. The first 
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"high-mannose” or 'simple' type (Fig. 12). The second contains a 
variable number of outer chains linked to a 3-mannosyl-di-N-acetyl- 
chitobiose unit, the same structure that occurs in the inner region 
of typical high-mannose oligosaccharides (Fig. 12).
Detailed information about the isolation and structural character­
isation of membrane glycoproteins and glycopeptides can be found in 
a number of recent reviews (Sturgess et al., 1978; Tanner, 1978; 
Komfeld and Kornfeld, 1980) .
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Membrane carbohydrates as specific determinants
In view of the presence of complex glycoprotein and glycolipid
molecules at the outer surface of animal cells, it might be expected
that these molecules are involved in the interaction of the cells
with their surroundings. The sugar complexes are excellent candidates
for participating in the various specific functions of the cell
membrane. With a basic set of seven monosaccharides (fucose, glucose,
galactose, mannose, N-acetylglucsamine, N-actylgalactosamine and.
sialic acid) the number of possibilities of structural variations in
the oligosaccharide complexes of glycosubstances is potentially very
great. There are, for exanple 10^^ possible structures for a
twelve-residue oligosaccharide containing three mannose, three
galactose, three N-acetylgucosamine and three sialic acid residues,
4and 2 possible structures for only two hexose units, glycosidically 
linked to protein, assuming that both monomers are pyranose rings.
Cell-surface-expressed carbohydrates have indeed been found to 
participate in a range of recognition phenomena including blood group 
specificity (Watkins, 1974; Hakomori, 1981; Anstee, 1981), hormone 
reception (Kohn et al., 197 8) and bacterial adhesion (Ofek et al., 1978)
(i) The ABH(0) blood group system
Antigenicity expressed through carbohydrate determinants is 
best established in the ABH blood group system (Watkins, 1972). 
Formulation of the relationship between the sequence and linkages of 
carbohydrates and their ABH and Lewis antigenic specificity was 
established as a result of the work of Morgan and Wakins and of 
Kabat and associates during the 1950s and the early 1960s. As a
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result of this work it has become established that a precursor-end- 
product relationship exists between related antigens, e.g., between 
H and A (or B) or between Le^ and Le^, cUid that the glycosyltransferases 
that catalyse these interconversions are the primary gene products 
(Marcus, 1969; Watkins, 1966, 1972). Although it has long been 
generally understood that the ABH determinannts expressed at the 
surface of erythrocytes are components of membrane glycolipids 
(Hakomori and Strycharz, 1968; Gardas and Koscielak, 1974), several 
workers (Whitemore et al., 1969; Liotta et al., 1972; Hamaguchi and 
Cleve, 1972; Gardas and Koscielak, 1973) have reported evidence for 
the presence also of ABH antigenically-active glycoprotein in human 
erythrocyte membranes. These conclusions were contested by Anstee and 
Tanner (1974 a,b), who ascribed the ABH activity of membrane-derived 
water-soluble glycoprotein fractions to tightly bound glycolipid 
molecules or to glycolipids with unusual solution properties. Never­
theless more recent advances in chemical and analytical methods in 
membrane biology have resulted in the validation of much of this 
work and, a relatively clear picture has now emerged showing that blood 
group ABH and li determinants are carried not only by glycolipids, 
but also by some membrane glycoproteins. It is now apparent that 
four classes of Ccirbohydrate chains carry ABH and li blood group 
determinants, these are:
(i) Simple glycolipids containing 5 - 1 0  glycosyl residues 
(Koscielak, 1978).
(ii) Polyglycosylceramides containing up to 30 glycosyl residues 
(Koscielak, 1978).
(iii) Alkali-stable oligosaccharide chains carried on band 3 and
band 4.5 glycoproteins (Krusius et al.,1978; Jarnfett et al.,
1978).
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(iv) Alkali-labile oligosaccharide chains probably carried on 
glyophorin (Takasaki et al., 1978).
The oligosaccharide determinannts contributing to human ABO 
blood group antigenicity cure shown in Fig.14. The current state of 
knowledge concerning the ABO and the related li antigens of human 
erythrocytes has been recently reviewed by Hakomori (1981).
(ii) The MNS blood group system
The MN antigens, the second major blood group system described 
by Landsteiner and Levine (1928 ) , are believed to be controlled
by two allelic gens, M and N (Springer et al., 1972a). As the genes are 
C O -dominant, the three possible phenotypes MM, MN and NN are found.
M and N antigenic activity is associated with giycophorin A, the major 
sialoglycoprotein of the human erythrocyte membrane (Azuma et al., 1973; 
Tuech and Morrison, 1974; Tomita and Marchesi, 1975), whereas the 
closely related Ss antigens are associated with giycophorin B on the 
same membrane (Dahr et al., 1975a; Tanner ot , 1977; Anstee et al.,
1979). An interesting piece of evidence concerning the assignment 
of MN antigen activity to giycophorin A resulted from the discovery 
that certain rare individuals with erythrocytes of type En(a-) 
have a total deficiency of giycophorin A and that this deficiency 
correlated with a gross reduction in MN antigen activity (Tanner and 
Anstee, 1976; Dahr et al., 1976a, b; Furthmayr, 1978).
Giycophorin A has been extensively studied and is now known to 
contain a polypeptide chain composed of 131 amino acids (Tomata at al., 










g 3O E - g g
TOt» TO TO ^  fdH* (D
M H M 4


















































TO TOTO M Mt— +i ÎE»
r'" f ̂  >











Fig. 15. Schematic diagram of giycophorin A, the major 
sialoglycoprotein of the human erythrocyte 
membrane.
cell and its carboxy terminus in the cell cytoplasm (Fig. 15). Glyco-I
phorin A consists of approximately 60% carbohydrate, all external to 
the cell and comprising 15 0-glycosidically linked oligosaccharides 
and 1 N-glycosidically linked oligosaccharide complex (Fig. 15).
Its oligosaccharide portion has been modified by periodate (Lisowska 
and Duk, 1972; Lisowska and Roelcke, 1973) or alkaline borohydride 
(Lisowska, 1969; Thomas and Winzler, 1971; Lisowska and Duk, 1975) 
treatments which resulted in the destruction of MN activity. Such 
activity is also lost following the removal of sialic acid from intact 
erythrocytes (Springer and Ansell, 1958), or from giycophorin 
(Romanowaska, 1959) and its proteolytic fragments (Lisowska and 
Wasniowska, 1978). These observations suggest that 0-linked oligo­
saccharides which contain sialic acid contribute to the antigenicity 
of M and N active structures. When antibodies directed against M or 
N determinants were raised in rabbits, it was noted that anti-N sera
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agglutinated MM cells in addition to a much stronger reaction with NN 
cells. However, monospecific anti-M serum showed no cross-reaction 
with NN cells (Springer et al., 1932)s. This observation together
with the fact that treatment of MM cells with neuraminidase results 
in an transient increase in their N-activity (Yokoyama amd Trams, 1962) 
prompted the proposal that the N antigen is a precursor substance 
which can be sialyated to form M antigen (Springer and Desai, 1975) as 
shown in Fig. 16. Despite the above observations, however, no difference 
between oligosaccharides derived from M or from N antigens has been 
found (Lisowska, 1969; Lisowska et al., 1980) and it is now generally 
accepted (Dahr et al., 1975b;1977; Furthmayr, 1978), that the genetically 
determined differences between M and N glycoproteins are located in 
the polypeptide chains. Covalent modification of the giycophorin poly­
peptide has been shown to alter the M and N antigenicity detected by 
both human and rabbit antisera as wall as by N-specific lectins (Ebert 
et al. , 1972; Lisowska and Duk, 1975a,b) and it has been established 
(Lisowska and Wasniowska, 1978; Blumenfeld and Adamany, 1978) that 
the nature of the amino acids at positions 1 and 5 (from the 
amino-terminus) of giycophorin A correlates with the expression of 
M or N antigen activity on the molecule (Fig. 17).
The role of alkali-labile oligosaccharide complexes in the 
expression of MN activity can be best explained in terms of their 
effect in determining the optimal conformation of giycophorin A for 
such activity. This conformation is probably primarily effected by 
charge interactions between carbohydrate (sialic acid) carboxyl groups 
and polypeptide amine residues (Anstee, 1981). Mutual stabilization 
of peptide and carbohydrate conformations by noncovalent association 
seems to occur in IgG where an N-glycosidically linked oligosaccharide
30
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less one a -N A N A  -»• N antigen
Fig. 16. Structural relationship between M and N antigens 
as proposed by Springer and Desai (1974).
CHO CfjIO CjHO 
N H j_S er_S er Thr—Thr.G ly _Val-A la_H se—COOH
M-active glycopeptide
NHj—Leii — — — — — — — — 0 III
N-active glycopeptide 
COOH
Fig. 17. Amino acid sequence of the smallest peptide fragments 
that have been shown to retain M or N activity (After 
Lisowska and Wasniowska, 1978).
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exists in an extended sheet-like conformation with memy contacts with 
the peptide sheet (Huber et al., 1976). The view of Springer et al.,
(1977) that the structural difference between M and N antigens is due
to the presence of an M-specific sialyltransferase, absent from 
individuals with NN cells, has been contested by Sadler et al., (1979) 
who showed that purified homogeneous sialyltransferases from porcine 
submaxillary glands are capable of restoring M antigenic activity to 
neuraminidase-treated M-positive erythrocytes but not to neuraminidase- 
treated cells that are M-negative prior to desialyation.
The MN system together with its related antigens and giycophorin
structure and function have been recently reviewed by Anstee (1981).
(iii)Receptors for bacterial toxins and glycoprotein hormones
In addition to their role as cell surface antigens, membrane- 
bound glycolipids and glycoproteins have the capacity to act as receptors 
for a range of extracellular agents such as hormones and bacterial 
toxins. In this respect, the clearest example is the function of 
gangliosides as cell plasma membrane receptors for certain toxins 
and hormones (for review see Fishman and Brady, 1976; Kohn, 1978; Kohn 
et , 1978) .
Early studies (Holmgren et al., 1973; King and van Heyningen, 1973; 
Cuatrecasas, 1973) on the interaction of cholera toxin with epithelial 
membranes showed that the toxin was specific for the oligosaccharide 
chains of ganglioside (Fig. 18). Subsequently, Holmgren _et al.
(1974) showed that the sphingosine portion of the molecule was also 
essential for toxin-binding. Kanfer et al.(1976), on the other hand.
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Fig. 18. Structure of the gangliosides
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suggested that is not the receptor for cholera toxin in adipocytes
as they were found to contain only G^^ and (Fig. 18). Furthermore,
although exogenously added G enhanced the effect of cholera toxinMl
on whole cells, the kinetics of stimulation (lypolysis) did not 
conform to the activity observed with untreated cells. This conclusion 
was later questioned by Pacuszka et al.(1978) who showed that G^^ 
was present in adipocytes in low concentrations.
Like cholera toxin, tetanus toxin has been shown (van Heyningen,
1976) to bind to gangliosides such as G and G , which contain twoDlb T1
internal sialic acid residues (Fig. 18), while the haemolytic activity 
of Staphylococcal alpha toxin has been shown (Kato and Masahara, 1976) 
to be inhibited by the glucosamine-containing ganglioside sialyl-a2,
3—Gal—6—1,4—GlcNAc—6—1,3—Gal—6~lr 4—Glc—ceramide.
Other toxins with similar abilities to bind to gangliosides have 
been recently reviewed by Kohn (1978).
Although the above findings are of great importance, they do not 
in themselves reveal the normal biological roles of gangliosides, 
as cells are not usually exposed to toxins. One possibility is 
that the toxins are chemical analogues of natural substances such 
as hormones and interferon and that the true role of relevcint 
gangliosides is to act as membrane receptors for these agents. Indeed, 
receptors for thyrotropin (Mullin et al., 1976), leuteinizing hormone 
(Kohn, 1978), human chorionic gonadotropin (Lee et al., 1976) and 
follicle stimulating hormone have all been shown to be gangliosides. 
However, recent studies showed that in addition to the ganglioside
34
receptor, at least another component, a glycoprotein, is involved in 
the binding of thyrotropin to thyroid plasma membrane (.Meldolesi et '
1977) . From these and other results (Kohn, 1978), it is difficult to 
reach a clear picture of the molecular nature of cell surface receptors 
for glycoprotein hormones but it is likely that carbohydrate receptors 
on both glycolipids and glycoproteins are involved in the cell membrane 
recognition sites. Further information may well depend upon the isolation 
by affinity procedures of the actual receptor molecules.
It is of interest to mention that investigation of the adherence 
of several strains of E. coli to human epithelial cells has shown 
that E. coli adhere by binding specifically and reversibly to D-mannose 
residues on the target membranes (Ofek et al., 1977, 1978). Similarly, 
the attachment of E. coli emd Salmonella typhi to mouse peritoneal 
macrophages has also been found to be specifically inhibited by D- 
mannose, methyl-a-D-mannoside and yeast mannan (Bar-Shavit et al., 1977). 
Adherence and its relation to pathogenicity will be discussed in 
Section C.
(iv)Liver receptors for desialyated plasma glycoproteins,
erythrocytes and lymphocytes
One of the best known examples of carbohydrate recognition 
by membrane-bound glycoproteins is the binding by hepatocytes of asialo- 
glycoproteins. This activity was first discovered by Morell et al.
(1968) who showed that desialyated. serum glycoproteins were rapidly 
cleared from the circulation by the liver. Subsequently, Pricer 
and Ashwell (1971) reported that plasma membranes of rat liver 
hepatocytes specifically bound asialoglycoproteins through galactose
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residues exposed by the removal of sialic acid. Sialic acid itself 
was also implicated as an essential part of the functional receptor 
molecules themselves (Ashwell and Morell, 1974). The rabbit hepatic 
receptor was isolated and shown (Hudgin e^ al., 1974) to be an 
integral glycoprotein containing 10% of its dry weight as carbohydrate. 
Although removal of terminal sialic acid leads to loss of receptor 
activity, it is likely that this loss results from binding of the 
receptor's own e^qposed galactose residues rather than to an essential 
role of sialic acid in binding (Paulson £t al., 1977). Subsequent 
studies showed that the glycoprotein receptor consists of two sub­
units (A and B) of molecular weight; 48,000 and 40,000 forming 
aggregates of molecular weight 500,000 (Kawasaki and Ashwell, 1976a). 
Pronasè treatment of the intact receptor allowed the isolation of 
two distinct glycopeptide fractions for which the partial structures 
shown in Fig. 19 Were proposed (Kawasaki and Ashwell, 1976b). Similarly, 
Baenzinger and Maynard (1980);.isolated the human hepatic receptor 
and showed it to be an integral glycoprotein comprising a single sub­
unit (mol. wt. 41,000). The amino acid composition of the human receptor 
was shown to resemble that of A and B subunits of the rabbit hepatic 
receptor whereas the carbohydrate composition more closely approximated 
to that of the A subunit. Inhibition studies showed that the human 
hepatic receptor displays specificity for both terminal galactose 
and N-acetylgalactosamine. It is of interest to mention that, while 
the hepatic binding process in mammals involves the interaction of 
the receptor with galactose and possibly N-acetylgalactosamine, it 
involves N-acetylglucosamine in birds and possibly reptiles (Ashwell 
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(After Kawasaki and Ashwell, 1976b).
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As with asialoglycoproteins, neuraminidase-treated erythrocytes 
are rapidly eliminated from the circulation by the liver (Aminoff et al., 
1976, 1977; Kolb et al., 1978). It was suggested that the hepatic cells 
recognize sialic acid-depleted erythrocytes by interacting with sub­
terminal galactosyl residues that are exposed by the neuraminidase 
treatment (Kolk et al., 1978). However, there is no clear evidence 
to suggest that this is the true mechanism of erythrocyte elimination 
in vivo (Anstee, 1981). Kolb and Kolk-Bachofen (1978) pointed out 
that asialoerythrocytes apparently bind to Kupffer cells which should 
remove the red cells by endocytosis whereas glycoproteins could be 
metabolised exclusively by hepatocytes.
The mammalian hepatic receptors have been classified as mammalian 
lectins on the basis of their ability to agglutinate red blood cells 
(Stockert et ad., 1974) and to induce mitosis in lymphocytes (Novogredsky 
and Ashwell, 1977). Similar lectin activity has been reported to be 
present in lymphocytes (Kieda et al., 1978),calf heart (Childs and 
Feizi, 1979) and embryonic chick muscle (Kobiler and Barondes, 1979) 
extracts. The true biological functions of these surface carbohydrate- 
receptors remain to be determined.
Lectins, their function and biological activities will be 
discussed in Section B.
(v) Carbohydrates in Cell-Cell adhesion
Intercellular adhesion is a fundamental biological property 
of cells in multicellular organisms and it is certainly important in 
a wide variety of physiological processes including growth, morphological
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differentiation and metastasis (Curtis, 1962). Oppenheimer e^ al. (1969) 
used trypsin treatment to isolate single cell suspension of mouse 
teratoma tumours which, when placed in a synthetic tissue culture 
medium, showed rapid reassociation of individual cells. However, the 
recovery of adhesiveness required the presence of glutamine which 
could be specifically replaced by glucosamine or mannosamine. The 
conclusion drawn from this was that conversion of non-adhesive to 
adhesive cells correlates with the ability of the cells to synthesize 
complex carbohydrate. The involvement of cell surface carbohydrate in 
cellular adhesion has also been studied by treating cells with 
specific glycosidases; Roth et al.(1971) showed that treatment of 
dissociated neural retina cells with g-galactosidase alters their 
adhesive properties. Similarly, the preferential adhesion of dorsal 
retinal cells to the ventral half of the tectum was prevented by 
treatment of the retinal cells with g-N-acetylhexosaminidase or by 
treatment of the tectum with proteases (Marchase, 1977). It was 
concluded from these experiments that one of the ligands involved in 
retinal-tectal adhesion is a ganglioside (G^^) with a terminal 
GalNAc residue, and that the other is a protein molecule which can 
bind to G^2' possibly a galactosyl transferase. This conclusion was 
supported by the observation that liposomes containing G^g bound 
preferentially to dorsal tectal halves (Marchase, 1977). The involvement 
of cell surface glycosyltransferases in cell-cell adhesion had, in 
fact, been postulated in a general hypothesis (Roseman, 1970), in 
which adhesion was suggested to be mediated by enzyme-substrate 
recognition. However, this hypothesis has not since been satisfactorily 
supported by experimental data and while it certainly stimulated 
considerable work is not now generally regarded as a fundamental 
mechanism of cell-cell adhesion (Culp, 1978). It is quite likely that
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the functional role of cell surface enzymes, if any, will be clarified 
only when they can be purified and when antibodies to them have been 
prepared. Both the pure enzymes and their antibodies can then be 
tested as potential inhibitors of adhesion (Culp, 1978).
In view of the presence of lectins in plasma membranes and sub- 
cellular membrane : fractions, of a range of mammalian species, Ashwell 
and Morell (1977) suggested that carbohydrate-mediated cellular and 
intracellular recognition phenomena may be regarded as direct meini- 
festations of native, endogenous mammalian lectins. This suggestion 
is not dissimilar to the hypothesis of Roseman (1970) but provides 
for a better appreciation of the properties Of mammalian receptors 
such as the hepatic binding protein which is totally devoid of 
glycosyl transferase activity (Hudgins and Ashwell, 1974) and which 
exhibits lectin-like characteristics in promoting erythrocyte agglu­
tination (Stockert et al., 1974) and in stimulating mitogenesis in 
lymphocytes (Novagrodsky and Ashwell, 1977). More recently,Kobiler 
and Barondes (1979) isolated a lectin from embryonic chick muscle and 
suggested that the lectin might play a role in interaction of developing 
muscle cells with components of the extracellular matrix. Similarly, 
Childs and Fezi (1979) isolated from calf heart a lectin that is 
specific for blood group Ii antigens. The fact that they also 
reported the presence of receptors for this lectin in calf heart 
extract could suggest that the lectin might play a role in the inter­
action between calf heart cells. The presence of similar lectins 
in the human liver and in rat Kupffer cells has been discussed above.
Research over the past few years has indicated the involvement
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in cell adhesion of glycoproteins with subunit molecular weight of
200,000 - 250,000. These glycoproteins are now thought to be closely 
related, and are termed fibronectins (Yamada and Olden, 1978). 
Fibronectins from various sources probably represent just two specific 
proteins, cell surface and plasma fibronectins respectively. Cell 
surface fibronectin [also known as LETS, large external transformation- 
sensitive, (Hynes and Bye, 1974) or CSP, cell surface protein 
(Yamada and Weston, 1974)J is a major constituent of the cell surface 
of many cultured cells, and was discovered when cell surface proteins 
or carbohydrates were labelled radioisotopically or immunologically. 
Plasma fibronectins ^also known as Cig (Cold insoluble globulin)], 
on the other hand, circulate in vertebrate blood (Iwanaga et al., 1978) 
Current information suggests that although the two forms of fibronectin 
are very similar, they are probably not identical (Yamada and Older,
1978).
The first evidence suggesting that cellular fibronectin may play 
a role in cell-cell adhesion was the finding that fibronectin purified 
from cell surfaces behaves like a lectin and readily agglutinates 
fixed erythrocytes (Yamada et al., 1975; Baum et al., 1977). Purified 
cell surface fibronectin can also increase aggregation of living 
dissociated chick embryo and baby hamster kidney (BHK) cells (Yamada et 
a^., 1978).
Serum factors are required for the attachment of certain cells 
to collagen-coated dishes (Pearlstein, 1976; Hynes, 1978) or for cells 
to attach and spread on tissue culture dishes (Grinnell, 1975a, b,, 1977) 
These cell attachment and cell spreading factors are now thought to be
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serum fibronectin (Hook et al.,1977). Such serum factors can bind 
directly to collagen or to tissue culture dishes in the absence of 
cells (Grinnell et al., 1977)
In spite of our knowledge about structure, location and probable 
function, the mechanism by which fibronectin interacts with cells and 
with other adhesive molecules remains unclear.
(vi) Histocompatibility (transplantation) antigens;
A major histocompatibility complex (MHC) has been detected 
in all mammalian species so far studied (Ting, 1981). The two groups 
of histocompatibility cintigens are the classical major transplantation 
antigens (HLA-A, B and C in man; H-2K, D and L in the mouse) and the 
I-region-associated antigens (HLA-DR^ in man and la in the mouse)
(Owen and Crumpton, 1980). The primary function of the MHC is immune 
regulation of T-lymphocyte receptor and effecotr functions (Zinkernagel 
and Doherty, 1979).
The HLO-^ and G antigens are among the most extensively 
characterised plasma-membrane glycoproteins. Their structures appear to 
be closely related and are viewed as comprising four domains of 
the external surface of the lipid bilayer (Fig. 20). One of thèse is 
Bg-microglobulin (a non-glycosylated protein associated with HLA-A 
and B antigens) and the other three (a ,̂ and a^) are located in 
the papain-cleaved fragments of the heavy chain (Fig. 20). A hydro- 
phobic stretch of the heavy chain traverses the lipid bilayer of the 
plasma membrane (for review see Owen and Crumpton, 1980). It is 
currently believed that the antigenic specificity of the glycoprotein
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Fig. 20. Schematic representation of an HLâ-A or B molecule 
in the plasma membrane. The molecule is viewed as 
comprising of four deomains at the external surface 
of the lipid bilayer. gg^Microglobulin comprises one 
domain; the and domains are formed by the heavy
chain. Digestion of the plasma membrane or detergent- 
solubilized HLA-A and B antigens with papain produces 
a water-soluble fragment of apparent molecular weight
34,000 which retains alloantigenicity.(After Own and 
Michael, 1980).
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residues in its amino acid sequence (Orr et al., 1979) rather than in 
the carbohydrate side chain.
The serological determinant of H-Y (a minor histocompatibility 
antigen), on the other hand, was shown (Shapiro and Erickson, 1981) 
to be dependent on a carbohydrate. However it was not established 
whether the determinant itself is a carbohydrate or is affected by a 
carbohydrated. The histocompatibility-Y-antigen has been isolated 
from cell surfaces of vertebrates and invertebrates and is thought 
to be a male determining substance in mammals because of its almost 
perfect correlation with maleness among a variety of mammalian 
species (Pechan et al., 1979; Shalev et al., 1980).
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The Milk Fat Globule Membrane
Milk fat exists as minute globules with diameters ranging from 
0.1 - 20 pm (Walstra, 1969). The stability of these fat globules 
is almost entirely dependent on the interfacial layer at the globule 
surface, which separates the lipid from the aqueous environment 
of the milk serum.This layer is known as the milk fat globule 
membrane (MFGM), an understanding of which is clearly relevant to 
the storage and processing of milk and cream. The MFGM has, however,a 
more fundamental significance in that it is now generally accepted 
to be derived direclty frcan the apical membrane of the secretory 
cell. As such, the membrane provides a convenient and easily ob­
tainable source of defined mammalian cell membranes which can serve 
as a model for structural studies of biological membranes in 
general. In so far as the MFGM represents the mammary epithelial 
cell membrane in particular, it can serve as a source of mammary 
or epithelial cell antigens which are of potential medical importance 
in breast cancer, pathogenic bacterial adhesion and in a range 
of immunological phenomena. Interest in the membrane has accordingly 
grown in recent years and the present introduction will attempt to 
review the current state of knowledge concerning its origin and 
properties.
(i) Historical Background
After the discovery in 1674 by Van Leeuwen hoek of fat 
globules in milk, it was Ascherson (1840) who first recorded the 
presence of an emulsion-stabilizing substance surrounding the 
globules. He proposed that the 'haptogenic membrane' was formed as 
a result of 'capillary condensation' cind subsequent aggregation of
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albumin at the fat globule surface. Babcock (1885) compared the fat 
globules of milk with artificial emulsions of the oil-in-water type, 
which were known to be stabilized by cin adsorbed phase, possibly a 
thin film of serum proteins. He later (1889)reported that he had 
identified small percentages of 'Lacto-fibfin' in milk andt that 
it funcioned as a true membrane on the globule surface. Early 
attempts to identify the material coating the surface of fat globules 
were faced with difficulties arising from the fact that milk contains 
numéro^ proteins each of which is capable of stabilizing the 
fat phase. To overcome this problem Storch (1897) washed bovine cream 
with water at 35°C to remove these proteins before extracting 
the fat with alcohol or ether, leaving the membrane proteins.
Palmer and Samuelson (1924) were the first to isolate and partially 
characterise MFGM material. They detected high concentrations of 
phospholipids in the membrane, establishing for the first time that 
substances other than proteins were involved. Palmer and Weise later 
(1933) demonstrated that phospholipids made up 17.5 - 20.4% of the 
membrane material and showed that lecithin (phosphatatidylcholine)., 
cephalin (phosphatidylethanolamine) and sphingomyelin were present.
In addition they prepared an alcohol-insoluble, but ether-soluble 
fraction which contained neutral lipid composed of high-melting 
saturated fatty acids. These early studies were comprehensively 
reviewed by King (1955) who summarized the data, available at that 
time, concerning the isolation, origin, structure and composition 
of the MFGM. He proposed a two-layered membrane structure consisting 
of an inner-layer of high-melting triglycerides bounded by an 
outer-layer of uncoiled protein attached to the surface of the fat 












Fig. 21. After King (1955)
(ii) Origin and Structure of the MFGM
As seen from the above discussion, early workers accepted 
the idea that the interfacial layer at the surface of the fat globule 
was composed of milk components adsorbed to the fat. Bargmcin and 
Knoop (1959), using electron microscopy, presented the first clear 
evidence concerning the true nature of the membrane. Their electron- 
micrographs showed the progressive envelopment of the emerging 
milk fat globule by the apical cell membrane of the secretory cell. 
Finally the fat globule was seen to be released into the lumen 
surrounded by an intact membrane. This mechanism of secretion was 
represented diagrammatically by Bargman and Welsh (1969) (Fig. 22).
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As this mechanism of secretion involves the loss of membrane 
material from the apical regions of the mammary cell, Patton and 
co-workers (Patton and Fowkes, 1967; Patton and Hood, 1969) 
introduced a concept of membrane differentiation and flow involving 
fusion of the Golgi vesicle membrane with the plasmaleibma (Fig. 23) 
which would tend to make good such losses.
One problem with this concept, is that the amount of membrane 
present in surface-associated vesicles in the lactating cell greatly 
exceeds that removed by milk fat globule secretion. This problem 
is discussed by Patton and Jensen (1975). Wooding (1971a) produced 
electron micrographs which showed that Golgi vesicle membranes were 
directly involved in the secretion process and he later (1973) demonstrated 
the possibility t>f the formation of the MFGM, under certain conditions 
in goats, from the Golgi vesicle membrane without the participation 
of the plasma membrane. This observation appeared to be limited to 
one groijp of animals but nevertheless emphasizes the important role 
of the Golgi vesicles in the secretion of the milk fat. Wooding 
et al. (1970) reported that a small percentage (1-5%) of the fat 
globules in the milk of various species included small crescents 
of cytoplasm trapped between the fat droplet and the surrounding 
membrane, but very little cytoplasmic material is carried away by 
the fat globule, in this way. These crescents sometimes contained 
mitochondria and other cell organelles, a fact which was subsequently 
supported by chemical evidence (Swope and Brunner, 1968). Hood and 
Patton (1973) isolated intracellular milk fat droplets from bovine 
mammary tissue and found no evidence for the presence of a true 
membrane surrounding these droplets. However, the droplets appeared
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Fig. 22. After Bargmann and Welsch (1969)
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£i_g. 2 3. After Patton and Keenan (1975).
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to be enveloped by a discontinuous 'osmiophilic* layer and this was 
reported to be composed of a phospholipid-cholesterol film containing 
a small amount of adsorbed protein. It was thought that the phospho­
lipid originated from the endoplasmic reticulum and the proteins 
were adsorbed from the cytoplasm to stabilize the globule.
Whereas it is generally agreed that, immediately after secretion 
from the mammary cell, the milk fat globule is enveloped by an 
intact biologiccil membrane, the subsequent fate of this membrane 
has been the subject of debate. Electron micrographs suggested that 
structural changes start during (FarreH and Thompson, 1964;
Kurusomi et al., 1968) or directly after (Keenan et al., 1970;
Wooding, 1971b,Carroll et al., 1972) secretion. In view of the fact 
that the MFGM originates from a typical bilayer membrane it might 
be e:q>ected that its juxtaposition with non-polar fat globules 
would initiate structural rearrangement. Rearrangements of this 
type have indeed, been demonstrated in the anologous chylomicrons 
by Zilversmit (1968). While Keenan et al. (1971) explained composi­
tional differences between MFGM and plasma membrane, in these 
terms, Stewart and Irving (1970), on the other hand, observed that 
a dense layer (15 - 25 ym) of loosely-adsorbed material is present 
at the globule surface and suggested that this may be present 
within the secretory cell prior to its envelopment by the plasma 
membrane. Such an inner layer of polar material could well obviate 
the need for rearrangement of the outer MFGM. Even more dramatic 
changes were suggested by Wooding (1971b) who concluded, from 
electron microscopic evidence, that the 'primary' MFGM was actually 
shed from the globule surface leaving a structureless 'secondary' 
membrane. Chemically there is little support for microscopic
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evidence of extensive post-secretory changes in the membrane and 
both chemical and enzymic contents are generally reported to be 
unaffected by secretion (Patton and Trains,1971; Baumrucker and 
Keenan, 1973). Bauer (1972) has examined the effect of preparative 
procedures on the electron microscopic appearanceof the MFGM, cind 
concluded that conventional methods of fixation may lead to arte- 
factual displacement of the membrane from the milk fat globule.
Indeed, Patton (1973) reported that variations in ultrastructure 
can be produced by different types of fixation whereby it is possible 
to get double lines, single lines and layered effects on the same 
globule. The scanning electron micrographs of Horisberger et al.
(1977) made use of gold-labelled lectins to show that the greater 
part of the milk fat globule is covered by MFGM and the present 
view is that while compositional ohanges in the membrane O c in  certainly 
be induced by different types of processing (Mulder and Walstra,
1974) freshly expressed milk fat globules largely retain the unit 
membrane of the mammary secretory cell.
(iii) Isolation of MFGM
As stated above. Palmer and Samulson (1924) were the 
first to isolate and partially characterise MFGM material. Isolation 
of the MFGM is generally considered to be a straightforward procedure 
in view of the almost complete absence of cytoplasmic contamination. 
The first step in recovery of the globule membrane is to separate 
fat globules from milk serum. This can easily be achieved by centri­
fugation either in a conventional centrifuge or in a commercial 
cream separator. The separated globules are then washed several 
times with water or isotonic buffer to remove adsorbed milk serum
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components. Membrane material can be removed directly from the 
washed globules simply by churning, freezing-thawing or sonication 
all of which disrupt the membrane so allowing the globules to 
coalesce producing butter. The resulting buttermlik constitutes 
an aqueous suspension of membranes. Conditions for the washing of 
milk fat globules must be carefully chosen as the possibility clearly 
exists of removing loosely-associated membrane constituents, as well 
as adsorbed milk serum components. These problems have been discussed 
by Brunner (1974) and Mulder and Walstra (1974). Swope and Brunner 
(1968) showed that three washes with three volumes of deionized 
water reduced the concentration of serum proteins to acceptable levels. 
Patton and Keenan (1975) have reported that better eventual yields 
of membrane are obtained by the use of isotonic wash solutions 
(sucrose or NaCl) rather than with water or dilute buffer. They 
attributed this to greater stability of the globules and consequently 
to less separation of membrane fragments during washing. Anderson 
et al.(1972) demonstrated that cooling the milk before membrane 
isolation resulted in a lower recovery of membrane material. Data 
presented in table (2) clearly show the loss of membrane material 
as a result of globule washing.
The relative merits of the various disruption procedures have also been 
studied. Kobylka and Carraway (1972) investigated several procedure 
in order to optimize the preparation of bovine MFGM.*TV>«̂  showed that 
freeze-thawing in buffered sucrose containing magnesium ions was 
superior to the homogenization methods investigated. Martel et al.
(1973) on the other hand, compared churning and freeze-thawing 
procedures for preparation of human MFGM and reported that churning 
gave the higher yields and a superior fraction, based on morphological
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Sample
Content in cream 
(g/lOO ml)
phospholipids protein
Original cream 0.45 11.40
Washed once 0.34 1.66
Washed twice 0.24 Ô.73
Washed thrice 0.22 0.61
Washed 4 times 0.19 0.59
Original cream 0.40
Washed 4 times 0.35 0.69
Washed 8 times 0.28 0.61
Washed 12 times 0.18 0.54
Washed 24 times 0.13 0.46
Table 2. Loss of materials from fat globules in cream by 
washing (After Mulder and Walstra, 1974) .
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and enzymic comparisons.
Patton and Keenan (1975) Suggested that for certain studies 
of membrane constituents, (e.g. enzyme activities, electrophoretic 
mobility, labelling of external membrane constituents) washed 
globules can be used as such. Membrane proteins have been obtained 
directly from intact fat globules by sodium dodecyl sulfate (8DS) 
treatment (Kobylka and Carr away, 1972; Anderson e_t al., 1972;
Mather and keenan, 1975) and phospholipids have been similarly 
extracted using organic solvents (Huang and Kukis, 1967; Patton 
and Keenan, 1971). Moreover washed intact milk fat globules are 
an ideal starting point for the production of glycopeptide fractions 
which may be cleaved frcm the membrane outer surface by proteolytic 
enzymes (Harrison ^  al., 1975).
(ivj Composition of MFŒ4
Almost all data available on the composition of MFGM concern 
the bovine membrane. Proteins and lipids together account for over 
90% of the dry weight of the membrane material (Swope and Brunner, 
1970; Thompson et al., 1961) but the relative proportions of these 
two constituents vary greatly according to many factors including 
season, diet and stage of lactation in the animal. (Patton and 
Keenan, 1975). The method of membrane isolation is also relevant 
in this context (Anderson et al., 1972; Chandan et al., 1971;
Walstra, 1972; Anderson and Cawston, 1975) as it involves the 
separation of membrane material from a fat droplet containing 
over 95% triglycerides. The gross composition of the membrane, 
according to Patton and Keenan (1975) is given in Table (3).
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Constituent Amount
Proteins 25 to 60% of dry wt.
Total lipids 0.5 to 1.1 mg/mg protein
Neutral lipids 56 to 80% of total lipids
Hydroccirbons 1.2% of total lipids
Sterols 0.2 to 5.2% of total lipids
Sterol esters 0.1 to 0.8% of total lipids
Glycerides 53 to 74% of total lipids
Free fatty acids 0.6 to 6.3% of total lipids
Cerebrosides 3.5 nmol/mg protein
Gangliosides 6 nmol/mg protein
Sialic acids 63 nmol/mg protein
Hexoses 0.6 ymol/mg protein
Hexosamines 0.3 ymol/mg protein
Table 3. Gross composition of bovine milk fat globule 
membranes (After Patton and Keenan, 1975).
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I. Lipids
The lipid fraction of the MFGM was first characterized in detail 
by Thonç>son et al. (1961) who demonstrated that the membrane contains 
phospholipids, triglycerides including many with high melting point 
(>50°C) , mono and diglycerides, free fatty acids, cholesterol 
esters, carbtene and squalene-like substances. Distribution of 
individual phospholipids were shown to be similar in MFGM and in 
plasma membranes of the secretory cells (Table 4).










Lyso derivatives 1.8 2.3
Table 4 . Phospholipid distribution in MFGM and bovine mammary 
epithelial membrane XPatton and Keenein, 1975) .
Triglyceride may account for more than 60% of the neutral 
lipid of MFGM compared with a corresponding figure of 24% in 
the plasma membrane of the mammary cell (Keenan and Huang, 1972) 
while a comparison of the triglyceride fatty acid composition 
of plasma membrane (Keenan and Huang, 1972) and MFGM shows that, 
in general, plasma membrane has a much lower content of 16:0 and
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18:0 fatty acids than does MFGM. These observations indieate that 
it is most unlikely that all the triglycerides in MFGM could have 
arisen from plasma membrane triglyceride and it has been concluded 
(Walstra, 1974) that much MFGM triglyceride represents fat globule- 
derived .contaminant attached to the membrane during preparation.
That this triglyceride is associated with the inner face of the 
MFGM is supported by the microelectrophoretic studies of Newman 
and Harrison (1973) which indicated that the outer surface of 
intact bovine milk fat globules is predcxninantly ionogenic and 
contains little neutral lipid. Indeed microscopy shows the presence 
of a layer of material associated with one face of isolated MFGM 
and this has been identified as high melting point triglyceride 
derived from the fat globule itself (Bauer, 1972; Keenan et al., 
1970, 1971). A different point of view has been expressed by 
Wooding (1972) and Martel et al. (197 3) who regard this attached 
layer as representing one or more protein fractions.
Keenan (1974) was able to distinguish six different gangliosides 
in the bovine MFGM and he reported that 90% of total milk ganglio­
sides are present in the MFGM and represent approximately 8% of 
the total sialic acid. Detailed analysis of the lipid composition 
from human and bovine milk was published by Bracco e^ al., (1972).
II. Proteins
Early studies established that MFGM proteins are different 
from those of milk as a whole. Membrane preparations have been 
extracted by various procedures and both soluble and insoluble 
fractions have been investigated with respect to compositional, 
immunological, electrophoretic and sedimentation characteristics.
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These studies have been extensively reviewed by Brunner (1974).
Using polyacrylamide gel electrophoresis (PAGE), Keenan et al. 
(1970) demonstrated the presence of nine polypeptides in bovine 
MFGM and showed that these are similar to those isolated from 
bovine mammary cell membrane. It has since been found that more 
than 98% of the MFGM proteins can be solubilized by treatment with 
SDS and 2-mercaptoethanol (Mather and Kennan, 1975) and electro­
phoresis in SDS-containing polyacrylamide gels has demonstrated the 
presence of 5 - 7 major bands in the majority of investigations 
of bovine MFOl (Anderson et al., 1974 ; 1972; Anderson, 1974;
Kobylka and Carraway, 1972; 1973; Mather and Keenan, 1975). It is 
difficult to con^are the results from the different studies, as 
differing concentrations of acrylaimide and acrylcunide/bis-acryl- 
amide ratios have been used, and whereas some authors have dis­
regarded minor bands, others have included all bands whatever 
their concentration. Different methods of preparation and extraction 
give rise to varying relative preparations of individual MFGM 
proteins, but the same polypeptides appear to be present in all 
preparations (Kobylka and Carraway, 1972; Anderson et al., 1974y 
Anderson and Brooker, 1975). Coomassie-Blue stained electrophoretic 
patterns of human and bovine MFGM proteins were shown to be some­
what similar (Martel et al., 1973; Mather and Keenan, 1975).
Glycoprotein components of the MFGM have been detected by 
periodate-Schiff (PAS) staining of polyacrylamide gels. Six glyco­
proteins have been reported to be present in the bovine MFGM 
(Kobylka and Carraway, 1972; Anderson et al., 1974 , 1975)
whereas only five glycoproteins were observed by Kitchen (197 4) and
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Mather and Keenan (1975). Anderson et ad.(1974) examined the behaviour 
of bovine MFOi proteins and glycoproteins in several concentrations 
of acrylamide and calculated the free electrophoretic mobility 
and retardation coefficient for each protein. From these calculations 
three of the glycoproteins appeared to be identical to three of the 
protein bands, indicated by Coomassie-blue staining. This conclusion 
has since been supported by Mather and Keenan (1975). Combinations 
of centrifugation and extraction techniques have resulted in the 
separation of mixtures containing up to seven PAS-staining components 
(Anderson and Cawston, 1975; Kannp at al., 1975; Shimizu et al.,
1976; Murray et al., 1979). Keenan et al.(1977) have used lithium 
diiodosalicylate to extract a high molecular weight glycoprotein 
fraction from bovine MFGM. This fraction had three electrophoretically 
distinguishable glycosylated proteins but was free of nonglycosylated 
proteins. The isolated final fraction was shown to be water-soluble 
and antigenic when injected into rabbits. Nielsen and Bjerrum (1977), 
have established crossed immunoelectrophoretic patterns showing a 
number of precipitin arcs when detergent-solubilized bovine MFGM 
was electrphoresed into a gel containing anti-bovine MFGM antisera.
The introduction of intermediate concanavalin A gels demonstrated 
that all the antigenic MFGM components were glycoproteins. Snow 
et (1977)isolated a water-soluble glycoprotein from bovine MFGM.
This glycoprotein was purified to approximately 95% purity by 
hydroxyapatite chromatography followed by gel filtration. Chemical 
analysis indicated that it contains 50% by weight carbohydrate,
30.5% of which is sialic acid. The other major monosaccharides are 
N-acetylgalactosamine, N-acetylglucosamine, galactose, mannose and 
fucose. The major amino acids are leucine, glutamic acid and glycine. 
Murray et al. (1979) have studied the ability of glycoproteins of
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bovine and human MFGM to bind to different lectins after electro­
phoretic separation. Seven lectin receptor glycoproteins were 
detected in bovine and five in human MFGM. The abilities of these 
glycoproteins to interact with certain lectins were also reported 
to be different. They also separated two major nonionic-detergent- 
insoluble glycoproteins from bovine and human MFGM. Detergent- 
insoluble polypeptides with similar or identical electrophoretic 
mobilities were also reported to be present in the milk fat globule 
membranes from four other species (rat, sheep, pig and goat). Tryptic 
peptide mapping revealed these polypeptides to be nonidentical 
between species.
A different approach to the study of MFGM surface components 
has involved the treatment of intact milk fat globules with proteo­
lytic enzymes. Treatment of bovine milk fat globules with pronase 
resulted in the release from the membrane surface of sialoglyco- 
peptides containing, in addition to sialic acid, N-acetylgalactosamine, 
N-acetylglucosamine, galactose, mannose and fucose (Higginbotham 
and Harrison, 1972; Harrison e^ al, 1975; Harrison, 1977; Farrar 
and Harrison, 1978). Newman et al. (1976a)reported that alkaline 
borohydride treatment of a crude glycoprotein preparation from 
bovine MFGM gave a fraction from gel filtration that contained the 
reduced disaccharide B-D-galactopyranosyl-%1+3)-N-acetyl-D-galacto- 
saminitol together with two molecules of sialic acid. Periodate- 
oxidation and alkaline-degradation studies on the glycoprotein 
mixture suggested that the major alkali-labile oligosaccharide 
component was a tetrasaccharide containing 3-D-galactopyranosyl- 
(l->-3)-N-acetyl-D-galactosamine substituted by sialic acid at 
position C-3 of the galactose and C-6 of the N-acetyl-D-galactosamine
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residue (Fig. 24). Later, Farrar and Harrison (1978) isolated this 
tetrasaccharide together with the trisaccharides II and III (Fig.
24) which were fully characterised by méthylation analysis coupled 
with periodate-oxidation and gas liquid chromatography. The presence 
of tetrasaccharide I (Fig. 24) on human MFGM also has been suggested 
from studies of Newman et al., (1977).
The e3q>bsure of specific carbohydrate residues on the outer 
surface of intact milk fat globules has been little investigated. 
Microelectrophoretic studies of Newman and Harrison (1973) demon­
strated the exposure of sialic acid on the surface of intact bovine 
milk fat globules, but this technique did not allow the detection 
of other sugars. Horisberger et al. (1977) in an interesting electron 
microscopic study have shown the ability of certain gold-labelled 
lectins to bind in a specific manner to the surface of human and 
bovine milk fat globules. In view of the possible involvement 
of sugar residues in a range of cell surface interactions the nature 
of the exposure of such residues on the outer surface of biological 
membranes is of particular interest and the MFGM presents a con­
venient model system for the study of such exposure. Studies of 
this type accordingly constitute a part of the experimental work 
described in the present thesis.
III. Enzymes of the MFGM;
Many enzymes have been identified in cream and in isolated 
MFGM. The amount of each enzyme present is probably influenced by 
a number of factors including, method of preparation (Mulder and 
Walstra, 1974;Powell et al.,1977),stage of lactatation (Anderaon and 







































































































state (Anderson et al., 1974a, 1975; Anderson and Cheeseman, 1975; 
Kitchen et al., 1970). Plasma membrane marker enzymes have been 
detected with high specific activity in bovine MFGM preparations 
(Solym and Trams, 1973; de Pierre and Karh^vsky,1973; Morré et al., 
1974; Trams and Lauter, 1974). Mitochondria ^Morton, 1954; Baile 
and Morton, 1958; Dowben et al., 1967) and endoplasmic reticulum 
markers (Kitchen, 1974; Dowben et al., 1967; Keenan and Huang, 1972; 
Plantz et al., 1973) are absent from or present in very low specific 
activities in bovine MFGM. Results concerning the presence of Golgi 
marker enzymes in MFGM are less clear. As previously mentioned. 
Wooding (1971a,1973) reported electron microscopic evidence which 
implicated Golgi vesidtle membrane in the mechanism of milk fat 
secretion. However, a number of reports (Keenan et al., 1970;
Keenan and Huang, 1972; Kennan, 1974) documented the absence of
r
Golgi enzymes in MFGM and although Martel et al. ( 1972) rerpd)ted 
the presence of glucose-6-phosphatase and lactose synthetase 
(Golgi markers) in human MFGM preparations, they explained the 
presence of these enzymes as aurising frcm contamination by 
cytoplasmic components. Powell e^ al. (1977) suggested that the 
absence of Golgi markers in isolated bovine MFGM preparations results 
from their deactivation by proteolytic enzymes at the relatively 
high temperatures used in the isolation and purification. Galactosyl 
transferase was in fact found in MFGM and was shown to be similar 
to that extracted from lactating mammary cell Golgi membrane, and 
to have a higher molecular weight than the soluble galactose trans­
ferase of milk serum.
Dowben e_t al. (1967) reported the presence of the plasma membrane 
enzymes acid and alkaline phosphatase and Na^ and K^-activated ATPases
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in bovine MFGM. Patton and Trams (1971) and Huang and Keenan 
(1972) have demonstrated that 5'-nucleotidase and Mg^^-activated 
ATPase were present in the MFGM but they were unable to determine 
the presence of Na^, K^ ATPase which has, in fact, been reported 
to be present in the basal but not the apical plasma membrane 
of the secretory cell. The presence of Mg^^-activated ATPase in 
bovine MFGM was later confirmed by the immunological studies of 
Nielson cind Bjerrum (1977). Like alkaline phosphatases from Escherichia 
coli and other mammalian sources, MFGM alkaline phosphatase is 
usually stable in the presence of SDS (Mather and Keenan, 1974).
This property allows detection of alkaline phosphatase in SDS- 
polyacrylamide gels. Table (5) summarizes the enzymes detected in 
the MFGM by Dowben et al. (1967).
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Enzyme Origin Presence in 
the membrane
Lactate dehydrogenase cytoplasm -
Xanthine oxidase microsomes +
Succinate dehydrogenase mitochondria +
NADH:cytochrome c reductase microsomes (little)
Cytochrcané oxidase Mitochondria -
Catalase cytoplasm, leucocytes +




Alkaline phosphatase microsomes +
Acid phosphatase lysosomes little
Glucose-6-phosphatase microsomes ? +
phosphodiesterase microsomes +
Mg^ activated ATPase microsomes +
+ + 2+(Na K Mg ) activated ATPase microsomes +
Aldolase cytoplasm little
Table 5. Milk enzymes and the milk fat globule membrane.
'Origin' refers to the probable site of the enzyme 
before secretion. (After Dowben et al., 1967).
Section A





D-galactose, D-mannose, D-glucose, N-acety1-D-glucosamine, 
N-acetyl-D-galactosamine; N-acetyIneuraminic acid (sialic acid), 
L-fucose, L-cysteinehydrochloride and thiobarbituric acid were 
purchased from Sigma (London) Chemical Co., London, S.W.6, U.K.
Pronase (B grade, Streptomyces griseus proteinase) was from 
Calbiochem Ltd., London, W.l. Sephadex and Sepharose gels were 
from Pharmacia (G.B.) Ltd., London, W.5. Complété and inconç)lete 
Freund's adjuvant were from Miles Laboratories, U.S.A.
The gas chromatographic columns and packings were frcm Phase 
Separations Ltd., Queensferry,Flintshire, U.K. Mercaptoethanesulphonic 
acid and microflux vials were from Pierce Chemical Co., Rockford, 
Illinois, U.S.A. All other reagents and solvents were obtained from 
BDH Chemicals Ltd., Poole, Dorset, U.K. and were AnalaR grade 
whenever possible.
SDS markers (IgM y-chain, IgG y-chain, IgG K-chain and ovalbumin) 
were donated by Mr. A.M. Jehanli, University of Bath.
II. Methods
Isolation of Milk Fat Globules:
Fresh cows milk, approximately 24 1, from a Friesian herd in 
mid-lactation was pooled and maintained within 3 - 4 °C of the 
milking temperature in an insulated container. The milk was warmed 
to 40°C, as soon as possible, and separated in an Alfa-Laval 
bench cream separator, calibrated to give approximately 40% cream.
66
The isolated cream (1 vol) was suspended in double distilled water 
(3 vol) and reseparated. The suspension and Separation procedure 
was repeated three times, after which the cream was suspended in 
50 mM Tris-hydrochloride buffer (2 vol), pH 7.8, containing 4 mM 
CaClg.
Gel filtration and Ion-exchange Chromatography:
All gel filtration arid ion-exchcinge chromatography procedures 
were carried out at room tenderature. Sephadex gels were swollen 
by equilibration with water, except for DEAE-Sephadex A-25 
which was swollen with 0.65 M pyridine acetate buffer, pH 5.
When not in use, columns were stored in the presence of 0.02% (v/v) 
hibitane (Chlorhexidine) to prevent bacterial proliferation.
Flow rates during column elution were maintained with LKB 
Varioperspex pump and fractions were automatically collected on an 
LKB Redirak 2112 fraction collector with an electronic timer. Column 
eluates were monitored continuously (at 280 or 240 nm) with a 
Cecil 272 spectrophotometer coupled to a Bryans 28,000 chart 
recorder.
Protein Determinations;
Total protein in aqueous column eluates was determined colori- 
metrically by the method of Lowry et al. (1951). Protein in the 
presence of Triton XlOO was estimated by the method of Bonsai1 and 
Hurst (1971).
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Hexose and Hexosamine determinations:
Total hexose was determined in samples and column fractions 
colorimetrically by a modification of the cysteine/sulphuric acid 
assay (Dische and Danilchenko, 1967), using a calibration curve 
based on D-galactose. Individual sugars, including aminosugars, 
were determined in the purified sialoglycopeptides and oligosaccharides 
as their alditol acetate derivatives by gas liquid chromatography 
(see gas liquid chromatography). Quantitative determinations were 
done by using alditol acetate derivatives conparing detector responses 
for individual sugars with those of identically-treated standards.
Sialic acid determinations:
Sialic acid in column eluates was determined by hydrolysing 
an aliquot (0.1 ml) with 0.2 N-H^SO^ (0.1 ml) at 80°Cfor 1 h, 
followed by assay of the free sialic acid by using thiobarbituric 
acid as described by Warren (1959) and modified by Aminoff (1961).
In the case of column eluates containing pyridine acetate buffer, 
aliquots (0.1 ml) were first freeze-dried to remove the volatile 
buffer and then redissolved in water (0.1 ml) before assay as 
above.
Gas liquid chromatography
As mentioned above, quantitative estimation of individual sugars 
in both oligosaccharides and sialoglycopeptides was carried out by 
analysis of their alditol acetate derivatives by gas liquid chroma­
tography (g.I.e.).This involves three steps, namely acid hydrolysis 
to release the bound monosaccharides, reduction to the alditol 
form by treatment with alkaline sodium borohydride and finally 
acétylation by treatment with acetic anhydride.
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Aliquots (0.1 ml) containing purified oligosaccharides or 
sialoglycopeptides (100 - 200 yg) in 1 ml microflux vials were 
dried down at 50°C in a gentle stream of nitrogen. 2N-Trifluoro- 
acetic acid (TFA) (50 y1) containing perseitol (lo - 20 yg), 
as an internal standard, was added to each sample and the vials 
were sealed and incubated at 121°C for 1 h after which they were 
dried as described above. 3M-NH^0H (100 yl) was added to ensure 
alkaline conditions and the reduction of the released monosaccharides 
was then carried out by addition of freshly-made sodium borohydride
(25 yl) in 3 M-NH^OH (20 mg/ml). Vials were sealed
and incubated for 1 h at room temperature. Excess borohydride 
was neutralised by addition of glacial acetic acid ( 1 - 3  drops) 
followed by addition of dry methanol (100 yl) and drying as described 
above. The addition of methanol (lOO yl) was repeated four times the 
first of which was carried out by using methanol-water (1:1). Acétyl­
ation was carried out by addition of dry acetic anhydride (50 yl) and 
o
incubation at 121 C for 1 h. The samples were dried and the residue
z^dissolved in dichloromethane (50 - lOO yl) .
Gas chromatography was performed by injection of samples 
(0.5 - 1.0 yl) of the dichloromethane solution directly into 
columns (2 m x 0.25 cm) of coiled glass containing either 3%
OV-17 or OV-225 on High performance Gas Chrom Q in a Pye Unicam 
Series 104 (OV-17) or a Perkin-Elmer, Sigma 3 (OV-225) gas 
chromatograph equipped with a dual flame ionization detector. 
Chromatography was carried out isothermally at 205°C (OV-17) or at 
200°C (OV-225) with carrier gas flow rates of 45 ml/h.
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Standards were prepared by derivatising aliquots (50 yl) of 
equimolar mixtures of standard hexoses (galactose, glucose, mannose 
and fucose), hexosamines (N-acetylglucosamine and N-acetylgalacto­
samine) and internal standard (Perseitol) under the same conditions, 
described for the samples. Quantitation of individual sugars in 
the purified sialoglycopeptides and oligosaccharides was achieved 
by reference to the internal standard using the following formula:
. Peak area of monosaccharide  ̂ ,W e i a h t  of monosaccharide = —— ;---------- ---- r—— ;-----  xKFxwt .PerseitolPeak area of Perseitol
peak area of perseitol______________ '
where KF = peak area of equal wet. of monosaccharide
Individual sugars were identified by conparisen of their retention 
times with those of the authentic standards.
Amino acid analysis:
Sialoglycopeptide samples (160 yg) in phosphate buffered saline 
(160 yl), pH 7.3, were dried down under vacuum. The residue from 
each sanple was then hydrolysed in a sealed tube under at 110 C 
for 22h with 3N-mercaptoethanesuIphonic acid (200 yl). The 
acid was then neutralised by addition of IN-NaOH (400 yl) before 
being injected into the amino acid analyser. The amino acids 
of the sanples were identified by reference to standard amino acids 
under the same conditions. Samples (200 yl) were injected directly 
into Chromaspek amino acid analyser (Rank Hilger).
Preparation of Sialoglycopeptides for immunisation
Sialoglycopeptides prepared in phosphate buffered saline, pH 
7.3, (2 mg/ml) were diluted by addition of equal volumes of Freund's
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complete (first injection) or incomplete (subsequent injections) 
adjuvant. The emulsion (1.5 ml) was then injected into full-grown 
New Zealand rabbits at four separate intramuscular sites. Animals 
were injected at four-weekly intervals, and blood was taken for 
estimation of antibodies seven days after each injection. Antisera 
raised in sheep and rabbits against the whole solubilised bovine 
MFGM were generous gifts from Dr. G. H.Farrar, University of Bath.
Collection of antisera
Blood (10 ml) was taken from peripheral ear veins and allowed 
to clot for 1 h at 37°C. The clotted blood was then left overnight 
at 4°C to shrink the clot. Serum was separated and centrifuged 
(7,000 X 2 ,̂ 15 min) to sediment cells. Aliquots (0.5 ml) of the 
serum were stored at -20°C until required.
Milk fat globule agglutination assay'
Washed bovine milk fat globules suspension (20 yl) was incubated 
with a serial dilution of antisera (20 yl) and PBS buffer, pH 7.3,
(20 yl) for 1 h at room temperature in a humid environment after 
vhich the globules suspension was examined at xlOO magnification using 
a light microscope. Control experiments vere carried out by using 
PBS buffer, pH 7.3, in place of antisera.
Inhibition assays were performed by preincubating four 
agglutination doses of the antisera (20 yl) for 20 - 30 min with 
inhibitor-containing buffer (20 yl) at room temperature in a humid 
environment before addition of the globule suspension (20 yl).
The mixture was allowed to stand under the same conditions for Ih 
before being examined, at XlOO magnification, by a light microscope.
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Agglutination titres were expressed as the reciprocal of the 
minimum dilution of the antisera giving less than 30% agglutination. 
Inhibition titres were expressed as the minimum concentration of 
the inhibitor, in the final volume, required to inhibit four 
agglutination doses of the antisera. The detailed experimental 
procedure concerning the preparation of milk fat globules for 
agglutination assays will be given in Section B.
Immunochemical gel preparation techniques
Gels for double immunodiffusion studies were prepared as follows
1% (w/v) Agarose (17 ml) together with half its volume of phosphate
buffered saline, pH 7,3 containing 0.02% NaN^ and 1.5% polyethylene
glycol with or without 1% Triton XlOO was poured onto a glass plate
o
(85 X 95 X 1.mm) and allowed to stand at 4 C in a humid environment.
Gels for Immunoelectrophoresis were prepared by using 1.5% (w/v) 
Agarose (17 ml) in 0.025 M barbitone buffer , pH 8.2, containing 
0.02% NaN^ and 1.5% polyethylene glycol. The electophoresis 
conditions involved application of 14 m anps per slide for 1 h as 
described by Hudson and Hay (1976).
Agarose gels were freed from soluble protein, dried and 
stained with 0.5% Panceu S in 5% acetic acid. Destaining was 
performed in 5% acetic acid.
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Experimental and Results
Proteolytic digestion of milk fat globules
Washed cream (500 ml) was suspended in 50 mM-Tris-HCl buffer, 
pH 7.8, (1000 ml) containing 4 mM-CaCl^ at 37°C and 50 mM-Tris-HCl 
buffer, pH 7.8, (500 ml) containing pronase (150 yg/ml) at 37°C 
was added. The digestion mixture was incubated for 1 h at 37°C 
with continuous gentle stirring, cooled on ice and centrifuged 
(2,300 X 2' lb). The aqueous phase (subnatant) was carefully separated 
from the fat, concentrated (to 200 ml) by rotary evaporation (at 37°C) 
and extensively dialysed against distilled water at 4°C. The 
non-diffusible material was further concentrated (to 60 ml) and 
centrifuged (100,000 x 2» Ih) to remove suspended lipid. The resulting 
yellow-brcwn aqueous phase was concentrated (to 25ml) and centrifuged 
(125,000 X 2» lb) to give a pellet,a lipid layer and a clear solution 
containing hexose and sialic acid. The clear layer was carefully 
removed and was divided into 4 ml samples which were stored at -20°C.
Treatment of washed cream in the absence of pronase resulted in
- $ .V
the separation of a much l^ss. intensely coloured solution which
 ̂ ' V  , » /
contained almost no soluble sialic acid although small amounts of -, 
fat membraneous pellet,.presumably resulting frcan mechanical mani­
pulation of the sample were present in the pronase-free control.
Purification of the pronase-cleaved glycopeptides
The pronase-digested material (4 ml) from the above step was 
applied to a column (90 cm x 2.5 cm) of Sephadex G-50 (fine) previously 
equilibrated with water at 22°C. The column was eluted with water 
at 22°C with a flow rate of 60 ml/h. Fractions (10 ml) were auto­
matically collected and continuously monitored at 280 nm. Individual
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fractions were assayed for hexose and sialic acid and a major, 
included peak was found to contain approximately 60% of the hexose 
and 80 - 90% of the sialic acid of the initial sample(Fig. 25). 
Fractions corresponding to the major sialic acid-hexose peak 
and showing low absorbance at 280 nm were pooled and freeze-dried 
to give a white fluffy residue (approx. 100 mg) which was dissolved 
in 0.05 M pyridine acetate buffer, pH 5, (4 ml) and samples (1 ml) 
were applied to a column (25 cm x 1.5 cm) of DEAE-Sepharose CL-6B 
previously equilibrated in the same buffer. The column was success­
ively eluted at 22°C with 0.05 M pyridine acetate buffer, pH 5, (100 
ml), 0.1 M pyridine acetate buffer, pH 5 (100 ml) and 0.5 M 
pyridine acetate buffer, pH 5 (lOO ml). Fractions (5 ml) were 
automatically collected and aliquots (0.1 ml) were assayed, after 
removal of buffer, for hexose, sialic acid and protein (Fig. 26). 
Elution with 0.05 M pyridine acetate gave two peaks one of which 
contained sialic acid cind both of which contained hexose and protein. 
Elution with 0.1 M pyridine acetate gave a small peak containing 
sialic acid with no detectable hexose or protein. Elution with 0.5 M 
pyridine acetate gave a sharp single peak which contained sialic 
acid, hexose and protein. Elution with buffer of higher molarity 
resulted in no more elution of sialic acid and/or hexose-containing 
protein species. The sialic acid-containing peak eluted with 
0.05 M pyridine acetate is referred to as 'sialic acid-poor' (SP) 
glycopeptide fraction and that eluted with 0.5 M pyridine acetate 
is referred to as 'sialic acid-rich' (SR) glycopeptide fraction. 
Fractions corresponding to each fraction were pooled separately 
and freeze-dried. The residue resulting from freeze-drying the 
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from SR glycopeptide fraction was a wet brownish residue smelling 
of pyridine. The freeze-dried materials of both fractions were 
separately dissolved in 0.1 M  acetic acid (1.5 ml) and applied 
to a column (ICO cm x 1.5 cm) of Sephadex 25 (fine) and eluted 
at 2 2 ° c  with 0.1 M  acetic acid with a flow rate Pf 40 ml/h to give 
in each case a single excluded peak containing sialic acid, hexose 
and protein (Fig, 27 a, b). Fractions corresponding to the main two 
peaks were collected as indicated, so as to exclude the tail of 
each peak (Fig. 27 a,b) and freeze-dried to give a white fluffy 
residue (approx. 5 mg) which was stored desiccated at -20°C.
Molecular Weight determination of SR and SP glycopeptides
The molecular weight of the SR (Fig. 27a) and SP (Fig. 27b) 
glycopeptides was estimated by gel filtration on a column (100 cm 
X 1.5 cm) of Sephadex G-75 by conçarison with protein standards. 
Ovalbumin (mol. wt. 43,000) (8 mg), chymotrypsinogen A (Mol. Wt.
25,000) (5 mg) and ribonuclease A (mol. wt. 13,700) (6 mg) were
combined together with blue Dextran (2 mg),dissolved in 0.1 M acetic 
acid (1.5 ml) and applied to a column of Sephadex G-75 (100 x 1.5 cm) 
The column was eluted at 22°C with 0.1 M acetic acid with a flow 
rate of 60 ml/h. Fractions (5 ml) were automatically collected and 
continuously monitored at 280 nm. The SR (5 mg) and SP (10 mg) 
glycopeptides were chromatographed separately under the same 
conditions and fractions (3 ml) were assayed for sialic acid and 
hexose to give in each case a single symmetrical peak. A plot of 
mol. wt. versus Kav (Fig, 28) gave a straight line from which the 
molecular weights of SR and SP glycopeptides were calculated to 

















Fig. 27. Desalting of the SR glycopeptide (a) and SP glycopeptide
(b) on Sephadex G-25. The column was eluted with
O.lM acetic acid. Aliquots (0.1 ml) of fractions
(2.5 ml) were individually assayed for hexose (A o)














0 . 5 1.0
Kav
Fig. 28. Calibration plot for Sephadex G-75 column of protein 
standards (ovalbumin (•), chymotrypsinogen A (■), 
ribonuclease A (A)) from which mol. wts. of SR(0) 
and SP (□) glycopeptides were determined.
Kav
V  -  Ve o
V  -  Vt o
where v = elution volume for the
protein
V = column void volume O
v^ = total bed volume.
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The homogeneity of the SR and SP glycopeptides was further 
tested and their molecular weights were again estimated by disc 
polyacrylamide gel electrophoresis (PAGE). Protein standards and 
sialoglycopeptides (SR and SP) samples were prepared for electro­
phoresis as described by Weber et ad (1972). Electrophoretic 
mobilities of the protein standards and sialoglycopeptides samples 
were examined at four gel concentrations (7.5, 10,0, 12.5 and 15.0% 
aery land, de) . Unlike the protein standards, neither the SR nor the 
Sp glycopeptides were stained with Coomassie Brilliant Blue ^0.25% 
(w/v) in methanol/glacial acetic acid/water (5:7:88, v/v/v)] 
suggesting that the soluble sialoglycopeptides were not precipitated 
at the fixation stage and were being washed out of the gel. However, 
when gels were fixed with TCA/sulphosalycilic acid (30 g; 9 g) in 
water (186 ml) as described by Vesterberg et al.,(1977) a single 
sharp band was observed in the case of SR glycopeptide and a single 
faint band was observed in the case of SP glycopeptide.
Mobility values were calculated according to the following 
formula:
distance migrated by protein length of gel before
Mobility = distance migrated by tracking dye  staining________  x lOO
length of gel after 
staining
Table 6 gives the mobility values (average of four experiments) 
for protein standards, SR glycopeptide and SP glycopeptide at four 
gel concentrations. Fig. 29 shows plots of log mol. wt. versus 
mobility for standards. Fig. 30 shows the apparent mol. wt. of the 
SR and SP glycopeptides (determined from the calibration curves
80
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M O B I L I T Y
Fig. 29. The calibration plots for four acrylamide gel
concentrations (7.5%®, 10.0% 12.5%^f 15%^) . Substitution
of mobility data for SR and SP glycopeptides (Table 
6) in this graph allows the estimation of their 
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Fig. 30. Estimation of asymptotic minimal apparent
molecular weights of SR (•--•) and SP glyco­
peptide (o— o) at four gel concentrations.
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of (Fig. 29), plotted against acrylamide gel concentrations according 
to the procedure of Segrest cind Jackson (1972) . The asymptotic 
minimal molecular weights of SR and SP glycopeptides, determined 
according to this procedure are approximately 23,000 and 17,000 
respectively.
Desialylation of sialoglycopeptides
The removal of sialic acid from purified SP and SR glycopeptide 
fractions was c^ried out by mild acid hydrolysis. Sialoglycopeptide 
sanples (5 mg) were incubated at 80°C for 1 h in 0.2 N HgSO^ (1.5 ml) 
The hydrolysate was passed through a column (lOO cm x 1.4 cm) of 
Sephadex G-25 (fine) to separate free sialic acid from the residual 
desialylated glycopeptides. The column was eluted at 22°C with 
a 0.1 M acetic acid with.ia flow rate of 40 ml/h. Fractions (3 ml) 
were automatically collected and assayed for sialic acid and hexose, 
giving, in both cases, a major excluded hexose-containing peak 
together with an included peak of free sialic acid (Fig. 31).
Carbohydrate composition of the sialic acid-rich glycopeptide 
The purified sialoglycopeptide (200yg) in 2N-TFA (50 yl) 
containing perseitol (20 yg), as an internal standard, was hydrolysed 
at 121°C for 1 h and the hydrolysate was freed from acid in a stream 
of N^. The free monosaccharides were then converted to alditol 
acetate derivatives as described in the Materials and Methods section. 
The alditol acetate derivatives were dried and the residue was 
dissolved in dichloromethane (100 yl). Samples (0.5 - 1.0 yl) 
of the dichloromethane solution were injected directly into the 
gas chromatograph. The chromatographic trace obtained from injections 
onto the column of OV-225 is shown in Fig. 32 and that obtained 
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Fig. 33. Gas chromatogram of alditol acetates from hydrolysis 
of SR glycopeptide. Peaks 1, II and III represent 
N-acetyl-D-glucosamine, N-acety1-D-galactosamine 
and perseital respectively. Chromatography was 
performed isothermally at 205°C on a column of 3% 
OV-17.
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I, II, III, IV, V and VI in Fig. 32 were identified, by comparison 
with authentic standards, as the alditol acetates of L-fucose,
D-mannose, D-galactose, perseitol, N-acetyl-D-glucosamine and 
N-acety1-D-galactosamine respectively. Peaks I, II and III in 
Fig. 33 were similarly identified as the alditol acetates of 
N-acetyl-D-glucosamine, N-acety1-D-galactosamine and perseitol 
respectively. The relative average concentrations of the constituent 
sugars are shown in Table 7. The sialic acid content was estimated 
colorimetrically (P. 67) . Derivatives of the desialylated
glycopeptide (P. 83) obtained by the same procedure gave the same
pattern of sugars (apart from sialic acid) in the same relative prop­
ortions. This control experiment showed that charring, which was 
evident following hydrolysis of the sialoglycopeptide, but not ' 
of the desialylated product, did not influence the apparent mono­
saccharide composition.
Alkaline borohydride treatment of the sialic acid-rich glycopeptide 
The purified sialoglycopeptide (25 mg), excluded from Sephadex 
G-25 (Fig. 27a) was dissolved in 0.05 M-NaOH containing 1.0 M-sodium 
borohydride (25 ml) and the solution was incubated for 14h in 
the dark at 5Q°C in a sealed container under N^. The mixture was 
then cooled in ice and excess borohydride was neutralised by 
adjusting the solution to pH 6.0 by the careful addition of 25%
(v/v) acetic acid. The solution was then passed through Sephadex 
G-25 (fine) column (2.5 cm x 90 cm) to remove the salts. The salt- 
free mixture of the residual peptide and the alkali cleaved fragments 
was freeze-dried and the resultant residue was dissolved in 0.05 M 
pyridine acetate buffer, pH 5.0 (1.5 ml) and applied to a DEAE- 
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same buffer. The column was eluted with 0.05 M pyridine acetate 
buffer, pH 5.0 (100 ml) followed by a linear gradient (0.5 - 
0.65 M) of pyridine acetate buffer, pH 5.0(200 ml) with a flow rate 
of 40 ml/h. Fractions (5 ml) were collected and aliquots (0.1 ml) 
were assayed for hexose, sialic acid and protein, after removal of 
the volatile buffer eis described before.
The elution profile obtained (Fig. 34) showed three distinct 
peaks (I, II and III). Beak I, which was eluted with the stcirting 
buffer, was found to contain hexose,sialic acid cind protein. Peak 
II was a broad peak of two major components both of which contained 
hexose, sialic acid and relatively low levels of protein. Peak III, 
on the other heind, was a single symmetrical peak and contained hexose 
ahd sialic acid with no detectable protein. Fractions corresponding 
to each peak were pooled and freeze-dried. The freeze-dried material 
corresponding to Peak I was dissolved in 0.1 M acetic acid (1 ml) 
and chromatographed on a column (100 x 1.5 cm) of Sephadex G-25 
(fine) to give a single excluded peak containing high levels of 
hexose and relatively low levels of sialic acid and protein (Pig.
35). Fractions corresponding to this peak were pooled and freeze- 
dried to give a fluffy residue (approx. 2.5 mg). Samples (200 yg) 
of the freeze-dried material were hydrolysed with TFA and converted 
to alditol acetate derivatives as described for the native sialoglyco­
peptide. The gas chromatographic trace obtained from injections 
onto the column of OV-225 is shown in Fig. 36. Peaks I, II, III,
IV, V and VI in Fig. 36 were identified by conparison with authentic 
standards as the alditol acetates of L-fucose, D-mannose, D-galactose, 
perseitol, N-acetyl-D-glucosamine and N-acety1-D-galactosamine 
respectively. Relative concentrations of the constituent sugars are
90
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Fig. 35. Desalting on Sephadex G-25 of fractions
corresponding to peak I (Fig. 34). The column 
was eluted with 0.1 M acetic acid. Aliquots 
(0.1 ml) of fractions (3 ml) were individually 
assayed for hexose (A^g^ •)f sialic acid (A^^^ O)
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shown in Table 7.
Samples (200 yg) corresponding to peak II and III in Fig. 34 
were hydrolysed with TFA and converted to alditol acetates. While 
the chromatographic trace of peak II was found to be similar to that 
of the residual glycopeptide (peak I, Fig. 34), indicating relatively 
high contaminaions of the latter peak, the trace of peak III was 
found to contain only D-galactose and N-acetyl-D-galactosamine 
(Fig. 37). together with sialic acid. The molar ratio of D-galactose; 
N-acetylgalactosamine : sialic acid, in this peak was found to be 
1:1:2 respectively.
Periodate oxidation of the sialic acid-rich glycopeptide
Sanç)les of the purified desialylated glycopeptide (10 mg) in 
0.05 M sodium acetate buffer, pH 4.5 (2.5 ml) containing 50 mM 
sodium metaperiodate were incubated for 14 h at 4°C under an 
atmosphere of in the dark. Excess periodate was destroyed by 
addition of 20 mM ethylene glycol (1.5 ml) and the mixture was 
passed through a column (25 x 1.5 cm) of Sephadex G-25 to remove 
the salt. The column was eluted at 22°C with 0.1 M acetic acid 
with a flow rate of 40 ml/h to give an excluded peak containing 
hexose and protein and cin included salt-containing peak. Fractions 
corresponding to the excluded peak were pooled and freeze-dried. 
Sanples (200 yg) of the freeze-dried material were hydrolysed 
with TFA and converted to alditol acetates as described for the 
native glycopeptide. The chromatographic trace obtained from 
injections onto the column of OV-225 is shown in Fig. 38 and that 
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Fig. 39. Gas chromatogram of alditol acetates from hydrolysis of 
periodate treated SR glycopeptide. For chromatography 
conditions and identity of peaks I -III see Fig. 33.
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Peaks I, II, III, IV and V in Fig. 38 were identified, as described 
before, as the alditol acetates of D-mannose, D-galactose, perseitol,
N-acetyl-D-glucosamine and N-acetyl-D-galactosamine respectively.
Peaks I, II and III in Fig. 39 were similarly identifeid as the 
alditol acetates of N-acetyl-D-glucosamine, N-acetyl-D-galactosamine 
and perseitol respectively. Relative concentrations of constituent 
sugars of the periodate-treated SR glycopeptide are shown in Table 
7. Control experiments performed by omitting the periodate step 
showed that the carbohydrate content of the glycopeptide was 
essentially the same as that for the native glycopeptide (Table 7).
As can be seen frcxn Table 7, approximately 30% of the galactose 
and mannose were destroyed by periodate. N-acetyl-D-glucosamine 
and N-acetyl-D-galactosamine were largely protected from the action 
of periodate although about 8% of the latter was destroyed.
Treatment of the sialic acid-rich glycopeptide with mixed 
glycosidases from Trichemonase foetus
The glycosidase extract from T. foetus has been found (Watkins, 
19663;Westwood et al, 1976) to contain fucosdiase, galactosidase and 
hexosaminidase. The purified desialylated SR glycopeptide (10 mg) 
was incubated with T. foetus extract (5 mg) in 100 mM potassium 
phosphate buffer, pH 6.4, (2.5 ml) at 37°C for 4h. The mixture 
was then passed through a Sephadex G-25 (fine) column (100 x 1.5 cm). 
The column was eluted with 0.1 M acetic acid with a flow rate of 
40 ml/h. Fractions (3 ml) were automatically collected and continuously 
monitored at 240 nm and aliquots (O. 1ml) were assayed for hexose 
to give an excluded hexose peak and an included peak of free sugars. 
(Fig. 40). Fractions corresponding to the excluded peak were pooled 
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Samples (200 yg) were hydrolysed with TFA and converted to alditol 
acetates as described for the native glycopeptides. The chromato­
graphic trace obtained frcan injection of the T. foetus treated SR 
glycopeptide onto the column of OV-225 is shown in Fig. 41. Peaks 
I, II, III, IV, V, VI and VII in Fig. 41 were identified by comparison 
with authentic standards as the alditol acetates of L-fucose,
D-mannose, D-galactose, D-glucose, perseitol, N-acetyl-D-glucosamine 
and N-acetyl-D-galactosamine respectively. Relative concentrations 
of the constituent sugars are shown in Table 7. Dialysis (against 
0.1 M acetic acid or water) of the T. foetus treated SR glycopeptide 
to remove the released monosaccharide residues was found to be as 
effective as chromatography on Sephadex G-25. The nbn-diffusible 
material showed essentially the same chromatographic trace and 
carbohydrate composition as that of the excluded peak in Fig. 40. 
Control experiments carried out by replacing the enzyme with buffer 
alone or with heat inactivated (lOO°C, 10 min) enzyme showed that 
the carbohydrate content was similar to that of the native glycopeptide.
Carbohydrate composition of the sialic acid-poor glycopeptide
The purified sialoglycopeptide (200 yg) was hydrolysed with TFA 
and converted to alditol acetate derivatives as described for the 
SR glycopeptide. The chromatographic trace obtained from injections 
of the derivatised material onto the OV-225 column is shown in Fig.
42 and that obtained from injections onto the column of OV-17 is 
shown in Fig. 43. Peaks I, II, III, IV, V and VI in Fig. 42 were 
identified by comparison with authentic standards as the alditol 
acetates of L-fucose, D-mannose, D-galactose, perseitol, N-acetyl- 
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Fig. 43. Gas chromatogram of alditol acetates from hydrolysis 
of native SP glycopeptide. For identity of peaks 
I -III and chromatography conditions see Fig. 33.
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II, and III in Fig. 43 were similarly identified as the alditol 
acetates of N-acetyl-D-glucosamine, N-acetyl-D-galactosamine and 
perseitol respectively. The relative average concentrations of 
the constituent sugars are shown in Table 8. Again, derivatives 
of the desialylated SP glycopeptides obtained by the same procedure 
gave the same pattern of sugars (apart frcm sialic acid) in the 
same relative proportions indicating that the hydrolysis step has 
no effect on the sugars other than sialic acid.
Periodate oxidation of the sialic acid-poor glycopeptides
Samples of the purified desialylated SP glycopeptides (lo mg) 
in 0.05 M sodium acetate buffer, pH 4.5, (2.5 ml) containing 50 mM
sodium metaperiodate were treated with periodate as described for 
the SR glycopeptide. Scimples (200 v»g) of the periodate treated SP 
glycopeptide were hydrolysed with FTA and converted to alditol 
acetates as described for the native glycopeptide. The chromatographic 
trace obtained from injections onto the column of OV-225 is shown 
in Fig. 44 and that obtained in from injections onto the column 
of OV-17 is shown in Fig. 45. Peaks I, II and III in Fig. 44 
were identified by comparison with authentic standards as the alditol 
acetates of D-mannose, persetiol and N-acetyl-D-glucosamine 
respectively. Peaks I and II in Fig. 45 were similarly identified 
as the alditol acetates of N-acetyl-D-glucosamine and perseitol 
respectively. Relative concentrations of the constituent sugars of 
theperiodate treated SP glycopeptide are shown in Table 8. Control 
experiments carried out by omitting the periodate step showed that 
the carbohydrate content of the glycopeptide was the same as that 
of the native sialoglycopeptide. As can be seen from Table 8, 
fucose, galactose and galactosamine were completely destroyed by 
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Fig. 45. Gas chromatogram of alditol acetates from hydrolysis 
of periodate treated SP glycopeptide.Peaks I and II 
represent N-acetyl-D-glucosamine and perseitol 
respectively. For chromatography conditions see 
Fig. 33.
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glucosamine was totally protected from the action of periodate.
Treatment of the sialic acid-poor glycopeptides with mixed glycosidases 
from Trichomonas foetus
The purified desialylated SP glycopeptide (10 mg) was treated 
with T. foetus extract (10 mg) as described for the SR glycopeptide.
The mixture was then passed through a column (100 x 1.5 cm) of 
Sephadex G-25. The column was eluted with 0.1 M acetic acid with a 
flow rate of 40 ml/h. Fractions (3 ml) were automatically collected 
and continuously monitored at 240 nm and aliquots (0.1 ml) were 
assayed for hexose. The elution profile obtained(Fig. 46) showed an 
extra peak (Peak II) in comparison with the elution profile of the 
T. foetus treated SR glycopeptide (Fig. 40). Fractions corresponding 
to the excluded peak (peak I, Fig. 46) and to peak II (Fig. 46) 
were pooled separately, freeze-dried and samples (200 yg) were 
converted to alditol acetates as described above. The chromatographic 
trace obtained from injections of derivatives of peak I (fig. 46) 
onto the column of OV-225 is shown in Fig. 47 in which peaks I, II,
III, IV, V, VI and VII were identified as the alditol acetates 
of L-fucose, D-mannose, D-galactose, D-glucose, persetol, N-acetyl- 
D-glucosamine and N-acetyl-D-galactosamine respectively. The 
chrcanatographic trace obtained from injections of derivatives of 
peak II (Fig. 46) onto the column of OV-225 showed that it is 
composed largely of D-glucose together with traces of D-mannose 
and D-galactose (Fig. 48) and was in fact the same as that obtained 
from alditol acetate derivatives of T. foetus extract itself. This 
suggests that peak II (Fig. 46) is in fact fragments of the enzyme 

















0) (0 0 P
)4 ■P P 0)













in A<4-1 Ü 0 CO
0 •H X
4J 0) CM
in 0) x :
(N Ü CM
1 IT) p
u 0 1—1s ip •H
X U
1 V (UT3 iH Q U
IT) >1Æ o IT)A CO
0) Xi to O '
CO +J IT) G
-H •HC > >1 CO
0 1—1 P
'0 1—1
O ' CD IT) T3C ■P P 0)
•H P T3 P
4-> fH •H 0
I—1 0) > p i
IT) •H •H
cn cn T3 C
(U IT) C 0




















































































Fig. 48» Representative gas chromatograms of alditol acetates 
from hydrolysis of samples corresponding to peak II 
(Fig. 46) and also from hydrolysis of samples of 
T. foetus extract. A and B represent traces of D-mannose 
and D-galactose respectively. Peaks I and II represent 
D-glucose and perseitol respectively. For chromatography 
conditions see Fig. 32.
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Control experiments performed by replacing the enzyme with buffer 
alone or with heat inactivated (lOO^C, 10 min) enzyme showed that 
the carbohydrate content of the glycopeptide was the same as that 
of the native glycopeptide. Relative concentrations of the con­
stituent sugars of the T. foetus treated SP glycopeptide are shown 
in Table 8.
Amino acid analysis
The amino acid contents of the SR and SP glycopeptides were 
determined (Materials and Methods) by using a Chromaspek amino 
acid analyser. Samples (160 yg) were hydrolysed (110°C, 22h) with 
3N-Mercaptoethanesulfonic acid (200 yl). The acid was neutralised 
and sanples (200 yl) were injected directly onto the amino acid 
analyser. The data obtained are expressed as nmol/ml sample (Table 9).
The SR glycopeptide showed the presence of relatively high 
amounts of serine, threonine, glutamic acid, glycine and leucine in 
comparison with the SP glycopeptide which was found to contain 
relatively high amounts of aspartic acid. In both glycopeptides 
only traces of the aromatic amino acids (tyrosine and phenylalanine) 
were detected. This was expected as both fractions showed a very 
low absorbance at 280 nm.
Immunochemical Studies
I) Immunochemical characterization of the sialic acid-rich glyco­
peptide fraction
i) Generation of antisera
■ Antibody-containing serum against the purified SR glycopeptide
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Amino acid SR glycopeptide SP glycopeptide
Aspartic acid 39.3 102.3
Threonine 103.0 40.3
Serine 131.1 52.1
















Tables. Amino acid composition of the SR and SP glycopeptides.
ND = not determined. Values are nmol/ml sample.
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was raised in rabbits (Materials and Methods). Anti SR glycopeptide 
antibodies were first detected, by means of Ouchterlony double­
diffusion experiments, approximately 8 weeks after the first injection 
of the rabbit and the highest antibody titre was detected approximately 
14 weeks after the first injections.
ii) Ouchterlony Double-diffusion
Ouchterlony double^diffusion experiments in which anti SR
glycopeptide antisera was tested against a serial dilution of the
antigen showed that the end point, as judged by the absence of
3-4precipitin lines, was within the range of 2 (titres are expressed
as the reciprocal of dilution). The end points obtained with serial
dilution of the desialylated glycopeptide antigen were within the 
5"6range of 2 suggesting that carbohydrate determinants could play 
a role in the antigenicity of the SR glycopeptide. Precipitates 
were also obtained with the crude (membrcine material before partial 
purification on Sephadex G-50) pronase-digest and with the partially 
purified (PP) sialoglycopeptide off Sephadex G-50 (Fig. 25). In 
both cases the end points were within the range of 2^ Only 
very faint diffuse precipitates were obtained using the SP glyco­
peptide indicating that the anti SR glycopeptide antisera is fairly 
specific for the SR glycopeptide. Neither the periodate-treated 
SR glycopeptide nor the T. foetus-treated SR glycopeptide were able 
to interact with the anti SR glycopeptide.
(iii) Agglutination of bovine milk fat globules
The ability of the anti SR glycopeptide antibodies to 
interact with pooled bovine milk fat globules was studied and, as
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expected, the globules were found to be agglutinated by relatively 
high dilutions of the antibody (Table 10).
Inhibition studies showed that only the native and desialylated 
glycopeptides antigen were able to inhibit the agglutination of 
bovine milk fat globules by four agglutination idoses of the antibody.
As shown with the immunodiffusion experiments, neither the periodate 
treated SR glycopeptide nor the T. foetus treated SR glycopeptide 
were able to inhibit the agglutination of the bovine globules by 
four agglutination doses of the antibody (Table 11) indicating 
that carbohydrate residues are involved in the cintibody binding 
site.
In view of the evidence, obtained from periodate and glycosidase 
treatment, of the importance.of carbohydrate residues in the ability 
of SR glycopeptide to inhibit agglutination, the effect of various 
monosaccharides on the agglutination assay was investigated. Of 
the range of monosaccharides used in the inhibition assay only 
N-acetyl-D-galactosamine and to a lesser extent D-galactose were 
able to strongly inhibit the agglutination of the bovine globules 
by four agglutination doses of the antibody (Table 12). N-acetyl- 
D-glucosamine was found to be a weak inhibitor, whereas D-mannose 
and L-fucose did not show any. inhibition effect (Table 12).
II Immunochemical characterisation of the sialic-acid-poor glycopeptide
fraction
i) Generation of antiseta
Antibody-containing serum against the purified SP glycopeptide 




Anti SR glycopeptide antisera ,5-6
Anti SP glycopeptide antisera 25-6
Anti whole MFGM antisera
(raised in rabbits) ,7-8
Anti whole MFGM antisera
(raised in sheep) ^6-7
Table 10. Agglutination titres of washed bovine milk fat 
globules against serial dilutions of antisera 
raised against MFGM and MFGM-derived sialoglycopeptides. 
Titres are expressed as the reciprocal of the minimum 
dilution of agglutinin (antisera) resulting in no 
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glycopeptide antibodies were first detected in relatively high titres 
3-4(2 ) only four weeks after the first injection indicating that
the SP glycopeptide is a stronger immunogen than the SR glycopeptide. 
The highest antibody titre (2 ) was detected approximately 10 weeks 
after the first injection.
ii) Ouchterlony double-diffusion
As with the case of SR glycopeptide, precipitin lines were 
observed when Anti SP glycopeptide antisera were tested against 
native SP glycopeptide,the crude (membrane material before partial 
purification on Sephadex G-50) and against the PP sialoglycopeptide 
(Fig. 25). Neither the periodate treated SP glycopeptides nor the 
T. foetus treated SP glycopeptide were apparently able to interact 
with the anti SP glycopeptide antisera. No interaction was obtained 
with the SR glycopeptide.
(iii) Agglutination of bovine milk fat globules
Again, pooled bovine milk fat globules were found to be 
agglutinated by relatively high dilutions of anti SP glycopeptide 
antisera (Table 10). Inhibition studies showed that the agglutination 
of the globules by four agglutination doses of the anti SP glyco­
peptide antisera was inhibited the native SP glycopeptide and by 
the PP sialoglycopeptide (Table 11). The periodate treated SP glyco­
peptide and the T.foetus treated SP glycopeptide showed no inhibitory 
effect (Table 11).
Inhibition studies using a range of monosaccharides showed that 
N-acetyl-D-gucosamine and to a lesser extent D-galactose were able 
to inhibit the agglutination of the globules by four agglutination
119
doses of anti SP glycopeptide antisera (Table 13).
III. Studies with anti whole bovine MFGM antisera
Anti whole bovine MFGM antisera was kindly provided by Dr. G.H. 
Farrar, University of Bath, with the information that it agglutinates 
bovine milk fat globules and interacts only with the PP sialoglyco­
peptide and SP glycopeptide.
Inhibition studies showed the same pattern observed with the 
case of anti SP glycopeptide antisera. Thus the SP glycopeptide 
and the PP sialoglycopeptide together with N-acetyl-D-glucosamine 
inhibited the globule's agglutination (Tables 11, 14). The inhibitory 
activity of the SP glycopeptide was conpletely destroyed by corre­


















H  a +  +
>i td +  . +  +









•p +o +  +
id +  +  +  +  +  +






















0 p S  iT) n  <H (D
•p -p m CM vp m rH
•H C O in CM rH o  O Oa  (U
•H U rH o  O O  O O O
A  G
G 0H  U
a dP3 O
u dP CM0) O




rd c X 30
(D i4 44
b •P 0
r i lit dP
■p G O 01
A i 4 ro G
<D •P 0
A 3 •H0 1—1 + A
U O ' id
>1 O ' ■ G
rH Id •H
-O ' dP +J0) O 3
A rH r~ rH







0) 01 dP O '
A 0) O
A 1-4 in 03 A
-P A
•H 0 73
A rH + G
•H O ' + 3
A 0
G +J 44
-H id44 dP 0)0 O P
•P X O ' (D1—1 ?01 •H
(D a Id73 X p
-H 11) 0)
P G 01
id i 4 •H
A > o •p
U 0 r" g
O A id
Id0) 73 A0 O) + 3
G X ! + g0 01 + Æ
a Id 4J3 •H440 44 dP0 O 010) O ' rHO' G 0
G 0 A p
id •H + jP +J X 3
id 0
id G U
•H44 •P +0 3 4-




A 0) 73 X
id ü 0)3 P(U 73 0 73






+1-4 (0 +  4-
>1 0 4- 4- -f- +









•H  8 -5
>1 (d 4- 4-



































P Id 2  m m r4  vo
0 p iT» CM vp ro r4
■p -P O m CM r4  O O O
--4 3XJ Ç) rP  O  O  O  O  O  O
•H  0
x: 3











































































































In view of the mechanism of secretion of milk fat globules 
in which the emerging globule is coated by the apical membrane of 
the secretory cell, which then becomes the milk fat globule 
membrane (MFGM), the latter membrane can serve as a convenient 
source and model for epithelial mammalian membranes in general 
(General Introduction to this thesis). The glycoproteins of the 
membrane sur face, which extend out onto the aqueous surrounding are 
of particular interest in that they might be expected to carry many 
of the recognition characters of the parent membrane and the present 
thesis is largely concerned with an examination of the structure, 
exposure and function of these glycoproteins.
Most previous work on the glycoprotein components of bovine 
MFGM has concentrated.on the isolation and characterisation of the 
intact molecules extracted in various ways from the membrane.
Membrane proteins obtained in this way are generally hydrophobic and 
can only be maintained in solution throughout the isolation and 
fractionation procedures by the use of detergents. In the present 
studies, proteolytic enzymes are used to cleave the exposed glycopeptides 
from the outer surface of intact milk fat globule membrane. In this 
way water soluble glycopeptides are obtained which should contain 
many of the recognition factors of the original membrane.
Prior to their treatment with proteases, it is necessary to wash 
the fat globules with water or isotonic buffer in order to remove 
entrained or adsorbed milk serum components (e.g. casein)(Patton 
and Keenan, 1975). Such washing may well also remove loosely associated 
membrane constituents and while this is a disadvantage, it is one that
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is common to nearly all membrane fractionation procedures. Treatment 
of washed bovine milk fat globules with pronase resulted in the 
release of a sialoglycopeptide fraction which was chromatographed 
on Sephadex G-50 as a single peak containing approximately 80 - 90% 
of the sialic acid and 60% of the hexose applied to the column. 
Control e3q>eriments using milk fat globules in the absence of 
pronase and vice versa showed that the glycopeptide fraction was 
indeed proteolytically cleaved from the globule surface. Further 
fractionation of the sialoglycopeptide fraction on a colurni of DEAE- 
Sepharose CL 6B gave two sialoglycopeptide fractions, the sialic- 
acid -poor (SP) and the sialic acid-rich (SR) glycopeptide. The SP 
and SR glycopeptides were further analysed by gel filtration on 
Sephadex G-75 which showed that both glycopeptides were homogenous 
(in terms of size) and that their respective molecular weights 
were 13,000 and 23,000.
The molecular weights of the sialoglycopeptides and their 
homogeneity were further investigated by polyacrylamide gel 
electrophoresis in the presence of sodium dodecyl sulphate (SDS-PAGE) 
The method employed for preparation of acrylamide gels was that 
described by Weber et al.(1972). However, when staining was carried 
out according to this method it was not possible to visualise any 
bands for either the SP or the SR glycopeptide in spite of the fact 
that bands corresponding to the protein standards were easily 
obtained. The absence of protein bands in the.case of SP and SR 
glycopeptides could probably be due to the fact that fixing (by 
methanol-glacial acetic acid) of the glycopeptides was not effective 
and they were consequently washed away. Recently, Vesterberg e^ al. 
(1977) described a procedure for fixing proteins in isoelectric
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focusing gels which involves the use of trichloroacetic acid (TCA) 
in the presence of sulphosalycilic acid. Fixing the gels according 
to this method and subsequent staining and destaining as described 
by Weber et al.(1972) allowed the detection of protein bands corre­
sponding to the SP and SR glycopeptides, although they were relatively 
faint in the case of the former.
Glycoproteins are known to behave anomalously in molecular weight 
determinations on SDS-PAGE and an empirical procedure has been 
developed to take account of this (Sergrest et al., 1971). Apparent 
molecular weights of glycoproteins, determined from mol. wt./mobility 
plots of standard proteins, are found to decrease with increasing 
acrylamide gel concentration, asymptotically approaching a limiting 
value. Extrapolation of such a curve to the asymptotic minimum 
value has accordingly been recommended for molecular weight deter­
minations of glycoproteins. Application of this procedure to the SP 
and £R glycopeptides gave molecular weights of 17,000 and 23,000 
respectively (Fig. 30). While molecular weight estimation of the SR 
glycopeptide by SDS-PAGE was the same as that obtained by gel 
filtration, the former technique gave a higher value in the case of 
SP glycopeptide. It may well be that the SDS-PAGE value is too high 
in the case of the SP glycopeptide. It is generally acknowledged 
that glycoproteins binds less SDS than normal proteins and so 
migrate less fcir. This descrepancy could be at least partially 
compensated in the SR glycopeptide which has a high content of 
negative-charged sialic acid.
The Sp glycopeptide fraction was found to contain relatively 
high levels of D-mannose and N-acetyl-D-Glucosamine together with
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lower levels of L-fucose, D-galactose, N-acetyl-D-galactosamine and 
sialic acid. The presence of high levels of mannose and glucosamine 
in this fraction suggests that the majority of the oligosaccharide 
chains of this glycopeptide are N-glycosidically linked to asparagine 
which was indeed found to be the major amino acid on the SP glyco­
peptide. Thus, the major oligosaccharide chains of the SP glyco­
peptide could be of the 'simple* - type (Fig. 12) which contain 
only D-mannose and N-acetyl-D-glucosamine and/or of the 'complex'- 
type which additionally contains galactose and sialic acid. (Fig. 12.). 
The structure shown in Fig.12 has been suggested (Montreuil, 1975) 
as being typical of N-glycosically linked oligosaccharides <£>f 
soluble glycoproteins and the limited studies that have been carried 
out on membrane-bound glycoproteins suggest that it may well apply 
to them also (Sturgess et al, 1978; Kornfeld and Komfeld, 1980).
The SR glycopeptide, on the other hand, was found to contain relatively 
high levels of D-galactose, N-acetyl-D-galactosamine and sialic acid 
together with lower levels of D-mannose and N-acetyl-D-glucosamine.
The presence of high levels of galactose and galactosamine in the 
SR glycopeptide suggests that the majority of the oligosaccharide 
chains in this fraction are 0-glycosidically linked to serine and/or 
threonine which were indeed the major amino acids in this glycopeptide 
fraction (see later).
Treatment of the SR glycopeptide with alkaline borohydride 
resulted in the release of a tetrasaccharide which has previously 
(Farrar^ 1978) been established as N-acetylneuraminyl (2-*-3) -g-D- 
galactopyranosyl- (l->3) - [ N-acetylneuraminyl- (2-+6) ] -N-acetyl-D- 
galactosaminitol. In addition to this tetrasaccharide, Farrar (1978)
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reported the isolation (from the equivalent of peak II in Fig. 34) 
of two trisaccharides (N-acetylneuraminyl-(2->-3) -3-D-galactopyranosy 1- 
(l->'3)-N-acetyl gal act os amini toi cind 3-D-galactopyranosyl-(l+3)- 
N-acetylneuraminyl-(2-+6f -N-acetyl-D-galactosamininitol. In all 
ray experiments the tetrasaccharide was always recovered intact and 
with the same reported con^osition. Material corresponding to peak II 
(Fig. 34), on the other hand, was found to show a composition 
corresponding to that of a mixture of the trisaccharides contaminated 
by relatively high levels of protein from the residual glycopeptide. 
Farrar (1978) showed that the trisaccharide mixture can be recovered 
in relatively pure form by thin layer chromatography or by high voltage 
electrophoresis and paper chromatography (Lisowaska ̂  al., 1980),
The protein contamination of the released oligosaccharides is 
probably due to reductive degradation of peptide bonds by sodium 
borohydride. The ability of sodium borohydride to induce reductive 
degradation was utilized to isolate Fc fragments from IgM, IgG 
(Yakulis et al., 1968) and IgA (Yakulis et al., 1969). These-studies 
showed that sodium borohydride acts firstly to reduce the sulfhydryl 
bonds linking the subunits of these immunoglobulins and then on 
the peptide bonds between Fc and Fab fragments. It is of interest to 
mention that in the case of IgM only the bond linking the Fab and Fc 
appears to be affected by sodium borohydride and that it is conceivable 
that sodium borohydridge alters the special configuration of the 
protein in a way to make this area of the chain available for 
reductive cleavage without affecting the other ones (Yakulis e^ al. 
1968). Protein degradation was also reported by Lisowska (1969) 
who showed that alkali-labile oligosaccharides isolated from M and 
N active glycoproteins and glycopeptides were associated (but not
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linked) with low molecular weight peptides that were liberated during 
their treatment with alkaline borohydride. Again this possibility 
was not ruled out by Iyer and Carlson (1971) and Lisowska et al., 
(1980). Protein degradation of the SR glycopeptide following its 
treatment with alkaline borohydride was particularly reflected in the 
low yield of the residual (alkali-stable) glycopeptide.
Perickiate treatment of the SP glycopeptide resulted in the 
complete destruction of fucose, galactose and N-acetylgalactosamine 
whereas approximately 44% of mannose was destroyed while N-acetylgluco- 
samine was protected. This suggests that the and/or positions 
in galactose and N-acetylgalactosamine are free and approximately 
50% of these positions are free in mannose. Fucose is usually 
terminal and its complete destruction by periodate was expected. 
Similar treatment of the SR glycopeptide resulted in the destruction 
of approximately 30% of galactose and of mannose whereas N-acetyl­
galactosamine and N-acetylglucosamine were protected. These results 
suggest that approximately 70%of the galactose and of the mannose 
residues are substituted at position C^. As with the SP glycopeptide, 
fucose was completely destroyed by periodate suggesting that it is 
terminal in the oligosaccharide chains.
Treatment of the desialybted SR glycopeptide with T. foetus 
extract resulted in the release of approximately 80% of the original 
galactose and 56% of the original N-acetylgalactosamine. The total 
carbohydrate release was approximately 42% (apart from sialic acid). 
Fucose, mannose and N-acetylglucosamine were protected from the 
action of T. foetus glycosidases. This could have resulted from the
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presence on the SR glycopeptide oligosaccharide chains of a terminal 
sugar (possibly fucose) which is joined to the penultimate sugar 
by a linkage which is resistant to the action of the corresponding 
enzyme (fucosidase) in the T. foetus extract as suggested by 
Westwood et al.(1976). Thus, in such cases there will be intact 
sequences of monosaccharides from the N-acetylglucosamine linked 
to the asparagine through to the terminal sugar (fucose). Similar 
treatment of the desialylated SP glycopeptide, but by using double 
the T. foetus extract concentration, resulted in the release of 
approximately 78% of thé original carbohydrates (apart frcxn sialic 
acid). This is consistent with the results of Westwood e^ al.(1976) 
who showed that treatment of the carcinoemberyonic antigen (CEA) 
with T. foetus extract resulted in the release of 70 - 80% of the 
CEA carbohydrates, but there was no report on the concentration of 
T. foetus extract used in their eqq>eriment. The release of approximatly 
84% of fucose, 85% of mannose, 73% of N-acetylglucosamine and 53% 
of N-acetylgalactosamine as a result of treatment of the desialylated 
SP glycopeptide with T. foetus glycosidases suggests that terminal 
fucose resistant residues, if present, are less in the SP glycopeptide 
than in the SR glycopeptide although it must be borne in mind that 
the concentration of the T. foetus extract with the former was 
double that used, with the latter. It is inportant,in the context 
of the immunological studies to mention that the T. foetus glycosidases 
have been shown to have no proteolytic activity (Watkins, 1966a; 
Westwood et al., 1976). Further studies are required to establish 
the optimal conditions to achieve maximum carbohydrate release.
Preliminary amino acid analyses of the SP and SR glycopeptides
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were carried out by hydrolysis of the glycopeptides with 3M-mercapto- 
ethanesulphonic acid (lo5°C, 22h). The results showed a clear diff­
erence in the amino acid conç>osition of the two glycopeptides.
The SR glycopeptide was found to contain relatively high levels 
of serine, threonine, glutamate and glycine in comparison with the 
SP glycopeptide which was found to contain relatively high levels 
of aspartate (asparagine). The high levels of asparagine and low 
levels of serine and threonine in the SP glycopeptide could indicate 
that the majority of the oligosaccharide chains of the SP glyco­
peptide are most likely to be of the N-glycosidically linked type.
This is consistent with the fact that the major carbohydrates of 
the SP glycopeptide are mannose and N-acetylglucosamine. Similarly 
high levels of serine and threonine together with low levels of 
asparagine could indicate that the majority of the oligosaccharide 
chains are most likelty to be of the N-glycosidically linked type. 
Again, this is consistent with the fact that the major carbohydrates 
of the SR glycopeptide are galactose and N-acetylgalactosamine. 
Hydrolysis for 36 and 48 hrs were not carried out because of technical 
problems with the amino acid analyser in the department.
In view of the presence of ccmpelx glycoprotein and glycolipid 
molecules at the outer surface of animal cells, it might be expected 
that these molecules are involved in the interaction of cells with 
their surroundings (see the General Introduction, p. 24 ).
It is an attractive concept that carbohydrate patterns might play 
a major role in cell surface recognition phenomena. In a number of 
cases this has been found to be so, while in others the contribution 
of carbohydrate to the demonstrated specificity of certain membrane
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glycoproteins remains unclear. Taking this into consideration, one 
aim of this work was to study the possible contribution of surface 
carbohydrates of the bovine MFGM to the overall antigenicity of the 
membrane. -
Ahtisera were raised in rabbits against both the SP and SR 
glycopeptides. The antibody response to the SP glycopeptide fraction 
was observed four weeks after the first injection of the rabbit whereas 
the antiboc^ response to the SR glycopeptide was not detected until 
approximately 14 weeks after the first injection. The relatively late 
antibody response of the raibbit, in the latter case, could be due to 
the presence of high number of sialic acid residues in the glycopeptde 
antigen. This could mask the glycopeptide antigenic determinants 
(cryptic antigens). Alternatively the presence of a high negative 
charge on the glycopeptide molecules might Imit the number of B cells 
which can bind to the antigen. These observations together with the 
fact that only the SP glycopeptide fraction interacted with anti whole 
MFGM antisera suggests that the major membrane antigens are carried on 
the SP glycopeptide and none of these antigens are carried on the 
SR glycopeptide or if it does they are masked (e.g. by sialic acid).
Pooled bovine milk fat globules were found to be agglutinated 
by anti whole MFGM antisera, anti SP glycopeptide antisera and 
anti SR glycopeptide antisera. The agglutination of the bovine 
globules induced by anti SP glycopeptide and by anti whole MFGM 
antisera was specifically inhibited by the SP glycopeptide and 
the partially purified (PP) sialoglycopeptide mixture off Sephadex 
G-50. The agglutination of the globules by anti SR glycopeptide
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antisera was specifically inhibited by the native and desialylated 
S R  glycopeptide and to a much lesser extent by the PP sialoglyco­
peptide mixture. The SR glycopeptide did not inhibit the agglutination 
of the globules by anti SP glycopeptide antisera and vice versa 
indicating that each antisera binds to different receptors on the 
membrane surface.
Inhibition studies using a range of monosaccharides showed that 
N-acetylglucosamine specifically inhibited the agglutination of 
the bovine globules by anti whole MFGM antisera arid by anti SP 
glycopeptide antisera. On the other hand, N-acetylgalactosamine and 
to a lesser extent galactose were found to inhibit the agglutination 
of the globules by anti SR glycopeptide antisera. Thus^it seems 
that the antigenic determinants of the SP glycopeptide are associated 
with the alkali-stable (N-glycosidically linked) oligosaccharide 
chains whereas those of the SR glycopeptide are associated with 
the alkali-labile (0-glycosidically linked) oligosaccharide chains.
The ability of N-acetylglucosamine to inhibit the agglutination of 
the bovine globules by cinti whole MFGM antisera and by anti SP 
glycopeptide antisera and its failure to inhibit the agglutination 
of the globules by anti SR glycopeptide antisera supports the earlier 
conclusion that the major antigenic determinants on the bovine MFGM 
are carried on the SP glycopeptide fraction. The involvement of 
carbohydrate in the antigenic determinants of the bovine MFGM 
was further demonstrated by inhibition studies by using periodate 
treated and T. foetus extract treated glycopeptides. Treatment of 
the desialylated SR glycopeptide with T.foetus extract resulted in 
the release of approximately 80% of galactose and 56% of N-acetyl-
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galactosamine. These losses in galactose and N-acetylgalactosamine 
could account for the inability of the T. foetus extract treated 
SR glycopeptide to inhibit the agglutination of the globules by 
anti SR glycopeptide antisera. Similarly the inability of the 
periodate treated SR glycopeptide to inhibit the globules agglutin­
ation by anti SR glycopeptiiÏG antisera could be attributed to the 
loss of 30% of galactose. Similarly, treatment of the SP glycopeptide 
with periodate or T. foetus extract rendered the glycopeptide unable 
to inhibit the agglutination of the globules by anti whole MFGM and 
by anti SP glycopeptide antisera.
The results obtained from the agglutination-inhibition assays 
were confirmed by immunodiffusion studies. Ouchterlony double 
diffusion experiments showed that anti SR glycopeptide antisera 
reacted only with native and desialylated SR glycopeptide and to a 
lesser extent with the PP sialoglycopeptide mixture off Sephadex 
G-50 as judged by the formation of precipitin lines. No interaction 
was observed between anti SR glycopeptide antisera and SP glycopeptide 
and vice versa suggesting that each antisera is specific to its 
antigen, i.e. the SR and SP glycopeptide has no common antigenic 
determinants. As shown by the agglutination-inhibition assays, T. 
foetus extract treated and periodate treated SR glycopeptide did 
not interact with anti SR glycopeptide antisera as judged by the 
absence of precipitin lines which again stresses the involvement 
of the carbohydrate residues in the antibody binding sites. This 
could be as a result of direct involvement of the carbohydrate 
residues in the antibody binding site , as judged by the agglutination- 
inhibition assays, or that the carbohydrate residues are very close
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to the antigenic determinants on the glycopeptide antigen. As with 
the SR glycopeptide, T. foetus extract treated and periodate treated 
SP glycopeptide did not interact with either anti whole MFGM antisera 
and anti SP glycopeptide antisera.
Unlike the SR glycopeptide, the SP glycopeptide was able to 
form precipitin lines when tested against anti whole MFGM antisera 
which, again, suggests that the major antigenic determinants of the 
bovine MFGM are carried on the SP glycopeptide fraction.
Section B
Lectin receptors on the surface 
of milk fat globules.
134
Introduction
In view of the possible involvement of cell surface carbohydrate 
residues in a range of recognition phenomena (see the General 
Introduction) there is a need for reagents capable of detecting 
specific carbohydrate residues on the surface of intact cells.
Lectins (also referred to as agglutinins, phytohaemagglutinins, 
phytoagglutinins and protectins) are a class of naturally-occurring 
compounds that go some way towards fufilling this requirement.
The main characteristics of lectins are their ability to bind 
sugars, to agglutinate cells, and to stimulate lymphocytes. The two 
latter activities depend upon the former cind each lectin shows 
specificity in its ability to bind certain mono or simple oligo­
saccharides (Table 15).
Through their sugar-combining sites, lectins interact directly 
with polysaccharides and glycoproteins, to form precipitates in a 
manner similar to the interaction of antibody with antigen, in that 
it is specific, exhibits concentration dependence on both lectin 
and polysaccharide or glycoprotein and may be inhibited specifically 
by low molecular weight 'haptens'-compounds identical with or derived 
frcm the sugar(s) for which the lectin is specific.
The occurrence, in plant extracts, of proteins that possess 
the ability to agglutinate erythrocytes was first reported by Stilmark 
back in 1888. This was followed by the introduction of lectins in 
immunological studies by Ehrlich in the early 1890's, who showed that 
specific immunity to the toxic lectins ricin (Ricinus communis)
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Source Carbohydrate * specificity
Plant
Phytohaemagglutinin (red kidney bean) D.GalNAc
Wheat germ agglutinin D.GlcNAc, sialic acid
Ricinus communis (castor bean) 3-D-Gal
Soya bean agglutinin D—GalNAcf D«Gal
Concanavalin A (jack bean) a-D-Man, a-D-Glc
Lens culinaris (lentil) Man, Glc








Helix pomatia (garden snail) GalNAc
Limulus polyphemus (horseshoe crab) NANA
Table 15. Some plant and animal lectins
* GalNac: N-acetylgalactosamine; GlcNAc; N-acetylglucoseamine; 
Gal: galactose; Man: mannose; Glc: glucose; JsIANA: N-acetyl- 
neuraminic acid.
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and abrin (Abrus precatorius) could be achieved by repeated injection 
of small amounts of these antigens into white mice. In 1908, Landsteiner 
and Raubitschek established,that the relative haemagglutinating activi­
ties of various seed extracts were quite different when tested with 
blood cells from different animals. In spite of this demonstration 
of species specificity, it was presumed for several decades that 
plant agglutinins were non-specific. It was not until the end of the 
1940's that Boyd and Reguera (1949) and Renkonen (1948) indpendently 
discovered that certain seeds contain agglutinins specific for some 
human blood group antigens. The first evidence that sugars are 
determinants of blood group specificity was obtained in 1952 by 
Watkins and Morgan who studied the A-specific lectins and type 
H (0)-specific lectins from the serum of the eeel (Anguilla anguilla) 
and the seeds of Lotus tetragonolobus respectively. As haemagglutin- 
ation by A-specific lectins was specifically inhibited by N-acetyl- 
galactosamine, Watkins and Morgan (1952) concluded that this sugar 
serves as determinants of human blood group A specificity. Similarly, 
haemagglutination by type H(O)-specific lectins was specifically 
inhibited by methyl-a-L-fucopyranoside indicating that the a-L- 
fucopyranoside is the determinant of H(0) specificity. Both con­
clusions have been fully substantiated in subsequent studies (for 
reviews, see Watkins, 1972; Hakomori and Kobata, 1974).
In spite of the findings of Watkins and Morgan (1952), interest 
in lectins was limited until the discovery of the mitogenic activity
of phytohaemagglutinin (Nowell, 1960) and of the preferential
e
agglutination of malignantly transformed cells by whjat germ 
agglutinin (Aub et al., 1963, 1965; Burger and Goldberg, 1967).
137
As a result, lectin research and application entered, within a short 
period of time, a new and very active phase of development.
The nature of the cellular structures with which lectins interact 
has been probed by:
(i) Light- and electron-microscopic analysis of tissue
sections following reaction with appropriately derivatized 
lectins (e.g. radiolabelled lectins, or lectins labelled 
with fluorescein, ferritin, Perioxidase or haemocyanin) 
|Collard et a^. , 1975; Friberg and Hammarstrom, 1975; 
Horisberger et al., 1977; Lis and Sharon, 1977^.
(ii) Mono- and oligosaccharide inhibition of lectins or lectin
derivatives (Lis and Sharon, 1977; Goldstein and Hayes, 1978)
(iii) Competitive binding between lectins of known specificity 
(Feller, et al., 1979)
(iv) The effect of enzymic or chemical modification on lectin 
reactivity (Novogrodsky et al., 1975; Carter and Sharon, 
1976; Verbert et al., 1976; Lis and Sharon, 1977).
(v) Isolation of the reactive structures (Sharon and Lis, 1975; 
Lis and Sharon, 1977; Newman and Uhlenbruck, 1977;
Goldstein at ad., 1978; Lotan and Nicolson, 1979).
However, in applying any of these methods one should take great care 
that the lectins (or their derivatives) are homogenous and have 
been isolated with their biological activity unchanged. Moreover, 
their binding should be shown to be indeed sugar specific, i.e., it 
can be inhibited or reversed by the appropriate saccharide(s).
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As a result of these studies many normal and transformed cells 
showed differential agglutinability when tested with concanavalin A 
(Con A) jdnbar and Sachs, 1969a;b; Moscana, 1971; Roth et al.,
197sj, wheat germ agglutinin (WGA) [surger, 1969, 1973; Roth et al., 
1975\J , Ricinus communis agglutinin (RCA) [Nicolson and Blautein,
1972; Roth et al., 197s], soya bean agglutinin (SBA) [sela e^ al.,
197o] and lentil lectin ^Roth et al., 197sJ.
It was initially thought that the increased agglutinability of 
transformed cells resulted from the presence of a greater number 
of lectin binding sites on the latter cells (Lis and Sharon, 1977). 
This idea was supported by the fact that many untreinsformed cells 
which were not agglutinated by low concentrations of a lectin were 
agglutinated after mild proteolysis or neuraminidase treatment 
(Lis and Sharon, 1977). This suggested that cryptic (hidden) sites 
on the cell surface were being exposed by enzymic treatment resulting 
in agglutination. However, when the actual numbers of lectin on 
transformed (agglutinated) and their untransformed (non-agglutinated) 
counterparts were systematically compared it was found that with some 
exceptions [̂ e.g. agglutination of erythrocytes and lymphocytes, by 
peanut lectin (Carter and Sharon, 1976; Novogrodsky et a]̂ ., 1975)] 
there were no quantitative differences in binding of a given lectin 
to the two cell types. It has become clear that the reasons for 
the increased agglutinability of transformed cells are far more 
complex and that difference in this respect are also found between 
adult and embryonic cells and between interphase and mitotic cells 
iStobo, 1972; Stobo et al., 1972; Mosier, 1974; Reisner et al.,
1976 ; Sharon, 1976). Early ideas that high agglutinability could
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also be directly connected with loss of contact inhibition (Burger,
1971) and tumorigenicity (de Micco and Berebbi,1972) have also been 
abandoned (Berman, 1975; . Glimelius et al., 1975; Ukena et al.; 1976) 
and many factors relating to both the cell surface and to the relevant 
lectin have been implicated in what is clearly a far from simple 
process (Table 16).
Another important effect of the interaction of lectins with 
cells is the triggering of quiescent, non-dividing lymphocytes into ' 
a state of growth and proliferation (Ling and Kay, 1975; Rosenthal, 
1975; Openheim and Rosenstreich, 1976). As has been mentioned above, 
studies on lymphocyte activation began with the discovery by Nowell 
(1960) that phytohaemagglutinin (PHA) can stimulated lymphocytes 
to grow and divide. For a while PHA was the only mitogen known.
This was follcwed by the discovery of two more mitogens both of which 
were lectins pokeweed mitogen (PWM) (Fames et al., 1964) and 
the lectin from Wistaria floribunda (Barker and Fames, 1967)
The most significant finding, in this field,was the discovery of the 
mitogenic effects of Con A (Wecksler et al., 1968; Douglas et al.,
1969 ; Powell and Leon, 1970; Novogrodsky and Katchalski, 1971 ) 
because of the fact that Con A was the first mitogenic lectin whose 
activity could be readily inhibited in a reversible manner by low 
concentrations of simple sugars.
In earlier studies, mitogenic stimulation was estimated by 
counting under the microscope the number of lymphocytes that had 
been transformed into large, blast-like cells as a result of 
prolonged incubation (48 hours) with the mitogen tested. Now,
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I. Properties of lectins;
(i) Number of saccharide-binding sites.
(ii) Strength of saccharide binding.
(iii) Electric charge.
(iv) Molecular size.
II. Chemical structures of cell surface receptors.
III. Cell surface properties:
(i) Number, accessibility and distribution of receptor 
sites.
(ii) Mobility of sites (membrane fluidity).
(iii) Electrical charge.
(iv) Surface rigidity.
(v) Surface structures (microvilli, etc.).
IV. Cytoplasmic components*.
(i) Membrane peripheral proteins.
(ii) Microtubule-microfilament system.
(iii) Energy supply.
Table 16. Factors affecting cell agglutination by 
lectins.
(After Lis and Sharon, 1977) .
141
mitogenic stimulation is determined by measuring the increase in 
the rate of incorporation of labelled thymidine, uridine or leucine 
into DNA, RNA or protein, respectively, after suitable periods of 
incubation of lymphocytes with the mitogen tested (Hirschhorn et ,
1974). More recently, however, Udey at al.,(1980) reported that WGA 
(a non mitogenic or anti-mitogenic lectin) and Con A (a well known 
mitogen) showed the same qualitative and quantitative effects on 
human peripheral blood mononuclear cells and purified lymphocytes 
in regard to at least three paraemters (protein phosphorylation, 
aminobutyric acid transport and biosynthetic labelling of particulate 
proteins) of early activation. They suggested that the absence of 
more marked DNA synthetic and complete proliferative responses in 
human lymphocytes stimulated with WGA may be due to delayed inhibitory 
or cytotoxic effects of WGA on monocytes and perhaps subpopulations 
of lymphocytes as well. These results emphasise the importance 
of studying more markers of activation other than the traditional 
procedures. Indeed, what is needed is an assay based on an early 
irreversible step in the activation process which in addition to 
being practical, rapid and precise, would provide a better estimate 
of the number of cells responding to an activator and the degree 
of activity of these cells (Waithe and Hirschhorn, 1978).
The observations of Bain e^ ad.(1964) and of Bach and Hirschhorn 
(1964) that mixtures of lymphocytes from two genetically non-identical 
individuals are capable of stimulating each other vitro (the mixed 
lymphocyte reaction), and the subsequent genetic and immunological 
analysis of this phenomenon (Bach and Amos, 1967; Albertini and 
Bach, 1968; Amos and Bach, 19 established the mixed lymphocyte 
culture as a means of measuring the degree of histocompatibility
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(see the General Introduction) between individuals and has provided 
an important tool for the study of immunobiology and genetics of 
tissue transplantation (Silvers et al., 1967; Hirschhorn, 1968; 
Schellekens ejb al., 1970; Dausset et al., 1970) .
The major cell types responding to a stimulant are T lymphocytes
and vitro lymphocyte activation (transformation) is thought to 
reflect T cell function and cell-mediated immunity (CMI) (Bach et al., 
1971; Greaves and Janossy, 1972}. Non-specific transformation by 
mitogens can be used as an indicator of overall T cell function since 
a high percentage of cells are 'triggered' normally and a low level 
of transformation usually correlates well with depressed CMI. A 
significant degree of transformation (i.e. at least three times 
greater than the spontaneous incorporation) to a given antigen 
usually indicates prior sensitivity to that antigen (Urbaniak e^ ad., 
1978) .
Transformation tests are technically demanding and are subject
to many variables. It is essential to include a normal control or
even better a 'reference pool of responders' with each experiment.
If responses are significantly different from control values serial 
tests are necessary for confirmation. Some patients (e.g. cancer- 
bearing subjects) may have inhibitors present in their serum which 
will be detected if cultures are done with autologous as well as 
with 'standard' sera. Conversely, if cultures are always performed 
with autologous serum some negative results may be due to the presence 
of inhibitors and not to depression of CMI (Whittaker et al., 1971; 
Knocke et al., 1974). Methods of lymphocyte stimulation have been
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reviewed by a number of authors (Oppenheim and Rosentreich, 1976; 
Wender and Parker, 1976; Waith and Hirschhorn, 1978).
The properties just described led to increased interest and 
in the isolation of lectins from many sources (bacterial, fungi, 
snails and mammals). This appears to warrant an expansion of the term 
'lectin' as it was frequently used to describe substances which differ 
markedly from those classically considered lectins, that is plant 
seed carbohydrate-binding proteins. As a result Goldstein et al.,
(1980) proposed a more strict definition of lectins according to 
which they should have the following properties:
(i) A lectin is a sugar-binding protein or glycoprotein of 
non-immune origin which agglutinates cells and/or 
precipitates glycoconjugates.
(ii) Lectins should bear at least two sugar binding sites.
(iii) The specificity of a lectin should be defined in terms of 
monosaccharides (or simple oligosaccharides) that inhibit 
lectin-induced agglutination (or precipitation) reactions.
There are several other types of sugar-binding proteins including 
sugar-specific enzymes (glycosidases, glycosyltransferases...), 
transport protein, hormones (thyroid-stimulating hormone, follicle- 
stimulating hormone,...) and toxins (abrin, modeccin,...) etc. Under 
some conditions, sugar-specific enzymes with multiple combining 
sites can agglutinate cells (and/or precipitate glycoconjugates) and 
so act as lectins. On the other hand, in spite of similarities to 
true lectins from the same sources, toxins (which bear only one 
sugar combining site) should not be called lectins since they do not
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agglutinate cells or precipitate glycoconjugates (Goldstein et al.,
1980). More recently, Kocourek and Horejsi (1981) proposed the 
following definition of lectins: lectins are sugar-binding proteins 
or glycoproteins of non-immune origin which are devoid of enzymic 
activity towards sugars to which they bind and do not require free 
glycosidic hydroxyl groups on these sugars for their binding.
Lectins, their isolation, biological activities and applications 
have been reviewed by many authors (Lis and Sharon, 1973, 1977;
Komfeld et al., 1974; Sharon and Lis, 1975; Goldstein and Hayes,
1978; Lotan and Nicolson, 1979; Weir, 19 80) .
One of the most extensively investigated lectins, and the only 
one for which the primary sequence as well as the three-dimensional 
structure have been established is the lectin from j.ack. ̂ bean(Canavalia 
ensiformis) concanavalin A (Con A). It was first isolated and 
crystallized by Sumner in 1919 and later its ability to precipitate 
polysaccharides have been studied in some detail by Sumner and 
Howell (1936), who were the first to suggest that haemagglutination 
by Con A may be the consequence of the reaction of the lectin with 
carbohydrates in stroma proteins. In addition to its ability to 
agglutinate cells and to precipitate glycoproteins and polysaccharides.
Con A possesses strong mitogenic activity. Goldstein e^ al. (1964) 
established that the Con A binding site appears to require unmodified 
hydroxyl groups at positions C-3, C-4 and C-6 in the six-membered 
ring of u-mannopyranosides or a-glycopyranosides. Mannopyranosides 
and glycopyranosides bind to Con A in the C-1 chair conformation 
(Brewer et ^ . , 1973 ) and it has been suggested (Poretz and Goldstein,
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1970) that the protein has a specific site capable of interacting 
with the anomeric oxygen atom of the a-linked glycosides of these 
sugars. It is now known (Hardman and ,Ainsworth,, 197,2;, Wang et al., 1971; 
EdiQunds.on- et al. ,1971) that Con A consists of polypeptide subunits, 
of molecular weight 26,000. At pH 5.6 and below, two protomers 
are associated in a dimer of molecular weight 52,000; above pH 5.6, 
the idimer aggretate, forming tetramer. Con A exhibits also a 
reversible, temperature dependent dimer-tetramer transition(Gorden 
^ d  Marquardt, 1974 )
There is one binding site for saccharide per subunit (Yariv et al.,
2+ 2+1968), as well as one for Mn and one for Ca (Kalb and Levitzki,
1968). Both metals are reversibly removed from the protein at 
2+low pH. The Mn can be readily replaced by other transition metals,
2+such as Ni to yield fully active lectin preparations (Shoham e^ al.,
1973). Occupation of the transition metal site is required for the
binding of Ca^^, and both appear to be necessary for the binding of
saccharides (Kalb and Levitzki, 1968) although there is some un-
2+certainty about the exact role of Ca ; according to one view, it 
is not absolutely necessary for saccharide binding but acts only 
by enhancing the rate of conformational change leading to the formation 
of the functional protein (Koenig et , 1973. Richardson and Behnke, 
1976). Stark and Sherry (1979) reported that a variety of individual 
metal ions or mixtures of ions added to demetallized Con A convert 
the protein to the conformational form which has a high affinity 
for saccharides with the rates of conversion dependent upon the 
identity of the ions added and the sample pH. They also concluded 
that Zn̂ "*", Co^^ and Pb^^ were able to fill both metal binding sites
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2+ 2+and convert Con A to its active structure. Mn and Ca appear 
to stabilize the conformation of the protein,protecting it against 
heat inactivation (Doyle et al., 1976) and hydrolysis by proteolytic 
enzymes (Thomasson and Doyle, 1976).
Among the various applications of Con A is the isolation of Con 
A-binding glycoproteins frcxn normal and transformed cells of various 
species (for review see Lotan and Nicolson, 1979)using Con A affinity 
columns, measurement of acute phase proteins in serum of man and 
animals during inflammation and tissue breakdown (Kohn et ^ . , 1980), 
together with its wide use as a mitogen. Middlebrook et al. (1979) 
studied the interaction of Con A with diphtheria toxin and suggested 
that Con A could be used as a tool to study how the toxin crosses 
the cell membrane as Con A was found to prevent the internalization 
of the toxin into the cells. More details about the lectin can be 
found in a number of reviews (Cunningham, 1975; Bittiger and Schnebli, 
1976; Goldstein Hayes, 1978) .
One of the lectins emphasised in this work is the peanut lectin 
(Arachis hypogaea), whose discovery was associated with the phenomenon 
of T-polyagglutinability which usually arises as a result of vitro 
contamination of blood specimens through the degradive action 
of bacterial neuraminidase. This was first observed in 1927 by 
Thomsen who assumed that there exists a receptor L (latent), common 
to all red cells but normally Latent, which is activated or revealed 
through the effects of the bacterial 'agent' which was referred to 
as transforming bacterial enzyme by Friedenrich (1930). Thus the 
receptor was called T-receptor and the corresponding serum element
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T-agglutinin. The bacterial enzyme was later identified as neura­
minidase (Klenk, 1956; Gottschalk, I960), but the nature of the 
T-receptor (T-antigen) on the red cells remained obscure, despite 
the fact that neuraminidase-treated red cell glycoproteins showed a 
strong inhibitory power towards the T-agglutinin (Klenk and Uhlenbruck, 
I960). Following the work of other authors (Springer and Ansel,
1958; Makela and Cantell,1958; Painter et al., 1962; Klenk et al.,
1962) and from their own inhibition studies, Kim and Uhlenbruck 
(1966) were eventually able to determine the structure of the T-antigen 
to be the disaccharide 3-D-galactopyranosyl (l->-3)-N-acetyl-D- 
galactosamine. The T-antigen was later referred to as the Thomsen- 
Friedenrich antigen (Newman et al., 1977) to avoid any confusion 
with T for thymocyte or tumor antigen.
Bird (1964) was the first to extract from peanuts a T-agglutinin 
which resembled the naturally occurring antibody in having high 
affinity towards the disaccharide Gal-6-(1^8)-GalNAc. The peanut 
lectin was also found to be inhibited, to a lesser extent, by 
galactosides but not by the free N-acetylgalactosamine. iJie peanut 
lectin has been purified (Lotan et al., 1975; Terao et al., 1975) 
using affinity chromatography with a molecular weight of 110,000.
The finding of a unqiue sequence for the five NH^-terminal amino
acids of the peanut lectin suggested four identical subunits
(Lotan et al., 1975). The lectin was also shown to have no
covalently bound carbohydrate. Dahr et al.(1974, 1975c)showed that
the TF-antigen is part of the alkali-labile tetrasaccharide
that is involved in MN blood group activity. These findings confirmed
the earlier report of Klenk and Uhlenbruck (1960) that the TF-antigen
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is a cryptic antigen on human erythrocytic membrane glycoproteins and 
is usually covered by sialic acid. The lectin was found to be 
mitogenic (Novogrodsky et. al., 1975) to human peripheral blood 
lymphocytes and to rat lymphocytes only after treatment of the cells 
with neuraminidase, but not to stimulate mouse and guinea pig 
lymphocytes. On the other hand, the lectin was reported (Terao et al.,
1975) to have no mitogenic effects towards either native or neura­
minidase treated human peripheral blood lymphocytes in spite of the 
similarity of the lectin preparations by both groups. The question 
of mitogenicity of the peanut lectin, therefore, remains unresolved.
The peanut lectin has been used for clinical determinations 
of T-polyagglutinability (Bird and Wingham, 1971) to detect surface 
TF-antigen on normal mammary epithelial cells (Klein, e^ al., 1978), 
to detect TF-antigen on blood group M and N substances (Dahr al.,
1975c)and glycoproteins isolated from bovine MFGM (Newman et al.,
1976a). More recently, Reisner et al.(1980) reported that preleukaemic 
bone marrow and spleen cells of irradiated C57BL/6 mice that were 
inoculated with the radiation-induced leukaemia virus variant 
D-Rad LV differ from autonomous end-stage leukaemia cells in the 
expression of the receptor for peanut lectin. As a result, the 
preleukaemic cells are agglutinated by peanut lectin and the end- 
stage cells are not. They also demonstrated that the cells susceptible 
to D-Rad LV transformation in the thymus were present mainly among 
the peanut lectin-receptor-bearing cells.
Interest in the MN and precursor antigens has recently grown 
with the reports by Springer et a^. , (_ 1975, 197 7) that the TF-
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antigen is demonstrable in human malignant breast tissue and that 
anti-TF antibody, which is present in all normal human sera, is 
severely depressed in a significant number of patients with 
cancer of the breast. Depression of anti-TF antibody was reported 
to be caused either by binding of antibody to TF-antigen on the 
surfaces of intact tumour cells or by the presence of antigen shed 
from the tumour cell membrane (Springer et al., 1977; Anglin 
et al., 1977). These findings were later contested by Newman 
et al.(1979) who showed no significant differerence in the levels 
of anti-TF antibody and TF-antigen in serum and tissue cultures of 
normal individuals and patients with breast carcinoma.
As has been discussed in the general introduction to this thesis, 
the milk fat globule membrane can be regarded as a model mammalian 
membrane and in particular a model for epithelial cell membranes 
of the donor species. In view of the known difference in recognition 
type interaction between corresponding membranes from different species 
(I^ewman et al., 1976a,b) it was of interest to compare the exposure of a 
range of individual monosaccharide residues on the surfaces of 
bovine and human milk fat globules. This approach is of special 
importance since most of the analytical studies on MFGM carbohydrate 
of various species have been concentrated on the extraction of 
glycoproteins by various methods frc*n MFGMs (Newman et al., 1976 a; 
Keenan et al., 1977; Newman and Uhlenbruck, 1977; Murray et al., 1979) 
Sugar residues exposed on the surface of intact milk fat globules 
may well be subjected to differential extraction or to conformational 
changes during purification of glycoprotein fractions while glyco- 
lipid components, are largely lost. It is clear that contribution of
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carbohydrate structures to specific interactions of the MFGM and, by 
implication, also the mammary epithelial cell membrane, can most 
directly be studied in the intact fat globule.
This section describes a comparative study of the accessibility 
of various sugar residues on the surfaces of native and neuraminidase 
treated human and bovine milk fat globules. The study makes use of 
the fluorescence-activated cell sorter and of lectin-induced agglutination 




Arachis hypogaea (peanut agglutinin), Ricinus communis (type I 
and II), Lens culinaris (lentil lectin) concanavalin A (Con A), wheat 
germ agglutin, and Lotus tetragonolobus, both purified lectins and 
conjugated to fluorescein were all obtained from Sigma Chemical Co., 
London SW6, U.K. Native and fluorescein-conjugated phytohaemagglutinin 
(PHA) were generous gifts from Dr. R.A.Newman, Department of Immunology, 
Imperial Cancer Research Fund, London. Source plant material for 
soya bean, Ulex europeus and Dolichos biflorus lectins, extracted 
agglutinin from Helix pomatia and typed human red blood cells were 
generous gifts from Dr. D.J. Anstee. South West Regional Blood 
Transfusion Centre, Southmead, Bristol. Vicia graminea seeds were 
kindly supplied by Dr. W. Dahr, Department of Immunobiology,
Medical University Clinic, Cologne, W. Germany. Phosphate buffered 
s-aline (PBS) tablets were obtained from Oxoid Ltd., Basingstoke,
Hants, U.K. Microtiter plates were obtained from Sterilin Ltd., 
Teddington, Middlesex, U.K.
Neuraminidase ^Vibria comma (cholerae)] was purchased from 
Behringwekre, Marburg/Lahn, W. Germany. All other reagents were from 
BDH Chemicals Ltd., Poole, Dorset, U.K.
Fresh bovine milk was obtained from Friesian cows in mid-lactation 
and each sample was a pool frcxn four individual animals. Human milk 
and blood were from individual volunteers in established lactation.
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Methods:
Washed milk fat globules
Fresh milk (10 ml) was centrifuged at 15000 x ^  for.10 min at 
22°c. The separated milk fat globules (cream) were resuspended in 
phosphate-buffered saline (PBS), pH 7.3 (10 ml) and recentrifuged 
under the same conditions. The washing procedure was repeated a 
further three times after which the milk fat globules were resuspended 
in PBS, pH 7.3, so as to give an optical density of approximately 
1.7 O.D. when read against water at 700 nm.
Neuraminidase treatment of milk fat globules:
Washed milk fat globules (from 5 ml original milk) were suspended 
in PBS (1 ml), pH 5.6, containing 1 mM CaClg and neuraminidase 
(50 yl, 1 lU/ml) and the mixture was incubated at 37°C for 30 min.
The treated globules were removed by centrifugation at 15000 x g_ 
for 10 min at 22°C and resuspended in PBS, pH 7.3, (5 ml). The 
washing procedure was repeated a further three times after which 
the sialic acid-free globules were resuspended in PBS, pH 7.3, as 
described above.
Lectin-induced agglutination of milk fat globules:
A suspension of washed milk fat globules (20 yl) prepared as 
described above was mixed with lectin solution (20 yl) and PBS, 
pH 7.3, in a recessed microscope slide well and the agglutination 
was allowed to proceed at 22°C for 1 h. in a humid environment.
The fat globules were examined at lOOx magnification using a light 
microscope. Agglutination titres were expressed as the reciprocal 
of the minimum dilution of lectin giving agglutination of less 
than 30%. Control experiments were carried out by using buffer in place 
of lectins.
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Inhibition studies were performed by incubating the lectin 
solution (20 yl) (diluted 2^ ^ , where 2^ is the agglutination titre) 
with inhibitor (monosaccharides or MFGM-derived glycopeptides)
I
containing buffer (20 yl) for 30 min at 22 C prior to addition of 
milk fat globule suspension (20 yl). The mixture was allowed to 
stand for 1 h at 22°C in a humid environment after which the fat 
globules were examined at lOOx magnification using a light micro­
scope. Agglutination titres are expressed as the reciprocal of the 
minimum dilution of lectin giving agglutination of less than 30% 
of the total fat globules.
Analysis of human and bovine milk fat globules by the fluorescence 
Activated cell sorter
I. The instrument;
The fluorescence activated cell sorter (FACS) is an automatic 
electronic device of potentially great importance. It is capable of 
identifying and separating functionally distinct groups of viable 
cells that have, or can be made to have, either different fluorescence 
intensities, different light-scattering characteristics, or different 
combinations of these two variables. The instrument, its various 
modes of operation and its application have been described by many 
authors (Bonner et al., 1972; Hulett et al., 1973; Greaves et al.,
1976).
A simplified diagram illustrating the general principles is 
shown in Fig. 49. The cells are suspended in saline and emerge 
essentially in single file frcan an ultrasonically vibrated nozzle.





















a stream of 50 y diameter which is intersected by a beam from an 
argon-ion laser. As individual cells pass through the beam they 
scatter some of the light and, if labelled, they also fluoresce.
The two types of signals frcm the cells are detected separately 
(using microscope objectives), amplified and converted into voltage 
pulses the size of which is proportional to the input signal After 
the pulse hiehgt analysis, these data are displayed in the form of 
a histogram (see later); the ordinates representing the number of 
events (i.e. cells) recorded against pulse height (i.e. cell fluores­
cence intensity or size). Cells having particular characteristics 
of interest can be both enumerated and physically separated from 
the remainder. Separation is achieved by imparting a charge to 
the droplet stream. By 'informing' the FACS of the characteristics 
of the cells to be separated and by the use of finely controlled 
timing, droplets containing cells of interest can be charged and 
deflected into collection tubes, as they fall between charged 
plates (Fig. 49). Data are presented as polardid^photographs of 
the storage display following analysis of 10,000 globules. Standard 
settings of the FACS were. Laser: 200 mW, Photomultiplier tube;
760 V ,  fluorescence gain: 16/0.1 and scatter gain; 2/1.
II. Sample preparation
Native or neuraminidase-treated milk fat globule suspension 
(100 yl) prepared as described above, was incubated at 22°C with 
fluorescein-labelled lectin solution (50 yl) and PBS buffer, pH 7.3, 
(20 yl) for 30 min, after which more PBS buffer, pH 7.3, (2 ml) 
was added. The globules were then separated by centrifugation at 
15000 X  2 .  for 10 min and resuspended in PBS buffer, pH 7.3, (1 ml)
before examination by the FACS.
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Inhibition studies were performed by incubating fluorescence- 
labelled lectin solution (50 yl) with inhibitor-containing buffer 
(20 yl) for 30 min at 22°C after which globule suspension (100 yl) 
was added and the mixture was allowed to stand at 22°C for 30 
min before separating and resuspending the globules in buffer (1 ml) 
for examination by the FACS as described above. Inhibitor concen­
trations were 0.1 M in the case of monosaccharides and 1 mg/ml in 
the case of inhibition by MFGM-derived glycopeptides.
Lectin Solutions;
Commercially-obtained lectins were dissolved in PBS buffer, 
pH 7.3 , to an initial concentration of 2 mg/ml except in the case 
of Lotus tetragonolobus when 1 mg/ml were used. Samples were 
serially diluted (2x) with PBS buffer, pH 7.3, for agglutination assays 
For FACS analysis aliquots (50 yl) of fluorescein-labelled lectin 
solution containing lectin (150 yg) were used.
For lectins extracted directly fran plant material, dry source 
material (1 g) was ground in a mortar and added to PBS buffer, 
pH 7.3 (10 ml) at 4°C. The suspension was homogenized (MSE bench 
homogenizer, 6 x 30 sec) at 4°C and allowed to stand at 4°C for a 
further 5 min before centrifugation at 14,000 x ^  10 min at 4°C.
The aqueous supernatant was extracted ( 3 x 1  vol.) with diethyl 
ether, separated and freed from residual ether in a stream of 
at 4°C.
The activities of all lectin solutions were checked by demonstrating 
haemagglutination of neuraminidase-treated type 0,NN red blood cells
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(or native type A cells in the case of Helix pomatia and Dolichos 
biflorus) by high dilutions of the lectin solution (Table 17). 
Specificities were confirmed by showing complete inhibition of 
haemagglutination caused by four haemagglutination doses of lectin 
when a lO mM-solution of the immunodominant sugar (20 yl) was in­
cubated with the lectin solution for 30 min at 22°C prior to addition 
of red blood cells in the haemagglutination assay. The specificity 
of agglutination of milk fat globules was also checked directly 
by similar inhibition of three agglutination doses of lectin by 30 mM 
solutions of the respective immunodominant sugar. In the case of 
Arachis hypogaea specificity of milk fat globule agglutination was 
demonstrated by inhibtion of three agglutination doses of the lectin 
by 10 mM concentrations of purified Thomsen-Friedenreich antigen.
Haemagglutination assays :
Samples of human red blood cells (50% suspension in acid-citrate 
dextrose anti-coagulant) were diluted (to 10 ml) in PBS buffer, 
pH 7.3, and centrifuged at 3,500 x 2. for 10 min. The pelleted cells 
were resuspended in PBS and again centrifuged. The washing procedure 
was repeated three times after which, pelleted cells were diluted 
(to 3% v/v) in PBS buffer, pH 7.3, before being used in agglutination 
studies.
Neuraminidase-treated cells were prepared by suspending pelleted 
native red blood cells (0.5 ml) in PBS buffer, pH 5.6, (4.5 ml)
containing 1 mM CaCl^ and neuraminidase (50 yl, 1 lU/ml) and the 
mixture was incubated at 37°C for 30 min. Cells were freed from 








Ricinus communis (type I) 
(galactose, N-acetylgalactosamine)
2^^
Lens culinaris 2^: 2^: -
(mannose, glucose)
Lotus tetragonolobus 2^ 2^
(fucose)
2 _12Helix pomatia 2 2
(N-acetylgalactosamine)
Dolichos biflorus ne g 2®
(N-acetylgalactosamine)
Ulex europus 2^ 2^
(fucose)
Vicia graminea ^9 ^32 2




Table 17. Shows the activities of some of the lectins used 
with erythrocyte indicator cells. Titres are 
expressed as the reciprocal of the minimum 
dilution of lectin resulting in no agglutination 
of 3% suspension of cells.
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at 3,500 X 2  for 10 min and resuspended in PBS (pH 7.3, 10 ml).
Final packed washedccells were suspended (3% v/v) as described above 
for agglutination studies.
For the haemagglutination assay, tested cells, prepared as 
described above (20 yl suspension) were mixed with PBS buffer 
pH 7,3 (20 yl) and serially diluted lectin solution (20 yl) and 
allowed to stand in the well of a microtitre plate for 1 h at 26°C. 
Absence of agglutination was indicated by the presence of a compact 
'button'of cells at the bottom of the well.
Isolation of sialoglycopeptides from bovine MFGM:
Sialoglycopeptides were cleaved off intact washed bovine milk 
fat globules by treatment with pronase as described in Section A.
The pronase digested membrane materials were fractionated on 
Sephadex G-50 to give a major excluded peak which when fractionated 
by ion-exchange chromatography gave two fractions SP and SR (Section 
A, p. 72). The SR glycopeptide fraction was shown to contain 
high concentrations of the unsubstituted TF-antigen. Treatment of 
this fraction with mild acid (0.2 N HgSO^ at 80°C for 1 h) followed 
by chromatography on Sephadex G-25 resulted in the isolation of 
a purified sialic acid-free fraction containing approximately 0.3 mM 
of the free disaccharide 3-D-galactopyranosyl-(l->-3) N-acetyl-D- 
galactosamine (TF-antigen) (Section A, p. 83).
Preparation of free Thomsen-Friedenrich antigen:
As shown in Section A, treatment of the sialic acid rich (SR) 
glycopeptide (Fig. 27a) with alkaline borohydride resulted in the 
release of the alkali labile tetrasaccharide N-acetylneuraminyl-(2->-3)
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3-D-galactopyranosyl-(1^3) [^N-acetylneuraminyl-(2->^) J -N-acetyl- 
D-galactosaminitol (Peak III, Fig. 34). Fractions corresponding to 
the tetrasaccharide peak were combined and freeze dried to give a 
residue (0.5 - 1 mg). Combined residual tetrasaccharide material 
(5 mg) were incubated with 0.2 N HgSO^ (1.5 ml) at 80° C for 1 h. 
The hydrolysate was applied to the top of previously equilibrated 
column of DEAE-Sephadex A-25 (16 x 1.3 cm). The column was eluted 
with 50 mM pyridine acetate buffer, pH 5, (100 ml) followed by a 
linear gradient (50 - 650 mM) of pyridine acetate (200 ml) at 22°C 
with a flow rate of 40 ml/h. Fractions (5 ml) were automatically 
collected and aliquots (O. 1 ml) were assayed for sialic acid and 
hexose as described in Section A. The elution profile is shown in 
Fig. 50. Fractions corresponding to peak I (Fig. 50) were collected 
and freeze-dried to give the disaccharide 3-D-galactopyranosyl-3~ 
D-(l->3) N-acetyl-D-galactosaminitol ( = 2 mg).
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I. Leetin-induced agglutination of human milk fat globules
Native and neuraminidase treated human milk fat globules 
were subjected to agglutination by a range of purified lectins 
using the assay described in the Methods section and the average 
titres obtained are shown in Table 18. Titres represent the means 
of 20 sangles from different individuals of varying ABO and MN blood 
groups.
The individual titres obtained from a number of donors by 
using the pecinut agglutinin (PNA) , Arachis hypogaea, are shewn in 
Table 19. The data shown in Table 19 clearly demonstrates that unlike 
human blood cells, which are agglutinated by PNA .only after treat­
ment with neuraminidase, human milk fat globules from healthy 
individuals are readily agglutinated by h i ^  dilutions of PNA 
irrespective of the blood group of the donor with no significant 
increase of the titre after neuraminidase treatrrs£f*î’ of the globules. 
These findings indicate that in contrast to normal human red blood 
cells, receptors of PNA at the surfaces of normal human milk fat 
globules are almost totally unsubstituted with sialic acid. Thus^ 
high concentrations of the unsubstituted Thomse)-Friedenrich (TF) 
antigen (3-D-galactopyranosyl-(l-»-3)-N-acetyl-D-galactosamine) are 
exposed at the surfaces of normal human milk fat globules, and acces­
sible to the lectin. Indeed, this was confirmed by inhibition of 
PNA-induced agglutination of human milk fat globules by 10 mM 
concentrations of the purified (Materials and Methods) TF-antigen 
and by glycopeptide fraction (Section A, Fig. 31 ) containing 
0.3 mM of the unsubstituted (free) TF-antigen.
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Ricinus communis type I 
(galactose, N-acetylgalactosamine)
2^° 2^°
Ricinus communis type II 
(galactose)
2® 2«































* Values are the means of titres obtained by using 20 samples 
of milk all from different individuals of varying ABO and MN 
blood groups. No differences in titre were observed with 
different blood groups
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As shown in Table 18, human milk fat globules were not agglut­
inated by the fucose-specific lectins, Ulex europeus and Lotus 
tetragonolobus although weak agglutination was detected with the 
latter lectin following neuraminidase treatment of the human globules. 
Human milk fat globules were not agglutinated either by Helix pomatia 
or by Dolichos biflorus lectins irrespective of the blood group 
of the donor. Helix pomatia, however, was able to agglutinate human 
globules following their treatment with neuraminidase (Table 18). 
Vicia graminea failed to agglutinate human milk fat globules even 
after their treatment with neuraminidase (Table 18), which indirectly 
supports the results obtained with PNA (Vicia graminea requires the 
TF-antigen in part in its receptor). Table 18 also shows that human 
milk fat globules were specifically agglutinated by high dilutions 
of Ricinus communis (type I and II) soya bean, concanavalin A,
Lens culinaris and what germ agglutinin, demonstrating the accessi­
bility of galactose (Ricinus type I and II, soya bean), mannose 
and/or glucose (Con A, Lens lectins) and N-acetylglucosamine (wheat 
germ agglutinin) on the surfaces of intact human milk fat globules.
Of these lectins, soya bean. Con A, Lens and to a lesser extent 
WGA showed increased activity following treatment of the globules 
with neuraminidase (Table 18).
II. Lectin-induced agglutination of bovine milk fat globules: 
Native and neuraminidase treated bovine milk fat globules 
were agglutinated by a range of purified lectins as described in 
the Methods Section(p. 152 ) and the average titres are shown in 
Table 20. Titres represent means of experiments using five batches 
of pooled milk each of which was pooled from four individual cows.
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Ricinus communis type II 
(galactose)
2? 2*































*Values are the means of titres obtained by using 5 samples of 
milk each of which was pooled from 4 individual cows
Table 20. Agglutination titres of bovine milk fat globules 
with different lectins.
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Pooled bovine milk fat globules were found to be agglutinated 
by high dilutions of Ricinus communis (types I and II), soya bean 
and what germ agglutinins, Concanavalin A and Helix pomatia lectin.
In all cases agglutination was specifically inhibited by the corres­
ponding monosaccharide receptor (Table 20). Specific agglutination 
by these lectins demonstrates the accessibility of galactose (Ricinus 
types I and II, soya bean), mannose and/or glucose (Concanavalin A), 
N-acetyl-D-glucosamine (wheat germ agglutinin) and N-acetyl-D- 
galactosamine (Helix pomatia) on the surfaces of intact bovine milk 
fat globules. As with human globules, bovine milk.fat. globules were 
not agglutinated by the fucose-specific lectins, Ulex europeus and 
Lotus tetragonolobus, although fucose was detected in bovine MFGM- 
derived glycopeptides (Section A, p. 88). Bovine milk fat globules 
were agglutinated by Lens and PNA to a lesser extent than human 
globules and in both cases the agglutination titres were increased 
following treatment of the globules with neuraminidase (Table 20).
Thus the TF-antigen at the surfaces of bovine milk fat globules 
is apparently present both free and substituted with sialic acid.
These findings agree with the agglutination titres obtained with 
Vicia graminea which agglutinated bovine globules only after treatment 
of the latter with neuraminidase (Table 20).
Ill. Fluorescence activated cell sorter analysis of the interaction
of lectins with human MFGst
The degree of interaction of each of a range of purified 
lectins with native and neuraminidase-treated normal human milk fat 
globules was assessed by examining the percentage of globules carrying 
fluorescent-labelled lectins as described in the Methods section.
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The results obtained are shown in Table 21 which demonstrates a 
high percentage of fluorescent-labelling of the human globules by 
fluorescein-labelled PNA, Ricinus (type II), soya bean agglutinin 
and wheat :germ agglutinin. The percentage of labelling increased 
after neuraminidase treatment of the globules in the case of Ricinus 
and soya bean lectins but no significant increase was observed in 
the case of PNA (Fig. 51 A and B) and wheat germ agglutinins (Table 
21). No interaction between the human globules and phytohaemagglutinin 
was observed even after treatment of the globules with neuraminidase 
(Fig. 52 A and B). These findings agree with those obtained from the 
milk fat globule agglutination assay (Table 18), and, indeed, stresses 
the sensitivity of the agglutination assay.
The labelling of the globules with lectins listed in Table 
21 was specifically inhibited by 30 mM concentrations of the respective 
receptor of each lectin.
Fluorescence activated cell sorter analysis of the interacation of 
lectins with bovine MFCs;
The degree of interaction of each of a range of purified lectins 
with native and neuraminidase treated bovine milk fat globules 
was assessed by examining the percentage of globules labelled with 
fluorescent lectins as described for human globules. The results 
obtained (Table 22) were in general consistent with those obtained 
from the milk fat globule agglutination assay (Table 20). As shown 
in Table 22, pooled bovine milk fat globules were highly labelled 
by fluorescent Ricinus (type II), wheat germ agglutinin. Unlike 
human globules, bovine milk fat globules were poorly labelled with
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NORMAL HUMAN MILK FAT GLOBULES




90% ± 1 97% ± 1 
- +
Soya bean agglutinin 
(galactose)
80% ± 1 88% ± 1
Arachis hypogaea 
(TF-antigen)
88% ± 1 90% ± 1 -
Wheat germ agglutinin 
(N-acetyl-D-glucosamine)
76% ± 1 78% ± 1
Phytohaemagglutinin 
(N-acetyl-D-galactos amine) -ve -ve
Table 21. Percentage of fluorescence-labelling of native 
and neuraminidase treated normal human milk 




POOLED BOVINE MILK 
Native, washed
FAT GLOBULES
Neuraminid as e- 
treated
Ricinus communis 82% ± 1 89% ± 1
type II (galactose)
Soya bean agglutinin 50% ± 1 72% ± 1
(galactose)
Arachis hypogaea 10% ± 1 40% ± 1 -
(TF-antigen)
Wheat germ agglutinin 72% ± 1 73% ± 1
(N-acetyl-D-glucosamine)
Phytohaemagglutinin -ve - ve
(N-acetyl-D-galactosamine)
Table 22. Percentage of fluorescence-labelling of native 
and neuraminidase treated bovine milk fat 
globules following their incubation with a 
range of fluorescent-labelled lectins.
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fluorescent PNA, but the percentage of labelling was dramatically 
increased (3 fold) following treatment of the globules with neura­
minidase (Fig. 51C and D; Fig. 53) suggesting that the lectin 
receptor (TF-antigen) is largely substituted with sialic acid. 
Percentages of labelling of the bovine globules were also increased 
after their treatment with neuraminidase in the case of fluorescent 
soya bean agglutinin (Fig. 54) and to a lesser extent by fluorescent 
Ricinus (type II). As in the case of the human globules, bovine 
milk fat globules did not interact with phytohaemagglutinin even 
after their treatment with neuraminidase (Fig. 52 C and D). The 
interaction of bovine milk fat globules with the lectins listed in 
Table 22 were specifically inhibited by 30 mM Concentrations of the 
respective receptor of each lectin.
Inhibition by bovine-derived sialoglycopeptides of the interaction 
of specific lectins with human milk fat globules:
The ability of each of a range of bovine MFGM-derived sialog- 
lycopeptides (Section A) to inhibit the attachment of specific 
lectins to human milk fat globules was assessed by using the 
fluorescent activated cell sorter as described in the Methods 
section. The results are shewn in Table 23. As can be seen from 
Table 23, the partially purified (PP) sialoglycopeptides mixtures 
(Section A)completely or partially inhibited the interaction of 
human milk fat globules with fluorescent soya bean agglutinin,
PNA, WGA, Ricinus (type II) and Helix pomatia lectins. Mannose 
and/or glucose (Con A) and N-acetyl-D-glucosamine (WGA)-specific 
lectins were best inhibited by the SP-glycopeptide fraction indicating 
that the carbohydrate residues in this fraction are accessible to
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Fig. 51. Fluorescence Activated Cell Sorter (FACS)
analysis of peanut lectin binding to human
and bovine milk fat globules.
Ordinate: relative fluorescence intensity.
Abscissa: relative globule size.
A. Lectin incubated with native human 
globules.
B. Lectin incubated with neuraminidase- 
treated human globules.
C. Lectin incubated with native bovine globules.




Fig. 52. FACS analysis of phytohaemagglutinin 
binding to human and bovine milk fat 
globules.
Ordinate: relative fluorescence intensity 
Abscissa: relative globule size
A. Intact human milk fat globules.
B. Neuraminisae-treated human globules.
C. Intact bovine milk fat globules.
D. Neuraminidase-treated bovine globules.

174
Fig. 53. FACS analysis of peanut lectin to bovine 
milk fat globules.
Ordinate: relative globule number 
Abscissa: relative fluorescence intensity,
A. Lectin incubated with native globules




these lectins (Fig. 56 and Table 23) . On the other hand, the SR- 
glycopeptide fraction did not inhibit the interaction of fluorescent 
WGA and of fluorescent Ricinus II with human globules but inhibited 
the globules interaction with fluorescent Con A to a much lesser 
extent than the inhibition obtained using the SP-glycopeptide 
fraction. The SP-glycopeptide fraction also inhibited the interaction 
of the human globules with fluorescent soya bean agglutinin. In 
fact, soya bean interaction with the human globules was completely 
inhibited by all glycopeptides used (Table 23), demonstrating the 
accessibility of galactose residues in these glycopeptides to the 
lectin. Arachis (PNA) interaction with the human globules was 
only inhibited significantly by the acid hydrolysed SR glycopeptide 
fraction (Fig. 57) (sialic acid free) which was shown to contain 
approximately O.3 mM of the free TF-antigen (Section A). The PP- 
glycopeptide mixture inhibited fluorescent PNA interaction with 
the human globules by only 20% (Table 23) which could account for 
the interaction of PNA with galactose as the lectin is known.to 
have affinity towards galactose. To overcome the argument that 
PUfX binds galactose rather than the TF-antigen, competitive binding 
experiments were carried out using fluorescent Ricinus (type IT)together 
with non-1abelied PNA and vice versa. The percentages of labelling of 
the human globules in this experiment (Table 24) shows that each 
of Ricinus (type II) and PNA attaches to different receptors at the 
surfaces of intact human milk fat globules. Indeed, when inhibition 
studies were carried out by using galactose and TF-antigen the results 
showed that 10 mM of the TF-antigen were required to completely 
inhibit PNA interaction with the human globules while 33 mM of 
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A^ + - A ,R +R + — R ,A
% nf labelled 75% 72% 88% 80%globules ( 1)
= fluorescent Arachis
A = non-labelled Arachis
= fluorescent Ricinus (type II)
R = hon-labelled Ricinus (type II)
Table 24. Competitive binding of Ricinus and Arachis lectins 
to human milk fat globules.
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strongly suggests that the binding of PNA to human milk fat globules 
is through the TF-antigen rather than galactose.
The SR-glycopeptide fraction failed to inhibit Ricinus (type 
II) which has high affinity towards galactose indicating that receptors 
of this lectin in the glycopeptide are probably masked by sialic 
acid. Indeed this was shown to be the case when 50% inhibition was 
achieved by using the sialic acid free SR-glycopeptide fraction and 
by the alkaline borohydride treated SR-glycopeptide fraction (Fig.
55) .
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Fig. 54. FACS analysis of soya bean agglutinin binding 
to bovine milk fat globules.
Ordinate: relative globule number.
Abscissa: relative fluorescence intensity,
A. Lectin pre-incubated with galactose.
B. Lectin incubated with native globules,
C. Lectin incubated with neuraminidase- 
treated globules.
Fig. 55. FACS analysis of Ricinus-II binding to human 
milk fat globules.
Ordinate: relative globule number.
Abscissa: relative fluorescence intensity.
A. Lectin pre-incubated with galactose.
B. Lectin pre-incubated with desialylated 
SR glycopeptide.
C. Lectin incubated with native globules.
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Fig. 56. FACS analysis of con A binding to human milk 
fat globules.
Ordinate: relative globule number.
Abscissa: relative fluorescence intensity.
A. 1. Con A pre-incubated with SP glycopeptide
2. Con A pre-incubated with SR glycopeptide
3. Con A.




Fig. 57. FACS analysis of peanut lectin binding to 
human milk fat globules.
Ordinate: relative fluorescence intensity 
Abscissa: relative globule size.
A. Lectin
B. Lectin pre-incubated with SR glycopeptide
C. Lectin pre-incubated with PP glycopeptide





It is now well established that the milk fat globule membrane 
(MFGMX is derived primarily from the apical plamsa membrane of 
mammary alveolar epithelial cells (Patton and Keenan, 1975).
While the MFGM has become increasingly popular as a model for 
studies of plasma membrane properties, most research has been 
concentrated on the extraction of proteins and glycoproteins by 
various methods from milk fat globule membranes. Sugar residues 
e3g>osed on the surface of intact milk fat globules may well be 
subjected to differential extraction or to conformational changes 
during purification of glycoprotein fractions while glycolipid 
components are largely lost. It is clear that contribution of 
carbohydrate structures to specific interactions of the MFGM and, 
by implication, also the mammary epithelial cell membrane, can 
most directly be studied in the intact fàt globule. Exposure 
of monosaccharide residues has accordingly been examined on the 
outer membrane Surface of intact and neuraminidase treated bovine 
and human milk fat globules by making use of lectin-induced 
agglutination of milk fat gld^ules and of the fluorescent- 
activated cell sorter (FACS).
Pooled bovine milk fat globules were found to be agglutinated 
by high dilutions of Ricinus communis (types I and II), soya bean 
and wheat germ agglutinins, concanavalin A (Con A) and Helix pomatia 
lectin. In all cases agglutination was specifically inhibited 
by the corresponding monosaccharide receptor. Specific agglutination 
by these lectins demonstrates the accessibility of galactose 
(Ricinus types I and II, soya bean), mannose and/or glucose (Con A),
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N-acetyl-D-galactosamine (Helix pomatia) and N-acetyl-D-glucosamine 
(wheat germ agglutinin) on the surfaces of intact bovine milk 
fat globules. The degree of interaction of the fluorescent 
derivatives of the above lectins (with the exception of Con A) 
was assessed by the FACS and the results obtained were in general 
agreement with those obtained from the agglutination assay, a 
correlation which stresses the usefulness of the agglutination 
assay as a sensitive and reliable technique in studying surface 
receptors on milk fat globules. These observations are entirely 
consistent with the gas chromatographic evidence in that sialo­
glycopeptides isolated from the surface of bovine milk fat globules 
by proteolytic treatment contain all the above sugars together 
with sialic acid and fucose (Section A). Sialic acid was shown 
(Newman and Harrison, 197 3) by microelectrophoretic technique 
to be exposed on the surface of intact bovine milk fat globules 
whereas other sugars were not detectable by these means. Although 
the presence of fucose in bovine MFGM-derived glycopeptides has 
been demonstrated by gas chromatography (Section A), this was not 
reflected in agglutination of the globules by either of the fucose- 
specific lectins, Ulex europaeus or Lotus tetragonolobus.. Horis- 
berger e^ al.(1977) were similarly unable to demonstrate marking 
of bovine milk fat globules by gold-labelled anti-H lectin and 
it appears that although fucose is normally a chain-terminal unit, 
access to the sugar is hindered not only in the case of gold- 
labelled lectins but also in that of the underivatized reagents.
In contrast to the findings of Horisberger e^ al. (197 7), specific 
interaction of bovine milk fat globules with peanut agglutinin
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(Arachis hypogaea) could be demonstrated by means of . the agglutin­
ation assay and by the FACS. Peanut agglutinin has been shown 
(Lotan e_t , 1975; Pereira et , 1976) to have high affinity 
for the Thomsen-Fredenreich(TF) antigen (g-D-galactopyranosyl- 
(l+3)-N-acetyl-D-galactosamine) and the Arachis-induced agglutination 
of bovine milk fat globulès was specifically inhibited by low 
concentrations of the free reduced TF antigen. Another piece of 
evidence supporting the above observations was provided by the 
fact that the desialylated SR glycopeptide, which is known (Farrar, 
1978) to carry high concentrations of TF antigen, specifically 
inhibited the ArachiÉ-induced agglutination of bovine globules, 
whereas both native and alkaline borohydride-treated SR glycopeptide 
showed no inhibitory activities. Sialic acid-substituted TF 
antigen has been shown to be released from the PP sialoglycopeptide 
(Farrar and Harrison/ 1978) as well as from the SR glycopeptide 
(Farra, 19 78) by alkaline borhydride treatment in the form of 
two trisaccharides and a tetrasaccharide fraction (Fig. 24). The 
unsubstituted TF antigen was not specifically sought in these 
studies but has been detected in a phenol-extracted glycoprotein 
fraction from bovine MFGM by Newman et.ad., (1976) who used a
haemagglutination-inhibition technique. The present evidence 
for the exposure of unmasked TF antigen on the surface of bovine 
milk fat globules clearly complements these latter findings and 
indicates that the presence of unsubstituted disaccharide in 
extracted glycoproteins does not result from artefactual cleavage 
of sialic acid residues during the extraction procedure. The failure 
of Horisberger et a^., (1977) to mark bovine fat globules with
gold-labelled peanut lectin could reflect a more restricted access
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of the bulky labelled reagent to the surface receptors.
As might be expected, pre-treatment of bovine milk fat globules 
with neuraminidase led to cleavage of sialic acid residues from 
the surface tri-and tetra-saccharide (Farrar, 1978; Farrar and 
Harrison,1978) with consequent e^gosure of the TF antigenic core.
It is of interest that Vicia graminea which is known (Uhlenbruck 
and Dahr, 1971) to require the presence of TF antigen in its 
specific receptor site, only causes agglutination of bovine globules 
after neuraminidase treatment of the globules when the concentration 
of exposed disaccharide was increased.
The presence of N-acetyl-D-galactosamine in an exposed form 
on the surface of bovine milk fat globules was shown by the specific 
agglutinations induced by Helix pomatia and Dolichos biflorus 
lectins. This supports previous reports (Newman et al., 1976;
Newman and Uhlenbruck, 1977) that phenol-extracted glycoproteins 
from bovine |V(FGM carry unsubstituted N-acetyl-D-galactosamine.
This is also consistent with our findings that treatment of 
the SP glycopeptide with periodate (Section A) resulted in the 
destruction of all its N-acetyl-D-galactosamine indicating that 
this sugar is terminal in position. The agglutination titre 
was slightly increased by neuraminidase treatment of the bovine 
globules.
Human MFGM is less readily available than the bovine membrane 
and has been correspondingly less studied. Human milk fat globules 
were found to be specifically agglutinated by high dilutions of
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Ricinus coimnunis (types I and II), soya bean, concanavalin A, Lens 
and wheat germ agglutinins, demonstrating the accessibility of 
galactose (Ricinus, soya bean agglutinin)mannose and/ or glucose 
(Con A, Lens) and N-acetyl-D-glucosamine (wheat germ agglutinin) 
on the surfaces of intact fat globules. Agglutination of human 
globules by these lectins is generally similar to that of bovine 
globules although titres, particularly for Con A and Lens, were 
higher in the human case. As for bovine globules, agglutinations 
were specifically inhibited by the corresponding hapten sugars.
These observations are entirely consistent with the gas chromato­
graphic evidence (Safi, 1981) that sialoglycopeptides isolated 
from the surface of human milk fat globules by proteolytic 
treatment contain all the above sugars together with sialic acid 
and fucose. These findings also support the electron microscopic 
data of Horisberger £t al. (1977) in which human milk fat globules 
were found to be marked by gold-labelled soya bean, wheat germ 
agglutinins and, although to a lesser extent, by Con A. The 
ability of intact human milk fat globules to bind soya bean 
agglutinin contrasts with the behaviour of extracted humain MFGM 
glycoprotein con^onents which interact weakly (Newman and Uhlenbruck,
1977) or not at all ( Murray et ^ . , 1979) with soya beam 
lectin. It may be that soya bean lectin-induced agglutination 
of intact human milk fat globules and marking of the globules 
by gold-labelled soya bean lectin (Horisberger et al., 1977) 
involves exclusively glycolipid-bound galactose. The increased 
interactions (Table 22 and Horisberger et al., 1977)observed 
following neuraminidase treatment of the globules suggest, however, 
that glycoprotein-bound galactose is involved at least in the
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response of sialic acid-free globules to soya bean lectin because, 
as Horisberger et al.(1977) have pointed out, MFGM proteins mask 
membrane gangliosides from neuraminidase attack (Tomich e^ al.,
1976).
As with bovine globules, human milk fat globules were not 
agglutinated by the fucose-specific lectins, Ulex europaeus and 
Lotus tetragonolobus although weak agglutination was detected 
with the latter lectin follwoing neuraminidase treatment of the 
human globules. Most lectins do, in fact, show increased agglutin­
ation titres after treatment either of bovine or human fat globules 
with neuraminidase. It is likely that such increases generally 
reflect unmasking of relevant sugar receptors as a consequence 
of the removal of terminal sialic acid-residues. It could be 
that enhanced agglutinability under such circumstances simply 
arises from non-specific aggregation resulting from loss of 
surface negative charges although the lack of increase of 
agglutination of human fat globules by Arachis following neuraminidase 
treatment of the globules, argue against this.
The human milk fat globules were also agglutinated by 
relatively high dilutions of the peanut agglutinin and as in the 
case of bovine fat globules, agglutination was specifically 
inhibited by the free (reduced) TF antigen and by the desialylated 
SR glycopeptide which is rich in the unsubstituted TF antigen.
Neither the native SR glycopeptide nor the alkaline borohydride 
treated SR glycopeptide inhibited the Arachis-induced agglutination. 
The exposure of substituted TF antigen on the surface of intact
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human milk fat globules has not previously been demonstrated, 
although Klein e^ al.(1978) have provided evidence for exposure 
of the antigen on the surface of normal Aammary epithelial cells 
frcm which the globule membrane id derived. These results are 
contrary to those of Springer e^ al.(1975) who found the TF 
antigen to be exposed on breast carcinoma but not in normal 
tissue. Our results are also consistent with the findings of 
Newman e^ al.(1979) who found TF antigen in breast tissue 
cultures of normal individuals. As is the case with soya bean 
agglutinin, peanut lectin apparently behaves differently with 
extracted human MFGM glycoproteins. Thus, Newman and Uhlenbruck 
(1977) were unable to show inhibition of peanut lectin-induced 
agglutination of desialylated erythrocytes either by native 
or by desialylated human MFOi glycoprotines indicating that the 
TF antigen was not accessible on their glycoprotein extract, despite 
the fact that it was detected chemically in the same fraction 
(Glockner et al., 1976).
As mentioned above, human fat globules were not rendered 
more agglutinable by peanut lectin following their treatment 
with neuraminidase. This contrasts with the behaviour of bovine 
milk fat globules which carry appreciable amounts of sialylated 
TF antigen in tri- and tetrasaccharide forms (Farrar, 1978;
Farrar and Harrison, 1978) exposed on their outer surface. These 
conclusions are supported by the results obtained using Vicia graminea 
lectin which failed to agglutinate human fat globules even after 
neuraminidase treatment of the globules. Under similar circumstances 
the TF antigens of bovine milk fat globules were apparently
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unmasked sufficiently to allow agglutination by high dilutions 
of Vicia graminea lectin, even though, as in the human case, 
native globules were not agglutinated by highest concentrations 
of lectin. The above conclusions are suported by the findings 
of Safi (1981) that treatment of a major sialoglycopeptide 
isolated from intact human milk fat globules with alkaline 
borohydride resulted in the release of a tetrasaccharide fraction 
containing sialic acid, galactose, N-acetyl-D-glucosamine and 
N-acetyl-D-galactosamine in the approximate molar ratios 3:3.5:2:1 
respectively. TF antigen containing oligosaccharides were
not reported in the human MFGM-derived sialoglycopeptides 
(Safi, 1981).
In contrast to bovine globules, human milk fat globules
were not agglutinated by N-acetyl-D-galactosamine-specific
lectins. Helix pomatia and Dolichos biflorus, irrespective of
the blood group of the human donor. It is of interest that donors
of A-blood group specificity express the A antigen (N-acetyl-D-
galactosamine) on their red blood cells (by definition) but not
apparently on milk fat globules. The opposite is true of the bovine
system in which unsubstituted Helix pomatia receptor has been
detected on intact milk fat globules but not on erythrocytes
(Kim and Uhlenbruck, 1966). Results obtained from membrane-derived
glycoprotein fractions agree with these findings in the bovine
<\e\r
(Newman et al., 1977; Newman æd Uhlenbruck, 1977) butfin the 
human case, when Helix pomatia receptors (̂ de tec ted on phenol-extracted 
glycoprotein fractions from human MFGM (Glockner e^ al., 1976).
The above findings were, as in the case of bovine globules, 
assessed by the FACS and in all cases results were consistent with
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thos-e obtained from the milk fat globule agglutination assay 
again stressing the validity of the latter assay.
The accessibility of carbohydrate residues in bovine MFGM- 
derived sialoglycopeptides to a range of fluorescent labelled 
lectins was studied by inhibition of fluorescein labelling of 
human globules by these lectins. Thus, the SP glycopeptide 
fraction inhibited, labelling of the globules by Con A (mannose- 
specific) and wheat germ agglutinin (N-acetyl-D-glucosamine- 
specific). This is consistent with the gas chromatographic 
evidence that the SP glycopeptide is rich in mannose and N-acetyl- 
D-glucosamine (Section A) and suggests that these sugars are 
accessible to the above lectins. The SR glycopeptides, on the 
other hand, did not inhibit labelling of the globules by either 
Con A or wheat germ agglutinin whereas its desialylated and alkaline 
borohydride treated derivatives inhibited the labelling of 
globules by Con A but not by wheat germ agglutinin. This increased 
activity with respect to Con A could be due to unmasking of 
subterminal mannose residues following desialylation.
Sialic acid has been reported (Lis and Sharon, 1977; Goldstein 
and Hayes, 1978) to be important in the binding of wheat germ 
agglutinin to glycoprotein and glycopeptides but the present 
results do not support this. Agglutination titres of bovine and 
human globules by this lectin were not decreased following 
neuraminidase treatment of the globules and the SR glycopeptide 
failed to inhibit the interaction of this lectin with the human 
globules.
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In spite of the gas chromatographic evidence that the SR 
glycopeptide is rich in galactose, it did not inhibit interaction 
of Ricinus II with the globules. This is consistent with the fact 
that most of the galactose is internal in position as part of the 
sialic acid-substituted TF antigen with the fact that only 30% of 
total galactose was destroyed by periodate treatment (Section A). 
Indeed, desialylation and alkaline borohydride treatment of the 
SR glycopeptide increased this inhibition to 50%. Galactose 
residues on the SP glycopeptide were similarly inaccessible to 
Ricinus-II. This was as this glycopeptide fraction is poor 
in galactose and the sugar could be totally masked by sialic acid. 
Galactose residues on all glycopeptides tested (Table 23), on 
the other hand, were accessible to soya bean agglutinin. These 
observations are in agreement with those of Murray e^ al. (1979) 
who showed that soya bean agglutinin was cible to bind all seven 
glycoproteins isolated from bovine MFGM.
The milk fat globule agglutination assay employed in this 
study is a simple technique capable of rapidly providing 
quantitative information about the accessibility of a wide range 
of membrane-bound sugar components without the need for chemical 
derivatization. The general agreement of results obtained from 
this method and from the highly advanced FACS implies that the 
agglutination assay, besictes being rapid emd easy to perform is 
highly sensitive. The method is applicable to surface antigens 
in general and has been used to define immunodominant groupings 
(Section A) and receptors for bacteria (Section C) on the surfaces 
of bovine MFGM. The occasional differences between the agglutination
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assay and FACS on the one hand and the elegant but more limited 
studies of Horisberger et al. (1977) using gold-labelled lectins, 
on the other, can be explained in terms of hindered access of 
the rélatively-bulky gold-labelled lectins to the globule 
surface. Differences between interactions of lectins with intact 
globules on the one hand and with isolated glycoproteins on 
the other, are more marked and could well reflect changes resulting 
from extraction in the latter case. It may also be that glyco- 
1ipids contribute significantly to the specific interactions of 
the MFGM surface.
One of the most significant differences between human and ,
bovine MFGM show by agglutination and FACS studies is the lack 
of effect of neuraminidase on peanut lectin interaction with human 
globules suggesting that the latter do not carry significant 
amounts of tri- and tetrasaccharide residues which have been 
isolated from bovine globules (Farrar, 1978; Farrar and Harrison,
1978). These oligosaccharides have been characterized in membranes 
of human erythrocytes (Thomas and Winzler, 1969), porcine 
erythrocytes (Dukov, 1980),rat brain (Finne, 1975) and on other 
membranes (Krusius and Finne, 1977) and their apparent absence 
from human milk fat globules raises the problem of their function 
generally. A second major difference concerns the presence of 
Helix pomatia receptors on bovine but not on human milk fat 
globules despite the A-blood group specificity of many of the 
human donors. It is an intriguing fact that in both these cases the
structure present on bovine but not on human globules has been 
reported in human but not in bovine erythrocyte membranes (Kim 
and Uhlenbruck, 1966; Thomas and Winzler, 1969; Emers on and 
Kornfeld, 1976).
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The contribution of MFGM lectin receptors to specific 
interactions of the milk fat globule, or more significantly, of 
the mammary epithelial cell membrane, remain to be elucidated, 
but it is likely that these exposed sugar residues will be shown 
to play an important role in recognition processes involving 
mammary cells or epithelial cells generally.
Section C
Investigation of exposed receptors for the 
K99 adhesin on the surfaces of bovine milk 
fat globules and sheep erythrocytes
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Introduction
The mucous membranes of mammals are the major routes of entry 
for microbial infections, and infections which aure localized in, of 
invade via, the gastrointestinal tract are important causes of 
morbidity and mortality. Gastrointestinal disorders are especially 
common with many deaths occurring frcm Escherichia eoli (E. coli) 
infection (Sojka, 1973) and from transmissible gastroenteritis.
The latter has a mortality approaching 100% in pigs under 7 days 
of age although older pigs are not seriously aiffected (Bohl, 1973) .
Metchinikoff (1905) was one of the first to consider the dis­
turbing inç)lication of man*s lifelong coexistence with the huge 
numbers of potentially unpleasant organisms within him. Now, the 
immunological relationship of host to pathogen in the intestine is 
better understood, but still many questions remain concerning the 
nature of the usually peaceful relationship between the animal host 
and its normal enteric flora. The major property of the immune system 
is its ability to distinguish with great specificity between 'self 
and 'non-self' organisms or substances. In the gastrointestinal 
tract, however, the immune system has evolved alongside the development 
of powerful and specific systems which allow totally separate 
organisms (such as man and E. coli or bacteroids)to.maintain close 
symbiotic relationships.Thus, the immunological system of the 
gastrointestinal mucosa must have evolved the ability to distinguish 
not merely between self and non-self antigens, but also between 
'acceptable' and 'non-acceptable' microorganisms within the intestine. 
It thereby preserves the ability to mount a defensive response against 
pathogens, and avoids the production of an appropriate response 
agciinst the normal microflora (McCelland, 1979) . Besides the 
adaptive immunological mechanisms of the intestinal immune system.
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non-immune factors including diet, gastric acid secretion, intestinal 
mobility, anatomical disturbance, bile salt concentration, pH, redox 
potential as well as the interactions of various members of the 
intestinal microflora with each other and with the host (Savage,
1972; Jones, and Rutter, 1972) are also involved. The overall 
stability of the intestinal flora is dependent upon the complex 
interactions between the above factors (Fig. 58).
Certain enteropathogenic strains of E. coli are associated with 
diarrhoeal diseases in pigs, calves, lambs and humans. Despite the 
differences between strains isolated from different animal species 
there are two general requirements for the production of disease; 
firstly successful binding of the organism and colonisation of the 
intestine and secondly releeise of he at-labile or heat-stable entero-
toxins. The heat-labile enterotoxin of E. coli resemble
n.
cholera ^terotoxin and activates adenylate cyclase with a resultant 
increase in cAMP and inhibition of sodium absorption. Thus, sodium 
no longer acts as a driving force and chloride is actively moved 
from blood to lumen, pulling cations and water with it into the gut 
lument to maintain the osmotic equilibrium with blood plasma (Fig. 59) 
(Finkelstein, 1976; Du Pont and Pickering, 1980).
The first cleeir evidence of the significance of bacterial 
adhesion in expressing pathogenicity came in the early 1970s when 
Smith and Linggood (1971) reported that the virulence of E. coli 
for early-weaned piglets increased after the bacteria had acquired 
the ability to produce K88 adhesin (antigen). This was followed 
by the report of Jones and Rutter (1972) in which they demonstrated
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interaction 









Fig. 58. The normal bacterial flora of tlie intestine are
determined by complex interactions of bacteria with each 
other and with host's defence mechanisms. A pathogen 
must be able to disturb these relationships to establish 












Fig. 59 Schematic representation of intestinal binding of cholera 
toxin and heat-labile E. coli toxin leading to intestinal 
secretion of fluid and electrolytes (After Du Pont and Pic- 
Kering, 1980).
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that the K88 adhesin was synthesized by a K88-positive enteropathogenic 
E. coli (EPEC) in the upper intestine of both gonobiotic and con­
ventional neonatal piglets where it functioned as an adhesive 
agent enabling the bacteria to adhere to and colonize the intestinal 
mucosa. K88-negative mutant strains, on the other hand, did not 
adhere to and colonize the mucosa. More recently, Rutter et al. (1976) 
reported that piglets suckled by dams vaccinated with K88 vaccine 
are not susceptible to challenge with K88-positive EPEC.
Another adhesin, referred to as adhesin, was reported to 
be present in enteropathogenic strains in calves and lambs. (Smith 
and Linggood, 1972). The adhesin is now known as K99 adhesin (0rskov 
et al., 1975) and has since been found on some atypical strains of
E. coli isolated from piglet neonatal diarrhoea (Moon et al., 1977). 
Burrows et al.(1976) concluded that the K99 adhesin is responsible 
for both adhesive and haemagglutinating (of sheep erythrocytes) 
properties of K99 positive E. coli strains. Both the K88 (Smith and 
Linggood, 1971) and the K99 (Smith and Linggood, 1972) adhesins 
are governed by transmissible extrachromosomal genes or plasmids.
K99 adhesin isolated by acetate precipitation from E. coli B41 
(the established K99 reference strain) was found to be anionic 
with pi of 4.2 and to agglutinate guinea pig and sheep erythrocytes 
(Morris et al., 1978a). Similarly, Burrows et al.(1976) reported 
that the K99 adhesin isolated from a K12 (K99^) recombinant by 
ammonium sulphate precipitation was cationic with a pi of lO and 
failed to agglutinate erythrocytes from either guinea pigs (Isaacson,
1977) or sheep (Morris et al., 1978a). Subsequent work by Morris 
et al.(1978b) showed that cell-free K99 adhesin from the reference 
strain B41 is composed of two antigenically distinct components, an
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anionic component with stable haemagglutinating activity and a 
cationic component with a labile haemagglutination reaction.
More recently, it was shown that both canponents adhere to calf 
brush borders (Morris et al., 1980a). As with the case pf piglets, 
lambs can be passively protected from diarrhoea after oral challenge 
with a virulent enteropathogen by ingestion of colostrum from dams 
vaccinated with K99 vaccine (Sojka e^ al., 1978). This was attributed 
to the neutralisation of the adhesive properties of the K99 
positive E . coli by colostra1 antibodies (Morris et al,, 1980b)
The general characteristics of the K88 and K99 adhesins are shown 
in Table 25. More details about bacterial adhesion can be found 
in a number of reviews (Carpenter, 1932; McClelland, 1979; Porter, 
1979; Arbuthnott and Smyth, 1979; Du Pont and Pickering, 1980).
Reiter and Brown (1976) briefly reported that bovine milk fat 
globule membranes have the ability to inhibit the agglutination 
by K99 adhesin of sheep erythrocytes. In view of the availability 
of surface glycopeptides of bovine milk fat globule membrane (MFGM) 
it was decided to investigate their possible involvement in the 
interaction of the K99 adhesin with the brush border membrane, the 
suggestion being that certain membrane components might be common 
to bovine epithelial membranes. In the first instance the 
interaction of K99 adhesin with MFGM components was investigated 
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K99 adhesin from E. coli reference'-strain B41 was kindly supplied 
by Dr. J.A. Morris, Central Veterinary Laboratory, Weybridge,
Surrey, U.K. Fucose, mcinnose, galactose, glucose, N-acety 1-glucosamine 
and N-acetylgalactosamine were all obtained frcm Sigma Chemical Co., 
London, SW6. Sephadex gels were from Pharmacia Ltd., London W5. 
Phosphate buffered saline (PBS) tablets were obtained frcm Oxoid 
Ltd., Basingstoke, Hants, U.K. Microtiter plates were obtained from 
Sterilin Ltd., Teddington, U.K. Anti A and Anti B antibodies 
were generous gifts from Dr. D.J. Anstee, South West Regional Blood 
Transfusion Center, Southmead, Bristol.
Fresh bovine milk was obtained from Friesicin cows in mid-lactation 
cuid each sangle was a pool from four individual animals. Human milk 
was from individual volunteers in established lactation.
Human blocxi type A and B was from individual volunteers.
University Medical Centre. Sheep blood was obtained from Flow 
Laboratories, England, and calf blood from Tissue Culture Services, 
England.




Milk fat globule agglutination assay
The milk fat globule agglutination assay was carried out using 
the K99 antigen as described for lectins in the previous section. 
Inhibition studies were carried out by using free sugars and bovine 
MFGM-derived sialoglycopeptides. The inhibitor was serially 
diluted (2x) and incubated at 26°C for 15 min with four agglutinating 
doses of the K99 antigen followed by addition of globule suspension 
prepared as described in the previous section. The starting concen­
trations of the inhibitors were 1 M in the case of free sugars and 
8 mg/ml in the case of sialoglycopeptides. Agglutination titres are 
expressed as the reciprocal of the minimum dilution of the K99 antigen 
giving agglutination of less them 30% of the total fat globules. 
Inhibition titres are expressed as the minimum concentration of the 
inhibitor required to inhibit four agglutination doses of the K99 
antigen.
Haemagglutination assays
Blood samples were washed and 3% cell suspensions were prepared 
as described in the previous section. For the haemagglutination 
assays, test cells (50 pi,of 3% suspension) were mixed with K99 
antigen (50 yl) and allowed to stand in the well of a microtitre 
plate for 1 h at 26°C. Absence of agglutination was indicated by 
the presence of a compact 'button' of cells at the bottom of 
the well. Inhibition studies were carried out by preincubating 
four agglutination doses of the K99 adhesin with inhibitor-containing 
buffer for 15 min at 26°C followed by addition of the cell suspension. 
Inhibition titres are expressed as stated for the globule assay.
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Bovine MFGM-derived sialoglycopeptides
Sialoglycopeptides were cleaved off intact washed bovine milk 
fat globules by treatment with pronase as described in Section A.
The pronase digested membrane materials were fractionated on 
Sephadex G-50 to give a major peak which, when fractionated by 
ion-exchange chrcmatography gave two fractions SP and SR (Section A). 
The SR glycopeptide fraction was shown to contain high concentrations 
of galactose and N-acetyIgalactosamine whereas the SP fraction was 
shown to contain high concentrations of mannose and N-acetyIglucosamine,
chemical and enzymic modifications of the sialoglycopeptides 
were carried out as described in Section A.
Gas liquid chromatography
Quantiative estimation of individual sugars in the K99 adhesin 
as their alditol acetate derivatives was carried out by gas liquid 
chromatography as described in Section A for the glycopeptides.
Samples containing 2.4 mg protein of the adhesin were derivatized . 
and aliquots (1 yl containing 120 yg protein) were injected onto 
columns (2 m x 0.2 cm) of coiled glass containing 3% OV-225 
on H.P. Gas Chrom Q. Chromatography was done isothermally at 
200°C with a flow rate of 45 ml/min. The instrument was a Perkin- 




Agglutination by K99 adhesin of intact cells and fat globules
K99 adhesin was found to agglutinate sheep red blood cells 
7-8with a titre of 2 , in accordance with the presently accepted use
of this system as a measure of K99 adhesin activity (Burrow et al., 
1976; Morris et al., 1980 a) .
Washed bovine milk fat globules were also agglutinated by 
similarly high dilutions of K99 adhesin, suggesting that bovine 
intestinal cell membrane receptors for the adhesin ard also present 
on bovine milk fat globules. In accord with the demonstrated 
species specificity of the pathogenicity of the parent K99-bearing 
strain of E. coli, human milk fat globules were not agglutinated 
by K99 adhesin.
In contrast to bovine milk fat globules, calf red blood cells 
were not agglutinated by K99 adhesin. Human erythrocytes were, on 
the other hand, agglutinated, type A cells being more strongly 
affected than type B cells.
The agglutination titres are listed in Table 26.
Inhibition of agglutination of bovine MFG by glycopeptides of
bovine MFGM origin
Sialoglycopeptides were cleaved from intact bovine milk fat 
globules as described in Section A. and partially purified by gel 
filtration on Sephadex G-50. Material corresponding to the major 
hexose-sialic acid peak (Fig. 25) was freeze-dried and tested as an
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Agglutination titres
Sheep blood cells 2?-8
Bovine milk fat globules 24-5
Human milk fat globules -ve
Calf blood cells -ve
Human type A cells 2^-8
Human type B cells 2^-5
Table 26. Agglutination titres of a range of blood cells and milk 
fat globules by K99 adhesin. Titres are expressed as 
the reciprocal of the minimum dilution of the K99 giving 
no agglutination.
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inhibitor of agglutination of bovine milk fat globules as described 
in the Materials and Methods section. This material, referred to as 
PP (partially purified) sialoglycopeptide, showed an inhibition titre 
of 1^3.mg/ml (Table 27).
Further fractionation of PP-sialoglycopeptide by ion-exchange 
chromatography on DEAE Sepharose CL6B allowed separation of a sialic 
poor (SP) and a sialic acid rich (SR) glycopeptide as described in 
Section A (pp. 72-76 ) . Both of these glycopeptides showed increased 
inhibitory activity in the bovine fat globule agglutination assay 
relative to that of the precursor (PP glycopeptide) but the activity 
of the SR glycopeptide was particularly strong (Table 27).
In order to try and determine the relative contributions of 
the various components of the sialoglycopeptide molecules to their 
inhibitory activity, both SR and SP glycopeptides were systematically 
modified in a number of ways and the modified glycopeptides were 
examined as inhibitors of the agglutination assay. Thus desialylation 
of either SR or SP sialoglycopeptides increased the inhibitory activity 
by a factor of 2.3 fold showing that the activity was not simply a 
non-specific anionic effect (Table 27) . In order to assess the contri­
bution made by the carbohydrate components of the glycopeptides to 
their inhibitory activity, both SR and SP glycopeptides were treated 
with periodate (Section A, pp.93,103 ) and reassayed. Again the 
result was the same in both cases but this time showed complete 
abolition of inhibitory activity suggesting the importance of the 
carbohydrate in this respect. This conclusion was supported by 
further experiments in which approximately 50% of the carbohydrate
■ 206
Inhibitor Inhibition titre
PP sialoglycopeptide 1.30 mg/ml
Alkaline borohydride treated pP 2.60 mg/ml
SR glycopeptide 0.08 mg/ml
Desialylated SR 0.04 mg/ml
Periodate oxidized SR -ve
T. Foetus treated SR —ve
Alkaline borohydride treated SR 0.04 mg/ml
SP glycopeptide 0.66 mg/ml
Desialylated SP 0.2 mg/ml
Periodate oxidized SP -ve








Table 27. Inhibition titres of K99-induced agglutination of
bovine MFGs by MFGM-derived sialoglycopeptides and a range 
of free monosaccharides. Titres are expressed as the 
minimum concentration of the inhibitor (in the final 
volume) required to inhibit the agglutination of bovine 
MFGs by four agglutination doses of the K99 adhesin.
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residues of both SR and SP glycopeptides were removed by a mixture 
of glycosidases from Trichomonas foetus (Section A, pp. 97, 107) 
and the treated glycopeptides failed completely to inhibit the 
agglutination of bovine milk fat globules (Table 27). In contrast 
to these findings, however, treatment of the SR glycopeptide with 
alkaline borohydride, designed to remove O-glycosidically-linked 
oligosaccharide residues from the glycopeptide slightly increased 
its inhibitory activity. Corresponding treatment of PP-glycopeptide, 
on the other hand, led to a two fold decrease in inhibition potency 
(Table 27).
In view of the evidence, obtained from periodate and glycosidase 
treatment, of the inportance of carbohydrate residues to the ability 
of the MFGM sialoglycopeptides to inhibit agglutination, the 
effect of various monosaccharides on the agglutination assay was inv­
estigated. As can be seen from Table 27, only N-acetylgalactosamine 
showed any ability to inhibit the agglutination of bovine milk 
fat globules and even this sugar was only effective at relatively 
high concentrations.
The Thomsen-Friedenreich, 3-D-galactopyrcinosyl-(l->3)-N-acetyl- 
D-galactosamine, is known (Section A)to be a major component of 
the SR glycopeptide and the antigen, or more accurately, its reduced 
form, 3“D-galactopyranosyl-(l-»-3) N-acetyl-D-galactosaminitol was 
examined as a potential inhibitor in the agglutination assay. No 
inhibition could be demonstrated at the levels of the disaccharide 
(0.33 mg/ml) tested.
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Inhibition of agglutination of sheep erythrocytes by glycopeptides 
from MFGM
The modified sialoglycopeptide fractions from bovine MFGM were 
tested for their ability to inhibit the agglutination of sheep red 
blood cells. Inhibitions were in all cases less powerful than in 
the corresponding case for bovine milk fat globules but the general 
tendencies were the same (Table 28). Thus inhibitory activity 
was slightly increased by desialylation or alkaline borohydride 
treatment of the glycopeptide and completely destroyed by corres­
ponding treatment with periodate or glycosidases. N-acetylgalactosamine, 
alone among the monosaccharides tested, was capable of inhbiting 
the agglutination of erythrocytes and this required relatively high 
concentrations of the sugar (O.5 M).
Carbohydrate composition of the K99 adhesin 
The purified K99 adhesin was subjected to hydrolysis and 
carbohydrate analysis exactly as described in Section A for milk fat 
globule-derived sialoglycopeptides. The results of gas chromato­
graphic analysis of individual monosaccharide components 




PP Sialoglycopeptide 2.0 mg/ml
Alkaline borohydride treated PP 4.0 mg/ml
SR glycopeptide 2.0 mg/ml
Desialylated SR 1.0 mg/ml
Periodate oxidized SR -ve
T. Foetus treated SR -ve
Alkaline borohydride treated SR 1.0 mg/ml
SP Glycopeptide >10.0 mg/ml
Desialylated SP 8.0 mg/ml
Periodate oxidized SP -ve








Table 28. Inhibition titres of K99-induced agglutination of
sheep erythrocytes by MFGM-derived sialoglycopeptides 
and a range of monosaccharides. Titres are expressed 
as the minimum concentration of the inhibitor required 
to inhibit the agglutination of sheep erythrocytes by 
four agglutination doses of the K99 adhesin.
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The ability of certain bacteria to adhere to biological membranes 
is recognised as being a fundamental requirement for colonisation 
of the host vivo. With pathogenic organisms adhesive mechanisms 
can be of paramount importance for these strains to be established 
in preference to normal commensals. In particular this phencanenon 
plays cui important role in the pathogenesis of enteric infections 
cuid dental plaque. While it is clear that adhesion is an inportant 
factor in pathogenicity the biochemistry of the process in general 
is poorly understood, A clear understanding of the biochemical basis 
of adherence requires knowledge of the surface components on the 
pathogen responsible for adherence and knowledge of the corresponding 
receptor(s) on the tissue cells of the host. Model systems may 
play a valuable role in defining such receptors and consequently 
the mechanisms involved in the adhesion process. In this respect 
haemagglutination techniques can often prove useful and, indeed, 
an association of adhesion and haemagglutinating properties is now 
well recognised in many species of Enterobacteriaceae (Duguid et a^., 
1955; Duguid and Gillies, 1958). Thus, the ability of the K88 
adhesin of procine enteropathogenic E. coli to effect haemagglutination 
of guinea pig erythrocytes has been used in detection (Jones and 
Rutter, 1974) and in correlation of the adhesin with adhesion.
(Gibbons et al., 1975). More recently. Parry and Porter (1978) 
showed that chicken erythrocytes can provide a useful model for 
defining the underlying mechanisms of interaction between K88 
adhesin-bearing E. coli and host cell membranes. Burrow et al.
(1976), on the other hand, showed that K99 adhesin activity is 
readily demonstrated by haemagglutination of sheep erythrocytes 
and brush border attachment tests. This was later confirmed by
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Morris et (1980a) who showed that the anionic component of the 
K99 adhesin which is able to adhere to calf brush borders also 
agglutinated sheep, guinea pig and horse erythrocytes. The cationic 
component, on the other hand, failed to adhere to calf brush 
borders and also to agglutinate sheep erythrocytes (Isaacsson,
1978; Morris et al., 1980a) but was able to agglutinate horse 
erythrocytes (Morris et al., 1980a). From these results it was 
concluded that the adhesin(s) for calf brush borders are carried 
on the structure that haemagglutinates sheep erythrocytes.
Reiter and Brown (1976) have briefly reported that the agglutin­
ation of sheep erythrocytes ty the K99 adhesin could be inhibited 
by bovine MFGM preparations. Following this report and in view of 
the establishment of the milk fat globule agglutination assay 
(Section B)^ it was decided to investigate tiie use of bovine MFGM 
as a model system, in which to study the interaction of the K99 
adhesin with intestinal brush border membranes.
Bovine milk fat globules were found to be agglutinated by 
relatively high dilutions of K99 adhesin while human milk fat globules 
were not agglutinated even by undiluted adhesin. In view of the 
fact that the K99-bearing strain of E. coli (B41) is pathogenic to 
calves but not to humans, this suggests that the specific receptor 
for the adhesin is, as hoped, common to and specific for the 
epithelial membranes of the intestinal and mammary cells of the 
ccM. The specificity of agglutination was further demonstrated 
by the inability of K99 adhesin to agglutinate calf erythrocytes. 
Insofar as erythrocytes and milk fat globules of particular species
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have been systematically compared with regard to their surface 
properties, it has been found that there is little similarity 
to be found in the glycopeptide components of the two membranes 
(Newman et al., 1976a,b; B, pp. 182-193) . Further evidence
of the differences between fat globules and erythrocytes from the 
same species was provided by the observation that, unlike human 
globules, human erythrocytes cind particularly type A cells were 
readily agglutinated by relatively high dilutions of the K99 
adhesin. This supports the above arguments and raises the possibi­
lity that N-acetylgalactosamine is important in receptor binding 
sites for the K99 adhesin.
In an approach to defining the molecular nature of the 
receptor(s) for K99 adhesin on the surface of bovine milk fat 
globules experiments were carried out in which the agglutination 
of bovine milk fat globules by K99 adhesin was inhibited by MFGM 
surface components. Thus, agglutination was found to be strongly 
inhibited by a crude sialoglycopeptide fraction (PP) cleaved by 
proteolytic enzymes from bovine milk fat globules suggesting that 
the PP sialoglycopeptide carries at least part of the K99 adhesin 
receptor(s). When the PP sialoglycc^eptide was further fractionated 
by ion-exchange chromatography the resulting fragments (SP and SR 
glycopeptides)showed increased inhibitory activity in the bovine 
milk fat globule agglutination assay relative to that of the 
precursor glycopeptide. The activity of the SR glycopeptide was 
particularly strong with an end point of 0.08 mg/ml which represents 
over sixteen fold increase following ion-exchange. These results 
strongly suggest that the major receptors for K99 adhesin on the 
surfaces of bovine milk fat globules are carried on the SR glycopeptide
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fraction. It initially seemed possible that the inhibitory activity 
of the SP and SR glycopeptides might simply reflect the presence 
of negatively-charged sialic acid units exerting a non-specific 
effect. In order to examine this possibility the sialoglycopeptides 
were individually desialylated by treatment with dilute acid and 
then retested as inhibitors in the agglutination assay. Far from 
being decreased, the inhibition actually increased following desialy- 
1ation indicating that the sialic acid residues were not the 
importcint factors in the inhibitory effect. A similar conclusion 
can be drawn from the observation that inhibitory activity also 
increased when the SR glycopeptide was treated with alkaline 
borohydride. Alkaline borohydride is k n o m  to remove oligosaccharides 
rich in sialic acid (SectionA) and it appears that the sialic acid 
residues might be acting to shield the true receptors from interacting 
with the adhesin.
Treatment of either SR or SP glycopeptide with periodate 
resulted in the abolition of their inhibitory activity suggesting 
that the carbohydrate residues on the glycopeptides are important 
in their interaction with the K99 adhesin. It is possible, however, 
that loss of activity as a result of periodate treatment of the 
glycopeptides could have resulted from the oxidation of amino acids, 
particularly hydroxy amino acids, in the glycopeptide chains. Spiro 
(1964) has stressed that the molar ratio of periodate:glycoprotein 
is critical if the specific destruction of carbohydrate is to be ensured 
and recommended ratios of 100:1 and 300:1 for this purpose.
Ratios in excess of these values could lead to oxidation of protein 
residues. In our experiments the ratio of periodate:glycopeptide was
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within these limits (200:1) and the loss of activity of the periodate- 
treated SR and SP glycopeptides can most probably be attributed solely 
to the destruction of carbohydrate residues.
In order to further examine this conclusion both SR and SP 
glycopeptides were treated with mixed glycosidases from T. foetus 
before being examined as inhibitors of the agglutination assay.
Neither the SR glycopeptide nor the SP glycopeptide retained its 
inhibitory activity in the bovine milk fat globule agglutination 
assay following exposure to glycosidases. These observations 
strongly support the idea that carbc^ydrates are important in the 
interactions of the K99 adhesin with the bovine MFGM-derived 
sialoglycopeptides and by implication with bovine MFGM itself. As 
a check on the extent of deglycosylation brought about by the 
glycosidase mixture, the residual polypeptides were analysed by 
gas-liquid chromatograjdiy when it was found that approximately 42% 
and 78% of total carbohydrate had been removed frcxn the SR and SP 
glycopeptides respectively. It has been shown by others (Watkins, 
1966a; Westwood ejt al., 1976) that the T. foetus mixture is free 
from protease activity.
Inhibition studies us£ct the particular carbohydrate residues 
that are involved in the binding of the K99 adhesin to bovine MFGM.
Of these monosaccharides only N-acetylgalactosamine was able to 
specifically inhibit the agglutination of bovine milk fat globules 
by the K99 adhesin. Even in this case relatively high concentrations 
(0.5 M) was required before an effect was observed. The inhibitory 
activity of N-acetylgalactosamine helps to explain the fact that the 
K99 adhesin reacted more strongly with human type A erythrocytes
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than with type B erythrocytes and supports the finding that the 
SR glycopeptide, which has high levels of N-acetylgalactosamine, 
was the most active glycopeptide in the inhibition assay. Furthermore, 
the failure of the K99 adhesin to interact with the human milk fat 
globules might well be partially explained by their lacking exposed 
N-acetylgalactosamine on their surfaces (Section B).
As N-actylgalactosamine is part of the Thomsen-Friedenreich 
(TF) antigen (g-D-galactopyranosyl- (l-»"3) -N-acetyl-D-galactosamine) 
and in view of the presence of relatively high levels of the substi­
tuted TF antigen in the SR glycopeptide (Section A) it was thought 
that the K99 adhesin might actually have specificity for the TP 
antigen. As shown in SectionA, treatment of the SR glycoptptide 
with alkaline borohydride resulted in the release of the tetra- 
saccharide N-acetylneuraminyl- (2+3) -B-D-galactopyrahosyl- (1+3) -Ĵ 
N-acetylneuraminyl-(2+6)J -N-acetyl-D-galactosamininitol. Mild 
acid hydrolysis (0.2 N HgSO^, 80°C, Ih) of this tetrasaccharide 
followed by ion-exchange chromatography on DEAE-Sepharose CL 6B 
resulted in the isolation of the free reduced TF antigen (B-D- 
galactopyranosyl-(1+3)-N-acetyl-D-galactosaminitol). E^q>eriments 
using the reduced TF antigen at a concentration of 0.33 mg/ml 
showed no inhibitory activity. In fact the failure of the TF 
antigen to interact with the K99 adhesin might with hindsight, 
have been predicted frcxn the fact that the K99 adhesin failed to 
agglutinate human milk fat globules, which were shown (Section B) 
to have high levels of the unsubstituted (free) TF antigen exposed 
on their surfaces. However,higher concentrations of the TF antigen 
should be used in the assay in order to confirm the above conclusion.
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These concentrations were in practice limited by shortage of 
material. The results of alkaline borohydride treatment of the 
sialoglycopeptide are not clear cut. Alkaline borohydride treatment 
of glycoproteins releases the alkali-labile oligosaccharide chains 
which are 0-glycosidically-linked to serine or threonine via 
N-acetylgalactosamine residues. Thus, one might expect that treatment 
with alkaline borohydride would result in the release of all N-acetyl­
galactosamine of the glycopeptide as this sugar is usually confined 
to O-glycosidically-linked ccxnplexes. However, gas liquid chromato­
graphy of the residual glycopeptide showed that only approximately 
53%of the N-acetylgalactosamine was released by these means. The 
slight increase in inhibitory activity of the SR glycopeptide following 
alkaline borohydride treatment matches that brought about by simple 
desialylation and can perhaps best be explained in terms of unmasking 
of an underlying (galactosamine-containing) carbohydrate structure.
From the data discussed above it can be concluded that 
carbohydrate complexes - containing N-acetylgalactosamine are the 
most likely candidates as the K99 receptors on the surfaces of 
bovine MFGM and by extension also the intestinal epithelial membrane.
Similar inhibition experiments carried out with agglutination 
of sheep erythrocytes rather than bovine milk fat globules gave 
essentially parallel results. Thus,the MFGM-derived sialoglyco­
peptides and their modified derivatives inhibited agglutination 
according to the same pattern although the inhibitory activities 
were less in the case of sheep erythrocytes. The parallel results 
from bovine milk fat globule and sheep erythrocyte agglutination
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assays stresses the point that the bovine milk fat globule assay 
is, indeed, a valid assay to demonstrate the activity of the K99 
adhesin vitro. The use of milk fat globules in general as a 
model system for epithelial membranes is of considerable potential 
importance although it is premature to draw decisive conclusions 
as more detailed studies are needed to establish possible correlations 
between different adhesins and milk fat globule membranes of their 
respective hosts as well as other susceptible animals. Such 
studies may well lead to the establishment of the MFGM as a tool in 
studying the biochemical basis of the adhesion process.
The chemical nature of the K99 adhesin is not clear. Morris e^ 
al. (1977) concluded that the K99 adhesin of E. coli B41 is a 
glycoprotein with a terminal N-acetylgalactosamine moiety which is 
responsible for or involved in the K99 haemagglutination activity 
i.e. receptors for this sugar are present on the external surface 
of sheep erythrocytes. This conclusion was based on two observations 
firstly the loss of K99 adhesin activity following its treatment 
with periodate and secondly the great reduction (by 132 haemagglutination 
units) of the K99 haemagglutinating activity following its absorption 
iufth human anti A (anti GalNAc) substance. They could, however, 
not support this conclusion by using glycosidases. In contrast to 
the findings of Morris e_t al. (1977) , Isaacsson (1977) reported that 
the total carbohydrate content of the K99 adhesin isolated from K12 
(K99^) recombinant was only 0.6% and failed to detect the presence 
of either N-acetylglucosamine or N-acetylgalactosamine. Our experiments 
on the K99 adhesin (provided by Dr. J.A. Morris) showed that the 
total carbohydrate content was only 1.44% which suggests that these
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low levels of carbohydrate represent simply contaminations of the 
protein adhesin molecule. Such contaminations may well arise from 
the cell wall of the bacterium during the process of isolation.
With regard to N-acetylgalactosamine, its apparent concentration 
in the adhesin was 0.2%. Such a concentration is unlikely to account 
for the activity of the adhesin as relatively high concentrations 
of the free sugar were required before any inhibition of the 
haemagglùtination or milk fat globule agglutination assays were 
observed. The loss of haemagglutination activity of the K99 adhesin 
following its treatment with periodate could be explained by 
oxidation of hydroxy amino acids which might be present in the K99 
adhesin as suggested by Morris ét al. (1977). As stated before,
Spiro (1964) has stressed that the molar ratio of periodate:glyco­
protein is critical if the specific destruction of carbohydrate 
is to be ensured, and reccanmended ratios of between 100:1 and 
300:1 for this purpose. Ratios in excess of these values could lead 
to oxidation of protein residues. On the other hand, Westwood et.al.
(1976) showed that treatment of Carcinoemberyonic antigen with 
concentrations as low as 5 mM of periodate resulted in an undesired 
cleavage of the protein chain together with the destruction of 
30 - 60% of tyrosine and 60% of tryptophan. It is accordingly 
difficult to attribute the loss of the haemagglutinating activity 
of the K99 adhesin to concomitant loss of carbohydrate alone.
The position regarding the K88 adhesin is presently similar in that 
the K88 adhesin is regarded as a pure protein usually contaminated 
with carbohydrate (Stirm et al., 1967). The native filamentous 
structure of the K99 adhesin, its subunit structure and its physical 
location on the bacterial cell envelope are consistent with its 
being pilus or pilus-like structure (Isaacsson,1977). The pili are
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elongated filamentous protein-containing structures that ride on 
the outside of the bacterial cell envelope (Brinton, 1965).
From the above discussion it can be concluded that the K99 
adhesin of E. coli B41 is almost certainly a protein with some carbo­
hydrate contamination. It can be assumed to have specific binding 
sites for carbohydrate determinants, containing N-acetylgalactosamine, 
on the surfaces of bovine milk fat globules and sheep erythrocytes 
and presumably also on the intestinal epiethlial manbraines of the 
calf host. As the attachment of the K99 adhesin to bovine milk 
fat globules and sheep erythrocytes can be specifically inhibited 
by N-acetylgalactosamine, the K99 adhesin can be regarded as a 
lectin in accordance with the definition of lectins proposed by 
Goldstein et al., (1980) and Kocourek and Horejsi (1981).
The establishment of the bovine MFGM as a model system for 
studying the interaction of the K99 adhesin with the intestinal 
epithelial membranes should contribute to the state of our knowledge 
about the biochemical basis of the process of adhesion. The advantages 
of this model system over that of sheep erythrocytes can be summarised 
in two main points:
(i) Being from the same species, the bovine MFGM and calf
brush border membranes are expected to have more common 
surface receptors than the sheep erythrocytes and calf 
brush border.
(ii) The bovine MFGM is an easily obtainable source that
can be isolated in relatively pure form without cytoplasmic
contaminations.
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Suggestions for further work
(1) Isolation of plasma membranes from the mammary, epithelial cells 
would allow analytical comparison with the MFGM. The availability 
of antisera against whole MFGM and its isolated sialoglycopeptides 
would aid in the use of the comparative immunochemistry of
the two membranes. Such examination would establish whether 
any major change in the surface components of the MFŒ4 occurs 
during the process of milk secretion and would also provide 
more direct information about surface antigens of the mammary 
cell. Indeed, such information could help to identify any 
antigens that might be associated with disease such as breast 
carcinoma.
(2) Further studies are required to establish the glycosidic linkages
of the carbohydrate moeities of the SP glycopeptide fraction
and their contribution to the overall antigenicity of bovine 
MFGM, particularly in view of the evidence (Section A) that 
anti SP glycopeptide antisera and anti whole MFGM antisera 
showed similar spécificités towards N-acetyl-D-glucosamine.
The combination of data, derived by enzymic degradation with 
specific exoglycosidases coupled with periodate oxidation and 
méthylation analysis, would result in the accurate proposal 
of the structure of the carbohydrate chains.
(3) Further studies are needed to establish any correlation, if any,
between MFGMs from a range of different species and species-
specific bacterial adhesins. These studies could be carried 
out as described in Section C.
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Presence of the Thomsen-Friedenreich Antigen on the Surface of 
Normal Human .Milk Fat-Globule Membrane
G R A H A M  H. F A R R A R . RO G ER H A R R IS O N  and N A  EL A. M O H A N N A  
Department o f Biochemistry, University o f Bath, Bath B A l l  A Y , U.K.
The Thomsen-Friedenreich antigen has been identified with the disaccharide ^-d- 
galactopyranosyl-(l-^3)-iV-acetyI-D-galactosamine and its presence in masked (i.e. 
sialylated) form has been demonstrated on a number of mammalian membranes (Vaith 
&  Uhlenbruck, 1978; Farrar &  Harrison. 1978). AntKThomsen-Friedenreich) anti­
bodies are normally present in all human sera and the exposed Thomsen-Friedenreich 
antigen is not generally found on human cell surfaces. Springer et al. (1975). however, 
have reported that the Thomsen-Friedenreich antigen is exposed in breast carcinoma, 
but not in normal breast tissue and that concentrations of anti-(Thomsen-Friedenreich) 
antibodies are decreased in a relatively high percentage of cancer patients. In contrast, 
Klein etal. (1978) have used fluorescein-and ^H-!abelled peanut (.4roc/i«//.vpo^cfé’û) agglu­
tinin to show the present of exposed Thomsen-Friedenreich antigen on the surface of 
mammary epithelial cells of healthy individuals, and other studies (R. Newman, per­
sonal communication) have failed to detect significant differences in the anti-(Thomsen- 
Friedenreich) titres of sera from normal and from breast-cancer patients. We have made 
use of lectin-induced agglutination of intact milk fat-globules to provide evidence for the 
presence of receptors for peanut agglutinin on the surface of normal human milk fat- 
globule membranes.
The milk fat-globule membrane is generally accepted as being derived from the apical 
cell membrane, and probably also from the Golgi vesicle membrane, of the mammary 
secretory cell ( Patton &  Keenan, 1975; Powell e /a/., 1977; Wooding, 1977). The presence 
of antigens on the surface of the milk fat-globule membrane may accordingly be taken as
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evidence that such antigens are also present on the mammary cell membrane. Samples 
of human milk were taken from healthy individuals, including a range of ABO and M N  
blood types, and incubated with serial dilutions of the following lectins: Lens culinaris, 
Lotus tetragonohbus. Helix pomatia, Triticum vulgaris, Ricinus communis, Ulex europeus, 
peanut agglutinin, Dolichos bijiorus, Vidagraminea. All the human milk samples tested 
were agglutinated by peanut agglutinin [specific for Thomsen-Friedenreich antigen 
(Lotan et al., 1975)], Ricinus communis (galactose). Lens culinaris (mannose) and 
Triticum vulgaris (H-3Lceiylgl\icosaaninc) at moderate dilutions and only poorly, or not at 
all, by the remaining lectins. In contrast with pooled bovine milk, which was agglutinated 
by moderate dilutions of most lectins tested, human milk was not rendered agglutinable 
by higher dilutions of peanut lectin after neuraminidase treatment. The results obtained 
with peanut lectin are consistent with the presence o f the Thomsen-Friedenreich antigen 
in an exposed, but not sialylated. form on the surface o f normal human milk fat-globule 
membrane. This has not previously been shown. Horisberger et al. (1977) used gold- 
labelled lectins and electron microscopy to demonstrate the presence of wheat germ 
agglutinin, soya bean agglutinin and concanavalin A receptors on human milk fat- 
globule membrane, but results with labelled peanut lectin were inconclusive. Glockner 
et al. (1976) found chemical evidence for the presence of unsubstituted ^-D-galacto- 
pyranosyl-( I — 3)-.V-acetyl-o-galactosamine in a glycoprotein fraction extracted from 
human milk fat-globule membranes although haemagglutination-inhibition techniques- 
failed to show the presence of the Thomsen-Friedenreich antigen in any form in the 
same glycoprotein fraction (Newman &  Uhlenbruck, 1977).
The present indication of the unsubstituted Thomsen-Friedenreich antigens on 
normal human milk fat-globules and, by implication, also on the mammary secretory 
cell membrane of healthy individuals supports the histochemical data of Klein et al. 
(1978) and accordingly questions the significance of the Thomsen-Friedenreich antigen 
as a tumour-associated antigen.
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Hydrogenation of the Polyunsaturated Lipids of Chloroplast Membranes 
and the Effects on Photosynthetic Functions 
C. R E STA LL,* D . C H A P M A N * and P. J. Q U T N N f
* Department o f Biochemistry and Chemistry, Royal Free Hospital School o f Medicine, 
University o f London, London f tC l.V  \BP, U.K., and f  Department o f Biochemistry, 
Chelsea College, University of London, London S W } 6LX, U.K.
Plant membranes, particularly those of the chloroplast, contain a high proportion of 
highly unsaturated lipids. Linolenic acid (C i8 :3 ), for example, usually accounts for 
about 70%  of the total fattv acyl residues associated with the galactolipids of higher- 
plant chloroplast lamellae (Douce ei al., 1973). It has been argued that a high proportion
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SURFACE CARBOHYDRATES OF HUMAN MILK FAT GLOBULE MEMBRANE 
R. Harrison, N. Mohanna and A. Safi *
Department of Biochemistry, University of Bath, Bath BA2 7AY, 
UK
Milk fat globule membrane is derived from the apical membrane of 
the secretory cell and accordingly represents a convenient model system 
for structural and immunodiemical studies of mammalian epithelial cell 
membranes.
The presence of specific mcnosacharide residues exposed on the 
outer surface of human milk fat globules was demonstrated by lectin- 
induced agglutination of washed globules. Thus galactose, N-acetyl- 
glucosamine and mannose were all detected by means of specific 
agglutination using ricinus, wheat germ agglutinin and lens lectins 
respectively.
The above sugars, together with ^acetylgalactosamine, sialic acid 
and fucose were released in the form of glycopeptides when washed human 
Bilk fat globules were incubated in the presence of Pronase. The 
sialoglycopeptides were fractionated by gel-filtration and ion-exchange 
chromatography to give apparently homogeneous fractions the sugar 
contents of which were analysed by gas-liquid chromatography. Alkaline 
borohydride treatment of purified sialoglycopeptides released sialic 
acid-containing oligosaccharides containing galactose and N-acetyl- 
galactosamine similar to those derived from bovine milk fat globule 
membrane (Farrar & Harrison, 1978).
The pronase-cleaved sialoglycopeptides obtained from human milk 
fat globule membrane were found to *ct as powerful inhibitors of a 
radioimmunoassay (Heyderman et al. (1979) designed to detect human 
epithelial cell membrane antigens. Application of this assay (in 
collaboration with Dr.M.G.Ormerod of the Ludwig Institute for Cancer 
Research) has allowed a preliminary characterization of the molecular 
structure of the antigenic determinants derived from the milk fat 
globule.
These studies not only provide a model system for studies of the 
molecular nature of cell surface antigens in general but also offer the 
possibility of defining antigens specific for epithelial cell membranes. 
Such antigens emd their corresponding antibodies have potential 
application in clinical monitoring of patients suffering frcxn breast 
cancer.
Farrar, G.H. and Harrison, R. (1978) Biochem.J. 171, 549-557
Heyderman, R,, Steele, K, and Ormerod, M,G, (1979) J.Clin,Path, 32,
35-39
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COMPARISON OF LECTIN RECEPTORS ON THE 
SURFACE OF HUMAN AND BOVINE M ILK FAT 
GLOBULE MEMBRANES
Graham H. Farrar. Roger Harrison and Na'el A. Mohanna 
Department of Biochemisirv. University of Bath. Bath BA2 7AY. England
(Received 6 February 1980)
Abstract—1. The accessibility of specific carbohydrate residues on the surfaces of intact bovine and 
human milk fat globules has been compared by means of a lectin-based agglutination assay.
2. The presence of galactose, mannose and/or glucose and .V-acctyl-D-giucosamine, but not fucose 
was detectable on both bovine and human globules.
3. The major differences between bovine and human milk fat globules were firstly, the presence on 
human globules of high amounts of Arachis hypogaea receptor, none of which was apparently masked by 
sialic acid and secondly, the presence of unsubstituted .V-acetyi-o-galactosamine on bovine but not on 
human milk fat globules.
INTRODLCTION
Cell surface carbohydrate groupings, both glycolipid 
and glycoprotein in nature, are known to be involved 
in a wide range of cellular recognition processes (Har­
rison &  LunL 1980) and while considerable data have 
been accumulated concerning surface structures of 
blood cells, much less is known about the carbo­
hydrate components of other mammalian cell mem­
branes.
The milk fat globule is surrounded by a membrane 
(M F G M ) that is derived from the apical plasma mem­
brane of the mammary secretory cell (Patton &  Kee­
nan. 1975; Anderson &  Cawston. 1975; Wooding, 
1977) and expressed globules accordingly constitute a 
convenient and large scale source of epithelial mam­
malian membrane for structural and immunological 
studies. Thus, human M F G M  has been used as a 
source of antigen believed to be specific for epithelial 
cells (Heyderman e( al.. 1979) and HLA-DR-like anti­
gens have been detected on human milk fat globules 
(Wiman ei al., 19"9). Evidence has also been 
presented (Reiter &  Brown. 1976) for the presence of 
specitic gut epithelial cell membrane receptors for £. 
coli on (he surface of bovine M FG M
Structural studies of M F G M  constituents have 
been largely concentrated on the bovine membrane 
Thus sodium dodecyl sulphate-poly aery lamide gel 
analysis of bovine M F G M  has indicated the presence 
of up to 8 glycoprotein components (Kobylka &  Car- 
raw a\ 19"2; .^nderaon ei al.. 19"4. Shimizu et ai, 
19“6. Murray ei al. I9"9i while certain major glyco­
proteins have been isolated from this source and 
chemically analysed i Basch et ai. 19"’6; Newman et 
ai. 19'6; Keenan et ai. l ‘̂ "7; Snow et ai. 19^7). More 
detailed compositional and structural studies of the 
carbohydrate components of bovine M F G M  have 
resulted from proteolytic cleavage of glycopeptides 
from the surface of bovine milk fat globules followed 
by purification and analysis (Harrison et ai, 1975; 
Farrar &  Harrison. 19~8). Human M F G M  has been 
very much less studied Electrophoresis has been used
to separate five lectin-receptor glycoproteins from the 
human membrane (Murray et ai, 1979) and the lectin- 
binding properties of a phenol-extracted glycoprotein 
mixture from the same source have been studied 
(Newman &  Uhlenbruck, 1977). Preliminary carbo­
hydrate analyses of glycopeptides cleaved by pro­
teases from human M F G M  have also been reported 
(Harrison et ai, 1979).
All the above-mentioned analytical studies have 
concerned glycoproteins extracted in various ways 
from fat globule membranes. Sugar residues exposed 
on the surface of intact fat globules may well be sub­
jected to differential extraction or to conformational 
changes during purification of glycoprotein fractions 
while glycolipid components are largely lost. It is 
clear that the contribution of carbohydrate structures 
to specific interactions of the milk fat globule mem­
brane and, by implication, also of the mammary 
epithelial cell membrane, can most directly be studied 
in the intact fat globule. Microelectrophoretic tech­
niques have been applied (Newman &  Harrison. I9 '3 ) 
in demonstrating the exposure of sialic aad on the 
surface of intact bovine milk fat globules but other 
sugars were not detectable by these means. More 
recently Horisberger et ai, (19"'') in an interesting 
electron microscopic study have shown the ability of 
certain gold-labelled lectins to bind in a specific man­
ner to the surfaces of human and bovine milk :'at 
globules. We now report the results of a comparative 
study of the accessibility of various sugar residues on 
the surfaces of intact human and bovine milk fat 
globules carried out by using a quantitative assay 
involving lectm-induced agglutination of intact fat 
globules.
M A TFR I VLS A N D  M E TH O D S
.Araihl', hvpoguea (peanut agglutminl. R;anus communis 
(types 1 and III Lens euhnaris. concanavalin \.  wheat germ 
agglutinin and Lotus tetragonolohus lectins were all 
obtained from Sigma (London) Chemical Co.. London 
S.\V 6. L K Source plant material for Soya bean, i lex
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eurupeus and Doluhos hitiorus lectins, extracted agglutinin 
from Helix pomatia and txped human red blood cells were 
generous gifts from Dr D J Anstee. South West Regional 
Blood Transfusion Centre. Southmead, Bristol, iicia 
graminea seeds were kindK supplied by Dr W. Dahr. 
Department of Immunobiology. Medical University Clinic 
Cologne PBS tablets were obtained from O.xoid Ltd. Bas­
ingstoke. Hants.. U K
Neuraminidase t V ihria comma (choleraei) was purchased 
from Bchringwerke, Marburg Lahn. G PR All other re­
agents were from BDH Chemicals Ltd.. Poole. Dorset 
U.K.
Fresh bovine milk was obtained from Friesian cows in 
mid-lactation and each sample was a pool from four mdivt- 
duai animals. Human milk was from individual volunteers 
in established lactadon.
Washed milk fat globules
Fresh milk (10ml) was centrifuged at 1500ÿ for lOmin 
at 22'C. The separated milk fat globules were resuspended 
in phosphate-buflcred saline. pH 7.3 (10 ml) and recentn- 
fuged under the same conditions. The washing procedure 
was repealed a further three times after which the milk fat 
globules were resuspended in phosphate-buffered saline 
pH 7.3. so as to give an optical density of approx 1.7 O D 
when read against water at ''00 nm.
yeuramtnidase treaiment of milk fat globules
Washed milk fat globules (from 5 ml original milk) were 
suspended in phosphate-buffered saline. (I ml). pH 5.6. con­
taining 1 mM CaClj and neuraminidase (50 jd. 1 i.u. ml) 
and the mixture was incubated at 37 C for 30 min. The 
treated globules were removed by centrifugation at 1500 g 
for 10 min and resuspenoed in phosphate-buffered saline. 
pH " 3 (5 mil The washing procedure was repeated a 
further three times after which the globules were rcsuv 
pended in phosphate-buffered saline as described above.
Lectin-induced ugglutination of milk Jut globules
A suspension of washed milk fat globules (20 1̂) pre- 
f>ared as described above was mixed with lectin solution 
(20jil( and phosphate-buffered saline (20 id) pH '.3. in a 
recessed microscope -.lide well and the agglutination was 
allowed to proceed at 22 C for 1 hr in a humid environ­
ment. The fat globules were examined at 100 x magnifica­
tion using a light microscope. Agglutination titres arc 
expressed as the reciprocal of the minimum dilution of 
lectin giving agglutination of less than 30", of the total fat 
globules.
Lectin solutions
Commeraally-obtained lectins were dissolved in 
phosphate-buffered saline. pH ~ 3. to an initial concen­
tration of 2 mg ml except in the case of Lotus tetragono- 
lohus when 1 mg ml was used. Samples were serially 
diluted (2 X 1 with phosphaie-butTered -aline for agglutina­
tion assays.
For lectin- extracted directly from plant material, dry 
source material 1 1 g) was ground m a mortar and added to 
phosphate-buffered saline. pH " 3. (10 mil at 4 C, The sus­
pension was homogenized (MSE bench homogenizer. 
6 X 30 seci at 4 C and allowed to stand at 4 C for a further 
5 mm before centrifugation at 14.000 i/ for 10 min at 4 C. 
The aqueous supernatant was extracted (3 /  1 voli with 
diethyl ether, separated and freed from residual ether in a 
stream of N; at 4 C
The activities of all iectin solutions were checked by 
demonstrating haemagglatination of neuraminidase- 
treated type 0. N \  red blood eell< (or native type A cells in 
the cases of Helix rvxruriu und Doluhos hirforusi by high 
dilutions of the lectin solution bpccilicities were confirmed 
by showing complete inhibition of haemagglutination 
caused by I'.iur haemajglatination doses of lectin tie bv
16 X less dilution than the haemagglutination titrei when a 
10 mM solution of the immunodominant sugar (20/il) was 
incubated with the lectin solution for 30 mm at 22 C prior 
to addition of red blood cells in the haemagglutination 
assay. The specificity of agglutination of milk fat globules 
was also checked directly by similar inhibition of three 
agglutination doses of lectin by 30 mM solutions of the 
respective immunodominant sugars. In the case of Arachis 
hypogaea specificity of milk fat globule agglutination was 
demonstrated by inhibition of three agglutination doses of 
the lectin by a purified glycopeptide fraction (see below) 
containing approx 0.3 mM Thomsen-Friedenreich antigen 
(Farrar. 1978) or by 10 mM concentrations of purified 
Thomsen-Friedenreich antigen obtained by alkaline boro­
hydride treatment of this peptide The glycopeptide 
remaining after alkaline borohydride treatment (Farrar. 
1978) did not show inhibition at concentrations up to 
2 mg, ml
Thomsen-Friedenreich antigen-rich glycopeptide
Sialoglycopeptides were cleaved from the surface of 
intact washed bovine milk fat globules and purified by gel 
filtration on Sephadex G-50 as described by Farrar & Har­
rison (1978). The sialoglycopeptidc mixture was further 
fractionated by ion-exchange on DEAE-Scphadex when 
elution with a linear gradient of pyridine acetate gave a 
sialic acid-nch glycopeptide fraction (Farrar. 1978). 
carrying a high concentration of sialic aad-substituted 
Thomsen-Friedenreich antigens (Farrar & Harrison. 1978). 
The purified glycopeptide was freed from sialic acid by 
treatment with neuraminidase and gel filtration on 
Sephadex G25 (Farrar. 1978). The carbohydrate com­
ponent of the resulting glycopeptide was largely composed 
of alkah-labile Thomsen-Friedenreich antigen together 
with smaller amounts of alkali-stable oligosaccharides.
Haemagglutination assays
Samples of human red blood cells (50®o suspension in 
aad-atrate dextrose anti coagulant) were diluted (to 10 ml) 
in phosphate-buffered saline. pH 7.3. and centrifuged at 
3500 g for 10 min. The pelleted cells were resuspended in 
phosphate-buffered saline and again centrifuged. This pro­
cedure was repeated three limes after which washed, pel­
leted cells were diluted (to 3"* v/v) in phosphate-buffered 
saline. pH 7.3. before use in agglutination studies.
Neuraminidase-treated cells were prepared by suspen­
sion of pelleted native red blood cells (0.5 ml) in phosphate- 
buffered saline. pH 5.6, (4.5 ml) containing 1 mM CaCI; 
and neuraminidase (50 uL 1 i.u. ml) and the mixture was 
incubated at 37 C for 30 min. Cells were freed from enzyme 
by repeated (3 x ) centrifugation at 3500 for 10 min and 
rcsuspension in phosphate-buffered saline. pH 7.3 (10 ml). 
Final packed, washed cells were suspended (3"q v v) as 
above for agglutination studies.
For the haemagglutination assay, test cells prepared as 
above (20/il suspension I were mixed with phosphate- 
buffered -.aline, pH " 2. (20/il) and lectin solution (20/il) 
and allowed to stand in the well of a miaotitre plate for 
1 hr at 3" C. Absence of agglutination was indicated by the 
presence of a compact "button” of cells at the bottom of 
the well.
RKSL LTS A N D  D IS C IS S IO N
Pooled bovine milk fat globules were found to be 
agglutinated by high dilutions of Ricinus conununis 
(types I and III. soya bean and wheat germ aggluti­
nins. concanavalin A and Helix pomatia lectin. In all 
cases agglutination was specifically inhibited by the 
corresponding monosaccharide receptor (Table 11. 
Specific agglutination by these lectins demonstrates
Lectin receptors on milk globules
Table 1. Agglutination titres of human and bovine milk fat globules with different lectins
Bovine milk fat globules* Human milk fat globulest
Native. Neuraminidase- Native, Neuraminidasc- 
Lectin washed treated washed treated
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i-s
Ru'inus communis type I 2*
(galactose. V-acetylgalactosamine)
Ricinus communis 2 '
type II (galactose)




Lens culinaris 2 ‘
(mannose glucose)



















































• Values are the means of titres obtained by using 5 samples of milk each of which was 
pooled from 4 individual cows.
t  Values are the means of titres obtained by using 20 samples of milk all from different 
individuals of varying ABO and M N blood groups. No differences in titre were observed 
with different blood groups.
the accessibility of galactose IRicinus types I and II. 
soya bean), mannose and or glucose (concanavalin .AL 
.V-acetyi-D-glucosamine (wheat germ agglutinin), and 
iV-acetyl-t>galactosamine {Helix pomaiiai on the sur­
faces of intact fat globules. Our observations are en­
tirely consistent with the results of mild proteolytic 
treatment of washed bovine milk fat globules which 
released, in soluble form, glycopeptides containing all 
these sugars together with sialic acid and fucose (Har­
rison <?r al., 1975). Low concentrations (1 mg ml) of a 
crude mixture of such glycopeptides purified on 
Sephadex G-50 (Farrar &  Harrison. 1978) were found 
to inhibit strongly the agglutination of bovine milk fat 
globules by all the above-mentioned lectins.
Although the presence of fucose in bovine M F G M  
glycopeptides has been demonstrated by gas chroma­
tography (Harrison et al.. 1975k this was not reflected 
in agglutination of the globules by either of the 
fucose-specific lectins, i  lex europaeus or Lotus tetra­
gonolobus. Horisberger et a i. (197") were similarly 
unable to demonstrate marking of bovine milk fat 
globules by gold-labelled anti-H lectin and it appears 
that although fucose is normally a chain-terminal 
unit, access to the sugar is hindered not only in the 
case of gold-labelled lectins but also in that of the 
underivatized reagents.
In contrast to the findings of Horisberger et al. 
(1977), specific interaction of bovine milk fat globules 
with peanut agglutinin {Arachis hypogaea) could be 
demonstrated by means of the agglutination assay
(Table 1 ). Peanut agglutinin has been shown (Lotan et 
al., 1975; Pereira et al., 1976) to have high affinity for 
the Thomsen-Friedenreich antigen. ̂ -i>galactopy rano- 
syl-(l-3FV-acetyl-D-ga!actosamine. and the involve­
ment of this dissacharide in the Arachis-induced ag­
glutination of bovine globules was further indicated by 
the fact that agglutination could be inhibited by low 
concentrations of a purified glycopeptide (Materials 
and Methods) rich in unsubstituted Thomsen-Frie­
denreich antigen (0.3 mM disaccharide). A letrasac- 
charide and two trisaccharides containing sialic acid- 
substituted Thomsen-Friedenreich antigen have been 
fully characterized (Farrar &  Harrison. 1978) in 
bovine MFGM-derived glycopeptides. The unsubsti­
tuted disaccharide was not speafically sought in these 
studies but has been detected (Newman et al., 19~'6) 
by haemagglutination-inhibition techniques in a phe­
nol-extracted glycoprotein fraction from bovine 
M F G M  Our present evidence for the exposure of 
unmasked Thomsen-Friedenreich antigen on the sur­
face of bovine milk fat globules clearly complements 
these latter findings and indicates that the presence of 
unsubstituted disaccharide in extracted glycoproteins 
does not result from artefactual cleavage of sialic acid 
residues during the extraction procedure. The failure 
of Horisberger er al. (1977) to mark bovine fat 
globules with gold-labelled peanut lectin could reflect 
a more restricted access of the bulky labelled reagent 
to the surface receptors.
As might be expected, pre-treatment of bovine milk
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fat globules with neuraminidase increased the 
Arachis-induced agglutination titre, consistent with 
the cleavage of sialic acid residues from the surface 
tri- and tetrasaccharides (Farrar &  Harrison. 1978) 
with consequent exposure of the Thomsen- 
Friedenreich antigenic core. It is of interest that Vida 
graminea, which is known (Uhlenbruck &  Dahr, 19" 1 ) 
to require the presence of Thomsen-Friedenreich 
antigen in its specific receptor site, only causes agglu­
tination of bovine globules after neuraminidase treat­
ment of the globules when the concentration of 
exposed disaccharide is increased.
The presence of .V-acetyl-D-galactosamme in an 
exposed form on the surface of bovine milk fat 
globules was shown by the specific agglutinations 
induced by Helix pomatia and Dolichos biflorus lec­
tins. This supports previous reports (Newman et a i. 
1976; Newman &  Uhlenbruck, 1977) that phenol- 
extracted glycoproteins from bovine M F G M  carry 
unsubstituted N-acetyl-D-galactosamine. The aggluti­
nation titre was slightly increased by neuraminidase 
treatment of the bovme globules.
Human M F G M  is less readily available than the 
bovine membrane and has been correspondingly less 
studied. Human milk fat globules were specifically 
agglutinated by high dilutions of Ricinus communis 
(type I &  IIL soya bean, concanavalin A, Lens and 
wheat germ agglutinins, demonstrating the accessi­
bility of galactose. (Ricinus. soya bean agglutinin) 
mannose and, or glucose (concanavalin A. Lens 
lectins) and .Y-acctyi-o-glucosamine (wheat germ 
agglutinin) on the surfaces of the intact fat globules. 
Agglutination of human globules by these lectins is 
generally similar to that of bovine globules although 
titres, particularly for concanavalin A and Lens lec­
tins were higher in the human case (Table I). Our 
results support electron microscopic data in which 
human milk fat globules were found to be marked by 
gold-labelled soya bean and wheat germ agglutinins 
and, although to a lesser extent, by concanavalin A 
(Horisberger et a i. 1977). The ability of intact human 
milk fat globules to bind soya bean aggiut iin con­
trasts with the behaviour of extracted hum? M F G M  
glycopeptides which, unlike the corresponding bovine 
extracts, interact weakly (Newman &  Uhlenbruck. 
1977) or not at all (Murray et a i. 1979) with soya 
bean lectin. It may be that soya bean lectin-induced 
agglutination of intact human milk fat globules and 
marking of the globules by gold-labelled soya bean 
lectin (Horisberger et ai, 1977) involve exclusively 
glycolipid-bound galactose. The increased inter- 
ctions (Table and Horisberger et ai. 1977) observed 
following neuraminidase treatment of the globules 
suggest, however, that glycoprotein-bound galactose 
is involved at least ,n the response of sialic acid-free 
globules to soya bean lectin because, as Horisberger 
et a i  (1977) have pointed out. M F G M  proteins mask 
membrane gangliosides from neuraminidase attack 
(Tomich et ai, 1976i
As with bovine globules, human milk fat globules 
were not agglutinated by the fucose-specitic lectins. 
Ulex europaeus and Lotu.s leirogonolohus although 
weak agglutination was detected with the latter lectin 
following neuraminida.se treatment of the human 
globules. Most lectins do. in fact, show increased ag­
glutination titres after treatment of either bovine or
human fat globules with neuraminidase. It is likely 
that such increases generally reflect unmasking of 
relevant sugar receptors as a consequence of the re­
moval of terminal sialic acid residues. It could be that 
enhanced agglutinability under such circumstances 
simply arises from non-speafic aggregation resulting 
from loss of surface negative charges although the 
unchanged .Arachis-agglutination titres of human fat 
globules following neuraminidase treatment argue 
against this.
The strong agglutination of human milk fat 
globules by peanut agglutinm (Table I) has been pre­
liminarily reported (Farrar et a i, 1979). As in the case 
of bovine fat globules, agglutination was specifically 
inhibited by low concentrations (0.5 mg, ml) of a puri­
fied glycopeptide rich in Thomsen-Friedenreich anti­
gen. (Materials and Methods.) Agglutination was also 
strongly inhibited by 10 mM Thomsen-Friedenreich 
antigen from the above glycopeptide but not by the 
residual glycopeptide (2 mgyml) from which the disac- 
charide had been removed (Materials and Methods). 
The exposure of unsubstituted Thomsen-Friedenreich 
antigen on the surface of intact human milk fat 
globules has not previously been demonstrated, al­
though Klein et a i  (1978) have provided evidence for 
exposure of the antigen on the surface of normal 
mammary epithelial cells from which the globule 
membrane is derived. These results are contrary to 
those of Springer et al. (1975) who found the 
Thomsen-Friedenreich antigen to be exposed on 
breast carcinoma but not in normal tissue. As is the 
case with soya bean aggluumn, peanut lectin appar­
ently behaves differently with extracted human 
M F G M  glycoproteins. Thus. Newman &  Uhlenbruck 
(1977) were unable to show inhibition of peanut 
lectin-induced agglutination of desialylated erythro­
cytes either by native or by desialylated human 
M F G M  glycoproteins indicating that the Thomsen- 
Freidenreich antigen was not accessible on their 
glycoprotein extract, despite the fact that it was 
detected chemicallv m the same fraction (Glockner et 
ai, 1976).
As mentioned above, human fat globules were not 
rendered more agglutinable by peanut lectin following 
their treatment with neuraminidase. This is in con­
trast to the behaviour of bovine milk fat globules and 
suggests that unlike the latter, human globules do not 
carry appreciable amounts of sialylated Thomsen- 
Friedenreich antigen in tri- and tetrasaccharide form 
(Farrar & Harrison. 1978) exposed on their outer sur­
face. These conclusions are supported by the results 
obtained using I Vctj grammea lectin which failed to 
agglutinate human fat globules even after neuramini­
dase treatment of the globules. Under similar circum­
stances the Thomsen-Friedenreich antigens of bovine 
milk fat globules were apparently unmasked suffi­
ciently to allow agglutination by high dilutions of 
Vicia graminea lectin, even though, as in the human 
ca'c. native globules were not agglutinated by the 
higiiest concentrations of lectin.
In contrast to bovine globules, human milk fat 
globules were agglutinated neither by Helix pomatia 
nor by Dolichos hiflorus lectins irrespective of the 
blood group of the human donor. It is of interest that 
donors of A-blood group specificity express the A 
antigen. \  -acety 1-D-galactosamine. on their red blood
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cells (b> definition) but not apparently on milk fat 
globules. The opposite is true of the bovine system in 
which unsubstituted Helix pomatia receptor has been 
detected on intact milk fat globules (Table 1) but not 
on erythrocytes (Kim &  Uhlenbruck, 1966). Results 
obtained from membrane-derived glycoprotein frac­
tions agree with these findings in the bovine (Newman 
et a i. 1976; Newman &  Uhlenbruck, 1977) but not in 
the human case, when Helix pomatia receptors were 
detected on phenol-extracted glycoprotein fractions 
from human M F G M  (Glockner et a i. 1976).
The milk fat globule agglutination assay employed 
in this study is a simple technique capable of rapidly 
providing quantitative information about the accessi­
bility of a wide range of membrane-bound sugar com­
ponents without the need for chemical devivatization. 
The method is applicable to surface antigens in gen­
eral and has been used to define immunodominant 
groupings of MFGM  by hapten inhibition studies 
using anti- (bovine M FGM ) antisera (Farrar & 
Mohanna, unpublished results).
Insofar as our findings overlap with the elegant but 
more limited studies of Horisberger et ai. 1977. using 
gold-labelled lectins, similar results were largely 
obtained by the two methods and occasional di filer- 
cnees (e.g. response to peanut lectin) can be explained 
in terms of hindered access of the relatively-bulky 
labelled lectins to the globule surface Differences 
between interactions of lectins with intact globules on 
the one hand and with isolated glycoproteins on the 
other, are more marked and could well reflect changes 
resulting from extraction in the latter case It may 
also be that glycolipids contribute significantly to the 
specific interactions of the M F G M  surface
One of the most significant differences between 
human and bovine M F G M  found by these agglutina­
tion studies IS the lack of effect of neuraminidase on 
peanut lectin-induced agglutination of human 
globules suggesting that the latter do not carry signifi­
cant amounts of the tri- and tetrasacchande residues 
which have been isolated from bovine globules (Far­
rar &  Harrison. 197Si, These oligosaccharides have 
been characterized in membranes of human erythro­
cytes (Thomas &  Winzler. 1969). rat brain (Finne. 
1975) and on other membranes (Krusius &  Finne. 
1977) and their apparent absence from human milk 
fat globules raises the problem of their function gener­
ally. A second major difference concerns the presence 
of Helix pomatia receptors on bovine but not on 
human milk fat globules despite the A-blood group 
specificitv of many of the human donors. It is an intri­
guing fact that in both these cases the structure 
present on bovine but not on human globules has 
been reported in human hut not in bovine erythrocyte 
membranes iKim &  Uhlenbruck. 1966. Thomas &  
Winzler. 1969; Emerson &  Kornfeld. 19~6).
The contributions of M F G M  lectin receptors to 
specific interactions of the milk fat globule, or more 
significantly, of the mammary epithelial cell mem­
brane. remain to be elucidated, but it is likely that 
these exposed sugar residues will be shown to play an 
important role in recognition processes involving 
mammary cells or epithelial cells generally.
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